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Chapter 1 includes the Introduction and literature review which describes current 
developments within the field of in vitro/vivo imaging of cancers, with a particular 
emphasis on the techniques employing fluorescence emission-based spectroscopy and 
imaging modalities. Examples are cited whereby graphene and its congeners have 
been used in conjunction with various fluorophores and peptide sequences as a means 
of achieving highly specific imaging probes. This section discusses aspects of energy 
transfer and the possibility that molecular probes can be designed to achieve both 
therapeutic goals and diagnosis (Theranostics). This review concludes with a 
discussion of the use of organic supramolecularly assembled imaging agents as a 
means of achieving thermodynamically controlled nano-constructs for the 
functionalisation of graphenes and their potential future applications as theranostic 
agents. 
Chapters 2, 3 and 4 describe the synthesis of chiral and naphthalene diimides (NDIs) 
which are fluorescent. Spectroscopic investigations in the solution phase are described 
and the propensity for aggregation in these systems is discussed. The specific nature of 
the self-assembly processes involved is explored in different solvent systems and in 
the solid state. Fluorescence lifetime imaging microscopy (FLIM) and laser scanning 
confocal microscopy (LSCM) are used to investigate the cellular uptake of the NDI 
molecules and their capacity to image living prostate cancer cells (PC-3). The NDIs 
are subsequently complexed supramolecularly to poly-aromatic carbon systems such 
as C60 and coronene (Chapter 3), as well as thermally reduced graphene oxide 
(Chapter 4). Chapter 3 describes the explorations into the modelling of the donor-
acceptor interactions between the NDIs and the C60/coronene in order to establish 
binding stoichiometry and association constants. Both Chapters 3 and 4 discuss 
fluorescence titration and time correlated single photon counting (TCSPC) 
 x 
 
experiments which were performed as a means of establishing the presence of excited 
state energy transfer mechanisms. The chapters conclude with investigations in living 
cells in order to establish retention of in vitro fluorescence, with particular attention 
being paid to confirming the graphene complex stability. 
Chapter 5 describes the synthesis and functionalisation of a seven amino acid 
sequence peptide known as the G-receptor protein (GRP) binding unit of the 
polypeptide bombesin. The sequence binds GRPs that are known to be up-regulated in 
prostate cancer carcinoma and it has been widely utilised in the literature as a means 
of enhancing the up-take of various cancer imaging agents that employ a variety of 
imaging modalities. The peptide was attached to the fluorescent NDIs via 
carbodiimide activation protocols with the purpose of providing added specificity to 
the imaging agent with respect to PC-3 cells. Prior to NDI derivatisation with 
bombesin, electrochemical impedance spectroscopy (EIS) has been performed to 
establish the extent to which the peptide sequence binds to prostate cancer cells over 
healthy ones. The chapter concludes with confocal microscopy of the bombesin 
derivative NDI complexed to thermally reduced graphene oxide as a means of 
validating the utility of the fluorescent targeted bioconjugate as synthetic scaffolds for 
future early diagnosis and sensing devices for prostate cancer. 
Chapter 6 constitutes the summary of this work and highlights several possible areas 
of future developments of relevance to the results discussed and related future 
experiments proposed to fully validate the device assembly for prostate cancer 
sensing. 
Chapter 7 contains the Experimental section and the relevant data gathered over the 
course of the investigations. Additional supporting figures or data referred to but not 
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Biology is not simply writing information; it is doing something about it. A biological 
system can be exceedingly small. Many of the cells are very tiny, but they are very 
active; they manufacture various substances; they walk around; they wiggle; and they 
do all kinds of marvelous things---all on a very small scale. Consider the possibility 
that we too can make a thing very small which does what we want---that we can 
manufacture an object that maneuvers at that level! 








Chapter 1. Introduction 
1.1 Cancer incidence and diagnostic imaging techniques 
Cancer has become a pervasive problem of modern society affecting the health of the 
global population year on year in an ever increasing manner. Hundreds of thousands of 
people are diagnosed with cancer every year in the UK alone. It is characterised by over 200 
different types, each with its own symptoms, methods of diagnosis and treatment. The latest 
statistics indicate that in the UK alone there were over 330,000 new cases of cancer in 2013, 
of which over half of these cases were attributed to prostate, breast, lung and bowel cancer. 
During the period of 2009-2011, approximately a third of the diagnoses were in individuals 
above the age of 75.
1, 2
 
Figure 1.0 European age-standardised incidence rates for cancers excluding non-melanoma 
skin cancer, Great Britain, 1975-2011. Data was provided by the Office for National 
Statistics, ISD Scotland and Welsh Cancer Intelligence and Surveillance Unit on request, 
May – July 2013. 
 
One of the main reasons behind this increase in diagnosis is due to modern screening and 
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tomography (CT) methods, which have allowed physicians to expose cases of cancer that 
would have previously remained undiagnosed. The other issue is an ever ageing population 
that has made it necessary to anticipate further rises in cancer incidence that require broad 
and robust screening technologies in order to inform and assist medical professionals and 
their patients across the entire spectrum of cancer developments and treatments. Cancer is an 
extremely complex degenerative condition, whereby each type of cancer is biologically 
different from another. Depending on the cell origin and the extent of mutagen exposure, 
certain cancers will demonstrate varying propensities for proliferation.
3
 For instance, cancers 
can differ in terms of their tissue origin, with sarcomas arising from connective tissue or 
muscle, whereas carcinomas come from epithelial cells. Each of these cancers can have a 
wide array of contributory genetic abnormalities that can influence the overall nature of the 
cancer malignancy.  
Cancer of the prostate predominantly affects the ageing male population, with a large 
majority of the incidents occurring in men aged above 60 years. The latest statistics on 
prostate cancer (PCa) conclude that in 2010 there were 40 975 new diagnoses of PCa in the 
United Kingdom alone. In addition, in the same year there were 10 721 deaths as a result of 
prostate cancer
1
. Figure 1 indicates the rise in the number of prostate cancer cases in men 
aged above 50 years. The massive increase is largely due to more widespread screening and 
diagnostic measures instituted in order to detect prostate cancer at an early stage. Prior to 
these methods a large percentage of prostate cancers were left undiagnosed, but still 
contributing to considerable fatalities
4
.  The current lifetime risk estimates suggest that any 








Figure 1.1 Latest statistics on PCa diagnosis indicating a sharp rise in incidents as a result of 
modern screening protocols. Data was provided by the Office for National Statistics, ISD 
Scotland and Welsh Cancer Intelligence and Surveillance Unit on request, May – July 2013. 
 
The origin of cancer and the multiple genetic factors make it difficult to identify the way 
the particular cancer cells are behaving and how they are likely to metastasize or damage the 
body. Without a full understanding of the physiology of the cancer, effective treatments 
remain elusive. The highly individualised nature of cancer development and wide variation in 
tumour heterogeneity
5
 has led to the acknowledgment that an accurate determination of an 
individual’s specific state of cancer progression will allow clinicians to tailor their treatments 
to suit a particular patient’s needs. This will aid in achieving a more personalised approach 
towards the therapy and diagnosis of cancer. This is the primary principle of theranostics 
development whereby screening and diagnosis methodologies simultaneously incorporate 








MRI techniques have proven to be a quite effective method in cancer diagnosis due to its 
ability to provide detailed images of tissue and organs in a comparatively non-invasive 
manner.
8
 There is relatively minimal risk to patients associated with use of the established 
MRI contrast agent gadolinium chelate.
9
 However, despite its accuracy and considerable 
versatility with respect to identifying instances of cancer, it presents a very low sensitivity 
and there are still issues associated with incidental findings that can complicate the 
interpretation of resulting images. In addition, to date there are no instances incorporating 
simultaneous therapeutic strategies within MRI imaging. On the other hand, it has become 
necessary to look to alternative imaging techniques and broaden the scope of molecules that 
have the capacity to not only screen and diagnose, but to also treat cancer to ultimately 
achieve the theranostics’ goals.  
Amongst the many several imaging modalities for cancer diagnosis and treatment, 
fluorescence imaging, Positron Emission Tomography (PET) and single photon emission 
computed tomography (SPECT) have garnered considerable research interest, due to the 
availability of a wide selection of molecules with suitable properties for providing a good 
signal that can be exploited to image a variety of cancers.
10
  
Fluorescence techniques employ a number of well-established molecules directed to target 
cancer specifically, such as Rhodamine, derivatives of fluorescein and more recently near-
infra red emitting cyanine dyes.
11
 The characteristic of these molecules to emit fluorescent 
and phosphorescent photons after excitation with wavelengths in the visible and near infra-
red region of the spectrum has led to their conjugation to a variety of molecules in order to 
enhance their properties for cancer imaging and treatment. In particular, the use of near infra-
red absorbing molecules has transformed the way in which cancer is visualised. Considering 
that large portions of tissue are transparent to near-infra red wavelengths, such fluorophores 
have allowed for deeper penetration into living tissue that effectively eliminates the 
background auto-fluorescence. Furthermore, the capacity for certain fluorophores to undergo 
intersystem crossing after excitation and achieve triplet excited states has led to their 
incorporation into simultaneous therapeutic strategies that rely on the generation of cancer 
targeting singlet oxygen species.
12
 
The ability of imaging technologies to achieve both diagnosis and therapy is a 





express an inherent multitude of physical phenomena or to be easily conjugated to molecules 
that can provide the additional therapeutic effect. More commonly, the imaging strategy is 
used to monitor the progress or efficacy of a separately administered therapeutic strategy 
rather than providing the therapeutic effect as well. However, the field of biological imaging 
is beginning to expand into the incorporation of graphene materials to achieve just such a 
goal. 
Since its discovery in 2004, graphene and the advent of its associated technologies have 











 and now bioimaging. This is primarily due to 
its extensive array of impressive properties. Described as a single layer of sp
2
 hybridised 





 high specific surface area,
20
 high thermal 
electronic conductivity
21
 as well as interesting optical properties such as high near infra-red 
absorbance in its oxidised derivatives.
22
 A considerable body of graphene related work for 
biological applications has utilised the oxidised variants of graphene because of the ease in 




Graphene and its oxidised derivatives have proven to be quite versatile materials when it 
comes to serving as platforms for the immobilisation and delivery of imaging and therapeutic 
agents in vitro and in vivo. The abundance of oxygen functional groups on graphene oxide 
has led to a wide variety of covalent strategies towards the immobilisation of imaging agents 
and bio-targeting molecules. However, active areas of research are dedicated to methods of 
immobilisation driven primarily by van der Waals and electrostatic interactions. This can 




The capacity of graphene to provide a surface area and functional group targets makes it 
an obvious choice for the incorporation of multiple imaging agents, as well as bio-targeting 
and therapeutic molecules to achieve the Theranostic goals in cancer management. This 






1.2 Bioimaging probe design 
The development of graphene oxide based probes, with the aim of achieving imaging via 
multiple modalities as well as additional therapeutic effects, requires a multifaceted approach 
to imaging and diagnostic probes’ design. A careful selection of molecules exhibiting the 
appropriate characteristics for imaging via fluorescence is required. The chosen molecule will 
ultimately determine the method of immobilisation onto graphene oxide, whether it be a 
covalent or non-covalent strategy.  
 




For instance, numerous fluorophore compounds make use of the presence of π conjugation 
within their structures to attach to graphene through π-π interactions. Additionally, pre-
derivatisation of the fluorophore with a biomolecule can eliminate the need for multiple 
conjugation strategies. In some cases, the strategy involves exploiting the varied charged 
nature of biomolecules to immobilise them via electrostatics separately. Quite frequently, 
fluorophores and biomolecules are covalently immobilised via peripheral carboxylic acid 
groups, which are introduced to graphene after oxidation. Among these molecules that 
possess fluorescence characteristics, varieties of them contain or can be synthesised to 
contain metals used in PET/SPECT based imaging modalities.
26, 27





work are also dedicated to labelling biomolecules with radioisotopes, with the modification 
of peptide sequences with technetium proving to be an active area of research.
28
 
With respect to fluorophore attachment to a graphene-based scaffold, a number of studies 
have exploited the tendency of graphene to act as an efficient quencher of fluorescence via 
Forster Resonance Energy Transfer (FRET). Some of these fluorophores may also 
demonstrate the ability to achieve triplet excited states.
29
 These two phenomena make 
graphene a potential candidate for the facilitation of photodynamic and photothermal 
therapeutic effects.
30
 Multimodal imaging and therapeutic intentions require key design 
features to be met if a viable imaging agent is to be achieved. 
a) Presence of a suitable signalling agent to facilitate the imaging, such as a radioactive 
isotope, fluorescent molecule or a combination of both. 
b) A biological molecule to impart cancer specificity onto the intended imaging agent. 
c) An appropriate linking strategy to attach the molecule to the surface of graphene 
oxide; tailoring or controlling its stability in biological media. 
d) Selection of imaging agent which allows additional phenomena that can be exploited 
to impart a therapeutic effect 
e) The probe must include a suitable means of retaining stable dispersions of graphene 
oxide in vitro/vivo. 
 
In this Chapter, the imaging agents that constitute the focus of our attention are typically 
fluorescent molecules. The majority of the fluorophores discussed possess near infra-red 
absorbance characteristics. Particular attention is paid to peptide sequences and their 
versatility as cancer targeting biomolecules. 
1.3 Graphene oxide as a platform for fluorescent probe design  
1.3.1 The chemistry of graphene and graphene oxides 
Graphene is a one-atom thick carbon allotrope material comprised of sp
2
 bonded carbon 
atoms arranged in a regular honeycomb like lattice structure
31
. Discovered in 2004 by Andre 










, tuneable band gap
34
, high mechanical strength
19
 and thermal 
conductivity
21
 amongst others. 
 
Figure1.3 Idealised structure of a pristine graphene sheet containing honeycomb arrangement 
of hexagonal carbon moieties. 
 
A low cost carbon based material, such as graphene and its oxides, possessing the 
aforementioned properties is an ideal candidate material for the development of imaging 
probes and biosensors for cancer associated with optical methods of transduction. There are a 
variety of graphene-based materials that are distinguished based on their method of 
production. Graphene can be produced via chemical vapour deposition (CVD) processes
35
 
and mechanical exfoliation of bulk graphite and graphite oxide
36
. Large scale processing of 
graphene associated nanostructures is achieved by thermal, chemical and electrochemical 
reduction of graphene oxide.
37
 Unlike CVD derived or mechanically exfoliated graphene, 
graphene oxide and its reduced variants possess a significant number of defects as a result of 
the disruption of the sp
2
 bonded planar network of carbon atoms. The oxidation of bulk 
graphite introduces sp
3




These oxygen functional groups present viable targets for the modification of the material 
with a variety of molecules which can ultimately serve the purpose of providing a bio-
functional material suitable for fluorescent, PET/SPECT imaging and Theranostic 
applications.  
This section will focus primarily on the varied chemistry of graphene oxide and how these 






Figure1.4 Structure of graphene oxide containing oxygen functionalities across the basal 
plane and on the periphery. 
 
A considerable percentage of research has been devoted to graphene related materials over 
the last decade, since the publication of Novosolev and Geim’s seminal work reporting a field 
effect in atomically thin carbon films.
39
 Therefore, one might assume that the study of 
graphene materials is a relatively recent area. However, investigations into the chemistry of 
graphitic materials are thought to precede the 20
th
 century. In 1859,  B. C.  Brodie performed 
reactions with flake graphite with a focus towards determining the molecular weight of 
graphite.
40
 One particular reaction involved the addition of potassium chlorate to graphite in 
nitric acid. After four consecutive oxidative procedures, a plateau of oxygen concentration 
was reached with the resulting material having a Carbon: Hydrogen: Oxygen ratio of 61.04: 
1.85: 37.11 and it was readily dispersible in water but not acidic media. It was therefore 
termed graphic acid. Latter improvements were made to this method by L. Staudenmaier 
through the addition of concentrated sulphuric acid and by splitting the addition of potassium 
chlorate into multiple events throughout the duration of the reaction
41
. More than half a 
century after these works, Hummers and Offeman went on to establish the basis for what has 
now become the most established method for the large scale production of oxidised graphite 
as a precursor to graphene oxide (GO). In this method potassium permanganate and 
concentrated sulphuric acid are added in order to generate a diamanganese heptoxide species 









Scheme 1 Generation of oxidising agent during Hummer’s method. 
 
Having established effective methods of oxidising flake graphite, a significant body of 
work has focused on elucidating a reliable universal structural model for graphene oxide. 
This has proven to be a particularly challenging task, in large part due to the variation in 
atomic content of flake graphite derived from its amorphous berthollide mineral source. A 
further barrier to determining a general structure is the fact that the GO materials studied are 
usually derived from processes having modifications to the Hummers method, which vary 
from procedure to procedure. The following section describes some of the more established 
models developed for graphene oxide and the associated techniques used to establish the 
nature of its oxygen functional groups. 
The first concerted approach to developing a structural model for GO was performed by 
Hofmann and Holst. The structure they proposed contained repeating lattice units with epoxy 
groups littered across the basal plane of graphite conforming to a sp
2
 hybridized system. 
Reuss et al developed this model further by introducing hydroxyl groups into the structure 
proposed by Hofmann and Holst. This was also accompanied with a change in structure of 
the basal plane from a sp
2






Figure1.5 Hofmann and Reuss structures proposed for GO, the former containing epoxides 






This model retained the repeating unit nature of the Hofmann and Holst model, but the 
distinguishing feature was the suggestion of epoxide groups in the 1 and 3 positions of the 
cyclohexane moieties as well as hydroxyl groups in the 4
th
 position. 
Latterly, Scholz & Boehm and Nakajima & Matsuo proposed slightly differing structures, 
with one possessing quinoidal species without epoxides or ethers
44
 and the latter containing a 
stage two graphite intercalation structure
45
. Beyond these models, Lerf and Klinowski have 
proposed a different structure. They performed extensive solid state Nuclear Magnetic 
Resonance (NMR) investigations on the products of various reactions with graphene oxide in 
order to extract information regarding hydration characteristics and the material’s reactive 
functional groups. The key feature noted from these investigations was the suggestion of the 
presence of tertiary alcohols, epoxy groups and various alkenes evidenced by resonances 
situated around 60, 70 and 130 ppm respectively. Their work also explained the tendency for 
GO to stack due to the presence of hydrogen bonding facilitated by the alcohol and epoxide 
groups between the platelets of GO.
46
 This model largely conformed to previous models 
differing only in the suggestion that the ethers existed in the 1 and 2 positions as opposed to 
the 1 and 3 positions as suggested by earlier models. Lerf and Klinowski also re-evaluated the 
conclusions derived from the earlier spectroscopic studies to suggest that in addition to 
epoxides and tertiary alcohols, carboxylic acid groups also existed in relatively smaller 




Figure1.6 Lerf and Klinowski model containing epoxides, tertiary alcohols and carboxylic 







1.3.2 Facile and rapid routes to functionalising graphene oxide for biomedical 
applications 
Having established the presence of a variety of oxygen functional groups on GO, the 
material naturally becomes a promising candidate for various chemical functionalisations that 
would render it a far more valuable material for biomedical imaging and sensing applications. 
 
Carboxylic acid activation 
When considering the use of carboxylic acid groups as targets for functionalisation it is 
necessary to use some sort of activating agent. Thionyl Chloride,
48
 EDC (EDC = 1-Ethyl-3-
(3-dimethylaminopropyl)carbodiimide),
49
 DCC (N,N'-dicyclohexylcarbodiimide) and HATU 
are just some examples of compounds used for this purpose.
50
 Molecules containing amines 
and hydroxyls can then be added to form amide or ester linkages. The use of carbodiimides 
has proven to be a popular choice in regards to the conjugation of biomolecules to a variety 
of surfaces. This is in part due to this particular reagent facilitating the formation of what is 
known as a zero length cross-linker. In this methodology, two molecules are attached to each 
other via the formation of a bond that contains no extra interfering atoms.
51
 This is desirable 
in regards to the final application, as additional spacing atoms between two molecules may 
hinder the ultimate function of the hybrid molecule, which is of vital concern when 
establishing functional biomaterials. Carbodiimides are therefore a widespread choice 
because they are able to facilitate the creation of amide linkages between species containing 
carboxylic acids and amines. They are considerably versatile reagents in that they can be used 
to effectively couple peptides sequences, proteins and other complex biomolecules to each 
other as well as a variety of surfaces. 
EDC is one of the most widely used carbodiimides for coupling reactions involving 
biomolecules. EDC will react with a carboxylic acid containing molecule to create a stable 
ester intermediate. The addition of a nucleophilic amine containing molecule facilitates the 






Scheme 2 Schematic representation of reaction scheme to produce amide bonds via EDC 




The primary concern with the use of this reagent is the potential for self-polymerisation in 
which the bio-molecule may react with another molecule of itself due to the presence of 
carboxylates and amines. 
Studies have been performed whereby carbodiimide activation approaches have been used 
to modify GO sheets with poly ethylene glycol (PEG) as a means of developing a 
biocompatible drug delivery vector/vehicle for anti-cancer drugs.
52
 In this study in vitro tests 
were carried out in which they were able to demonstrate that the covalently functionalised 
GO served as a viable vector for the immobilisation of anticancer drugs via π-π stacking. The 
GO hybrid material was ultimately shown to possess a high performance towards the killing 
of human colon cancer cells. 
Carboxylic activation methods have also been used for the covalent attachment of 
porphyrins to GO as a means of developing light harvesting materials for photovoltaic 
applications.
53
 The overall broad applicability of carboxylic activation via carbodiimide 
mediated or alternative activation approaches demonstrate the suitability of these reagents for 





Epoxide ring opening reactions 
As discussed earlier, a significant number of structural models based on infra-red 
spectroscopic studies and solid state NMR investigations have suggested the existence of 
epoxy groups distributed along the basal plane of the graphitic domains. These are in a 
greater abundance with respect to the carboxylic acids and therefore present another attractive 
area for molecular functionalization.
37
 
In 2011, one study utilised an epoxide ring opening strategy with an amine containing 
ionic liquid in order to provide a suitably positive electrostatic charge for the immobilisation 
of a glucose oxidase enzyme.
54
 A relatively simple methodology in which the ionic liquid [1-
(3-Aminopropyl)-3-methylimidazolium bromide] (NH2-IL) was added to a GO dispersion 
along with potassium hydroxide and 24 hours of stirring overnight, with the subsequent 
immobilisation of glucose oxidase into the IL-graphene surface. Ring opening strategies have 
also been used to impart photoluminescent properties onto graphene oxide.
55
 In this work 
alkylamines of varying chain length were used to remove the opportunity of recombination of 
electron-hole pairs as a result of the presence of both epoxy and carboxylic acid groups, 
which is largely seen as the reason for the lack of strong fluorescence emission characteristics 
in GO.
56
 Acylation reactions to form surface amides followed by nucleophilic ring opening 
aminations lead to the removal of both the carboxylic acid and epoxy groups, which in turn 
greatly enhanced the fluorescent quantum yields of GO. 
 
Non-covalent tagging strategies 
The extensive sp
2
 hybridisation of the planar graphitic domains opens up the opportunity 
for functionalisation via π-π stacking or van der Waals forces in the areas that lack the 
oxygen functionality or hydrogen bonds. 
Hunter and Sanders have described a model for understanding the interaction between 
separate aromatic systems. In general, the electron density derived from the π orbitals of 
aromatic rings creates a quadrupole moment possessing an overall partial negative and partial 
positive charge on top of aromatic faces and on the periphery respectively. When these 







 The interaction between aromatic molecules that alternate in their extent of electron 
density is sometimes referred to as aromatic donor-acceptor interactions. Although there is 
still considerable debate in regards to the driving forces behind the interactions between 
aromatic molecules in close proximity to one another,
58
 it would still suffice to conclude that 
such interactions present an attractive strategy towards the construction of supramolecular 
assemblies based on aromatic graphitic and fluorescent bio-molecules. 
Studies are now beginning to understand the complex mechanisms by which graphene can 
be internalised by a variety of mammalian cells. Uptake of graphene nanosheets has been 
studied by Portoles et al. in which osteoblasts, hepatocytes and macrophages were incubated 
with PEGylated GO nanosheets modified with an FITC dye to trace their localisation in 
vitro.
59
 Cells were incubated with the GO conjugates, along with a number of endocytosis 
inhibitors in order to understand the pathways that influence the migration of GO into cells. 
They were able to show that micropinocytosis is the most prevalent means of uptake. 
Macropinocyctosis is a process in which a fluid containing vesicle, known as a 
micropinosome, breaks away from the cell surface and incorporates the material in 
question.
60
 The micropinosome along with its cargo is subsequently drawn into the interior of 
the cell. In addition to micropinocytosis, phagocytosis, microtubule and clathrin dependent 
mechanisms can also play a role in graphene endocytosis. Ultimately this study showed that 
there is a general method of cellular internalisation, however there can be additional 
mechanistic pathways depending on the cell type. 
Nano-graphene oxide, i.e. a graphene oxide whose 3 dimensions are under 100 nm, has 
been reported as a viable facilitator of drug delivery and cellular imaging applications. In 
2008, a study was carried out in which PEGylated nano-graphene oxide was used to image 
cells and deliver anti-cancer drugs. The GO materials that possessed fluorescent properties in 
the visible and near-infra red region were used to selectively image Raji-B cells via the 
detection of near infra-red photoluminescence.
61
 Furthermore, the physical adsorption of the 
anti-cancer drug doxorubicin via π-π interactions onto the nano graphene oxide with a cancer 
targeting antibody Rituxan was able to facilitate the selective killing of specific carcinoma in 
vitro. 
In summary, GO presents a number of options for functionalisation via various covalent 





fluorescent materials, drug delivery vectors, electrochemical through to light harvesting 
applications enhances its viability as a candidate for the development of multifunctional 
imaging and therapeutic tools that exploit optical transduction methodologies. 
 
1.4 Fluorescence imaging and therapeutic applications of graphene oxide-based 
probes 
A fluorescent probe is a compound that possesses an intrinsic ability to emit fluorescent 
photons after excitation with an appropriate wavelength. Upon conjugation to a biomolecule 
via a reactive site on the fluorophore, the resulting modified biomolecule can be suitable for 
applications such as imaging and fluorescent based biosensors. Labelling biomolecules with 
fluorescent compounds is seen as an attractive option for the aforementioned applications 
because of their highly specific emission characteristics after excitation with light. 
62
 
The processes that occur in fluorescence during the absorption and emission of light can 
be illustrated by the Jablonski diagram (Figure 7). 
 
Figure 1.7 Jablonski diagram illustrating the various radiative and non-radiative decay 
processes occurring after excitation.
63
 
The initial transition denoted in the Jablonski diagram is the process of photon absorbance. 
During this event a photon of a specific energy is excited from a lower ground energy level to 
a higher energy state. The photonic energy is transferred to an electron, which then excites to 









 Once an electron has reached an excited state, the 
energy absorbed can be dissipated through the loss of a photon. This event is known as 





Fluorescence phenomena tend to occur between the 1
st
 excited electron level and the ground 
state. At higher energies, dissipation of the absorbed energy is more likely to occur via 
internal conversion or vibrational relaxation. During vibrational relaxation, the energy 
absorbed during excitation can be given to other vibrational modes as kinetic energy. Internal 
conversion also occurs when vibrational energy levels overlap with electronic energy levels 
allowing for transitions between vibrational states of different electronic levels.
64
 Finally, 
intersystem crossing can occur in which electrons in a singlet state transition to an excited 
triplet state. The transition down from an excited triplet state to a singlet ground state is 
responsible for phosphorescence phenomena. It is such excited state energy transitions that 
allow for photodynamic therapeutic strategies or fluorescence resonance energy transfer 
based in vitro/vivo recognition and imaging methodologies that will be the main focus of the 
first section of this literature review. 
With respect to fluorescence imaging, the goal is to produce a high resolution image of the 
sample in order to extract crucial information about the localisation of fluorescent probes 
within cellular environments, and how aspects such as time, temperature, pH, ion 
concentration can influence the emissive properties of the fluorescent probe.
65
 During 
conventional wide-field epifluorescence microscopy, the fluorescence illumination of a single 
plane is achieved via the application of light of a particular excitation wavelength. It is then 
focused onto the sample through an objective lens. The subsequent emission of fluorescence 
from inside the sample travels through the objective and is focused through a tube lens onto a 
camera to produce an image. However, regions outside of the focal plane will also be excited 
and emit fluorescence. This fluorescence will not reach the appropriate focal point on the 
camera detector after entering the tube lens, leading to a blurriness and lack of image 
resolution.  Confocal microscopy overcomes this by including a pinhole between the tube 
lens and the detector in order to restrict the detection and observation of out of focus 
fluorescence emission.
66
 Naturally, this only allows for a single location in a sample to be 
imaged at any given time. Therefore, instead of attempting to image the entirety of a sample 
at once, a confocal microscope creates a matrix grid and images a single spot and measures 





the individual regions. The advent of laser technology has allowed for high power beam 
collimation to ensure the effective excitation and illumination of a single diffraction limited 
spot.
67
 A confocal laser scanning microscope is a particularly valuable tool for biological 
imaging operations as it can carry out optical sectioning whereby images are taken as the 
microscope separates and illuminates different focal planes of the sample in question. 
Interpolation and 3-D rendering of the resulting stack of images allows for the visualisation 
of the sample in the x,y and z plane for a 3-dimensional structural representation. 
Additionally, certain molecules can be utilised in 2-photon light microscopy. Invented by 
Denk, Webb et al., this technique relies on the phenomenon of two photon excitation, 
whereby fluorophores can be excited by the simultaneous absorption of two photons. The 
previous techniques rely on one-photon absorption, whereby excitation from the ground to 
excited state occurs principally via the absorption of single photons in the ultra-violet or 
blue/green spectral window. However, the same excitation process can be achieved with two 
photons of lesser energy, typically in the infra-red spectral window. Due to the lesser energy 
(longer wavelength) excitation source, this technique has the advantage of more rigorous 
deep penetration imaging and it can be performed over longer timescales with less 




Another ideal approach to detecting fluorescence emission from intracellularly located 
dyes is via fluorescence lifetime imaging microscopy (FLIM). The fluorescence lifetime 
decay of a dye is independent of concentration, intensity of illumination or photobleaching. 
The combination of FLIM with 2-photon excitation techniques can also be achieved. Due to 
2-photon excitation being a non-linear process, the resulting fluorescence is restricted to 
small focal volumes. This eliminates the absolute necessity for a pinhole to reject out of focus 
light, thus allowing for greater fluorescence signal intensity. However, it is common for 
pinhole bearing confocal microscopes to be used in tandem with 2-photon excitation sources. 
The imaging aspects covered in this thesis will combine aspects of confocal microscopy with 
two-photon FLIM to extract as much information as possible about the viability of the 









Figure 1.8 Schematic representations of focal planes arising from specimen irradiation and 
















1.5 Peptide sequences for targeting cancer and means to their incorporation onto GO 
During the process of developing functional nanomaterials for biological applications, it 
has been shown that it is essential to include in the probe composition a biomolecule to 
engender specificity. Over the years, various antibodies, DNA and RNA molecules have been 
used to derivatise surfaces and other small molecules as a means of developing bio-targeting 
surfaces and molecules for applications ranging from electrochemical biosensors, drug 









A significant body of work has focused on the use of peptide sequences as molecular 
targets for cancer Theranostics.
72,73
 Peptide sequences are seen as an alternative to antibody 
based targeting strategies due to their considerably smaller size in relation to their antibody 
counterparts used for similar applications. The large molecular weights of antibodies tend to 
result in difficulties when targeting large tumour masses and there are also issues associated 
with their non-specific uptake by the liver, spleen and bone marrow which further limit their 
effectiveness.
74
 Peptides are sequences of amino acids that can vary widely in size and 
function based on the number and type of amino acids attached to each other. Part of the 
reason for the utility of peptides in cancer Theranostics is associated with their ability to 





Recent work has demonstrated that relatively small peptides tend to assemble towards the 
edges of planar surfaces of graphene oxide (GO) via π-π interactions.75,76.77, 78 Katoch et al. 
carried out studies in which they were able to show that the peptide sequence of GAMHLP-
WHMGTL transformed from an α-helix to a reticular structure when adsorbed to graphene 
surfaces.
79
 Atomic level simulations have also demonstrated that peptides which possess α-
helices tend to unfold and form amorphous dimers upon conjugation to graphenes. Studies 
have suggested that the phenomenon of α-helix unfolding begins at the C-terminus of the 
peptide and the degree of unfolding is largely influenced by the strength of the interactions 
between certain amino acids. 
Density functional theory (DFT) studies have also been used to develop a deeper 
understanding regarding the interaction of graphenes with amino acids and peptides. 
Kawazoe et al. have modelled the interaction of Phenylalanine, Histidine, Tyrosine and 
Tryptophan with graphene and carbon nanotubes. Their results suggest that the aromatic 
components of these amino acids re-arrange themselves to a parallel conformation along the 
basal plane of the graphitic domains via π-π interactions. In addition to these theoretical 
studies, experimental investigations have probed the interaction of Lysine, Arginine, 
Tryptophan and Tyrosine with GO. They have also concluded that binding between amino 
acids and GO can be considerably influenced by π-π interactions. However, they also suggest 
that the positively charged side chains on Lysine, Histidine and Arginine can bind to GO via 
additional electrostatic mechanisms. In general a large majority of studies associated with 
experimental and atomistic investigations have implicated the amino acid residues such as 
Tryptophan as being the strong driving force behind the immobilisation of peptides to 
graphene and carbon nanotube surfaces.
80,81, 82,,83 
GO materials based on immobilised peptides are showing significant potential towards 
developing multifunctional and highly sensitive detection platforms. Recently dye-labelled 
peptides immobilised on GO surfaces have shown considerable promise towards developing 
multifunctional and highly sensitive detection platforms. The first reported study of a GO 
based sensing mechanism that utilised a non ssDNA molecule as a bio-recognition molecule 
was reported in 2011. In this work, a peptide labelled with fluorescein isothiocyanate (FITC) 
was used to target the serine protease Thrombin.
84
 The use of this fluorophore facilitated 





for the monitoring of protease activity. This work was able to demonstrate that the increase in 
fluorescence intensity was a direct correlation to the concentration of Thrombin. The 
fluorescence based detection mechanism allowed Thrombin to be quantified in concentrations 
as low as 2 nM. Additionally, a fluorescence-based detection mechanism for Caspase 3 (a 
known mediator for the triggering and spread of apoptosis events) was recently developed. In 
this research a peptide sequence of Asp-Glu-Val-Asp with a fluorescein amidite (FAM) 
labelled Lysine was bound to GO surfaces using EDC/NHS (EDC = 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide; NHS = N-Hydroxysuccinimide) activation approaches 






Figure1.10 Caspase-3 detection using GO–peptide conjugate and confocal fluorescence 
microscopy images of HeLa cells treated with 4 μM STS for 4 h after incubation.71 
 
The bio-fluorescent GO hybrid material was successfully taken up by cells, followed by 
cleavage of the dye labelled peptide by internal proteases. Cleavage of the bond released the 
dye labelled peptide from the quenching effects of GO allowing its fluorescence 
characteristics to be used as means of verifying and quantifying the presence of Caspase 3. 





media and a wider promise towards the applicability of peptide-GO conjugates as cancer 
sensing mechanisms. The majority of the examples discussed herein will focus primarily on 
peptide based methods of bio-targeting and how this ultimately influences the distribution of 
the probe in vitro/vivo and the effectiveness of the imaging modality. 
 
1.6 Targeted fluorescent molecules anchored onto graphene oxide for cancer 
theranostics 
Graphene has demonstrated a capacity to serve as an imaging, diagnostic and therapeutic 
platform in a variety of functional states. In some instances, it can be used in conjunction 
with other nanoparticles to form effective diagnostic tools. In 2014, Ji et al. developed a 
prognostic indicator for early-stage cancer based on a combined graphene-mesoporous silica 
nano-sheet.
85
 The value of such a system with respect to the in situ detection of 
prognostically significant bio-markers was fully realised after assembling the graphene-silica 
(GS) platform with a polyethylene glycol derivatised hexapeptide (PEG-RWIMYF) that 
served as recognition mechanism cyclin A2 (Figure 10). This particular cyclin has been 
implicated in the deregulation of cyclin dependant kinase (CDK) activity and hence 
chromosomal instability and ultimately tumour proliferation.
47
 Initially, the GS surface was 
functionalised with amines which were then converted to carboxyls (COO-) to allow for the 
electrostatic capping adsorption of the positively charged peptide. Prior to this step, the 
mesoporous silica had been loaded with Rhodamine B. Upon specific binding to cyclin A2, 
the peptide capping agent was removed from the GS nano-surface allowing for the release of 






Figure 1.11Covalent capping of graphene-silica platform with a hexapeptide for turn on.off 
detection of cyclin dependent kinases.
85
 
The tendency for graphene to act as an effective quencher, as well as its capacity to be 
functionalised to facilitate physisorption, allowed for the efficient intracellular delivery of the 
fluorescence based recognition imaging agent. This particular functional nano-system was 
able to demonstrate the in vitro concentration dependant detection of cyclin A2 in a variety of 
cancerous and healthy cell lines based on the observed fluorescence intensity. Furthermore, 
the probe could be used to monitor the efficacy of the anti-cancer drug doxorubicin (DOX). 
DOX is known to up-regulate the expression level of cyclin A2. Consequently, in cell lines 
that were treated with DOX a corresponding increase in situ fluorescence was observed. 
This multicomponent approach to graphene probe design is one example of how 
incorporating peptides and fluorophores opens up the opportunity to exploit cellular 
recognition mechanisms to not only image and detect diagnostically relevant biomarkers, but 
to also track the progress of therapeutic strategies. 
One of the more widely researched biomarkers for the screening of prostate cancer is 
Prostate Specific Antigen (PSA). PSA is a serine protease that is produced by both prostate 






of limitation associated with PSA diagnostic measures in that they regularly fail to provide a 
suitable degree of specificity with respect to identifying and distinguishing between prostate 
cancers based on their malignancy.
86
 The proteolytic active form of PSA has been shown to 
be a more effective discriminator of prostate cancers based on their metastatic potential.
87-90
 
This has led to the development of fluorescence based peptide targeting methods that can 
facilitate the “on-off” switching signal for this particular active form of PSA. Feng et al. 
developed an imaging based sensing probe through the modification of GO via peptide 
derivatised fluorescein isothiocyanate.
91
 The peptide containing the sequence HSSKLQ has 
been shown to be selectively cleaved by the proteolytic form of PSA. The construction of this 
sensing probe was achieved via the π-π and electrostatic interactions between peptide labelled 
FITC and the GO surface. As the active PSA bound to the nano-construct, protease would 
cleave the peptide allowing for the release of the dye due to diminished electrostatic 
interactions and hence recover the FITC fluorescence that was quenched due to the close 
proximity of the GO.  
 




This study showed that a rapid fluorescence response could be observed when the GO dye 
labelled peptide was exposed to varying concentrations of PSA, with a detection limit of 0.3 
nM. Quite crucially, they were able to demonstrate the effective detection of active PSA in 
urine samples despite the presence of a variety of interfering molecules such as CaCl2, 
MgCl2, L-histidine and glycine amongst others. This study ultimately showed that exploiting 
the charge transfer capacity of GO to induce quenching, can be used in conjunction with 






The utility of combined fluorophore, peptide and GO constructs has extended to the 
monitoring of peptide receptor interactions. Somatostatins are hormone receptors that play a 
role in the regulation of the endocrine system. They have been implicated in cell proliferation 
and are therefore of particular interest when aiming to characterise a variety of cancers.
92
 
Octreotide is an 8 amino acid cyclic peptide sequence consisting of FCFWKTCT. It is known 
to serve as an effective ligand for somatostatins and as such has led to its employment in 
graphene based recognition systems for imaging and sensing. Bianying et al. developed an 
imaging based sensory platform to characterise the aforementioned peptide-receptor 
interactions based on the combination of a FITC dye labelled octreotide (FOC) (Figure 12).
93
 
The FOC conjugate was adsorbed to the surface of GO and enhanced via the positively 
charged nature of the Lysine residue, as well as the π-π interactions associated with the 
Tryptophan and Phenylalanine residues. The presence of these particular residues 
demonstrated that the FOC molecule could readily bind to the surface of GO with efficient 
quenching and adsorption kinetics. After exposure of FOC to its antibody counterpart (anti-
octreotide – AOC), the corresponding competitive interaction forced the release of FOC from 
the surface of GO allowing for the re-emergence of its fluorescence.  
 
Figure 1.13 3-D Structure of Octreotide and schematic illustration of the concept of using 
FITC–Octreotide and GO to detect peptide–receptor interactions. 93 
A greater signal to noise ratio was also noted for the total observed fluorescence in vitro 
when GO was included in the probe construct to suppress cellular auto-fluorescence. A linear 
relationship of AOC detection was observed based on the total fluorescence intensity to 





cells and track the movement of the biomolecular interactions. AR42J rat pancreatic cells 
with a high expression of somatostatin receptors showed strong in vitro fluorescence upon 
release of FOC from the GO surface after receptor binding. This was in stark contrast to the 
significantly diminished fluorescence in CHO cell lines that possess a lower expression of 
somatostatin receptors. Ultimately, the study demonstrated that the combination of specific 
peptide interactions in conjunction with dye and GO molecules can serve to image and sense 
biomolecular interactions that are relevant to cancer development. 
The value of graphene oxide and its reduced derivatives extends beyond its capacity to be 
readily functionalised, in that it possesses intrinsic near infra-red absorbance properties. As 
alluded to in the introduction, this is of particular value with respect to imaging and 
therapeutic applications, primarily because the majority of living tissue is transparent to near 
infra-red light. Photothermal therapy relies on the capacity of the resulting heat generated 
from near infra-red light absorption as a means of achieving photoablation which ultimately 
leads to cancer cell death.
94
 Therefore, if selective uptake of graphene by cancer cells and 
tumours can be achieved there is potential for highly efficient imaging and photothermal 
therapeutic strategies.  
Robinson et al. employed nano-dimensional reduced graphene oxide with NIR absorbance 
characteristics that had been further functionalised with RGD targeting peptides and an 
additional cyanine dye (cy5) to further enhance NIR absorption. RGD peptides are known to 
target αvβ3 integrins distributed along the membrane of cancer cells.
95
 The derivatisation of 
the nRGO with RGD via supramolecular PEGylation resulted in a higher confocal 










This suggested that modifying nano surfaces with RGD like peptides is a viable means of 
enhancing uptake in vitro. The nano-conjugates also demonstrated minimal toxicity in human 
breast cancer cell lines. Furthermore, the targeted nano-construct could also be used to non-
covalently load the anti-cancer drug doxorubicin via aromatic stacking reinforced with 
additional supramolecular interactions. The combination of the targeted nano-conjugate and 
therapeutic doxorubicin effects allowed for the further reduction in the doses required for the 
respective photothermal and chemotherapeutic agents. 
Dendrimer immobilisation strategy has also been used to facilitate a synergistic imaging 
and photothermal therapeutic effect by incorporating targeted phthalocyanine dyes onto GO 
surfaces. Taratula et al. utilised a polypropylenemine dendrimer to immobilise the dye 
molecules, PEG chains and luteinizing hormone releasing hormone (LHRH) peptide to 
selectively target ovarian cancer.
96
 This particular design allowed for GO to demonstrate its 
capacity to facilitate photodynamic therapy, as well as photothermal therapy. Near infra-red 
radiation of the phthalocyanine allowed for heat generation as energy transferred between the 
excited dye and the GO. Additionally, the dye could also achieve a triplet excited state which 





effect. These combined strategies allowed for enhanced killing capability (90-95 %) at low 
dye and graphene concentrations. In vivo studies also confirmed the ability of the probe to 
image cancer tumours in mice. 
The exploitation of FRET to enhance photothermal therapy via NIR dyes and GO extends 
to probe design with much simpler assemblies. Guo et al. conjugated the NIR dye cypate to 
GO via a PEG linker. Upon irradiation of the dye, FRET induced an enhanced photothermal 
effect that was sensitive to pH.
97
 The dye-graphene conjugate demonstrated enhanced 
accumulation capacity in the tumours of mice, despite no specific derivatisation of the probe 
with a targeting biomolecule (Figure 17). Additionally, the rapid clearance of the probe from 
normal tissue was also demonstrated. In vivo studies showed remarkable tumour necrosis and 
regression 2 days after injection and no tumour re-growth 22 days after injection. This was 
not the case for control studies performed in absence of the dye. The GO-PEG construct 
alone demonstrated reasonable tumour re-growth within a 22 day period post-injection. This 
confirmed that the effective tumour ablation was ultimately due to the photothermal 








The examples described clearly present graphene as a versatile platform for the 





These molecules range from a variety of fluorescent dye molecules, solubility enhancing 
polymers, through to bio-targeting molecules and therapeutic agents. The presence of innate 
near infra-red absorption characteristics, enhanced by further derivatisation with NIR dyes 
facilitates photothermal and photodynamic therapeutic effects that have expanded the scope 
of the benefits of using GO in cancer imaging modalities. 
The need to ensure the retention of the stability of graphene based imaging probes is one 
of the key drivers behind the regular inclusion of certain dispersing agents such as PEG. 
However, naphthalene diimides are a particular class of fluorescent aromatic molecules that 
have demonstrated extensive utility in solubilising carbon allotropes and other aromatic 
systems.
98, 99
 Naphthalene derived molecules possessing donor-π-acceptor structures have 
shown promise as platforms for the design of two photon probes for a variety of biological 
targets. In a study by Kim et al. a series of naphthalene based fluorophores were developed 
that could visualise and ultimately detect intracellular free metal ions, acidic vesicles and 
lipid rafts to 300 µm depths inside live tissue samples.
100
 In this work, two photon 
microscopy was used to demonstrate that the wide two photon cross sections of the 
naphthalene fluorophores was suitable for obtaining bright two photon images at low 
concentrations upon binding with intracellular ions/molecules that triggered detectable 
emission events. The study also demonstrated that such fluorescent probes possessed high 
cell permeability, selectivity towards cytosolic and membrane bound cellular constituents and 
an overall high photostability. 
1,4,5,8 – Naphthalenediimides are a group of planar, electrochemically active aromatic 
molecules distinguished by their naphthalene core and diimide nitrogens. Functionalisation 
via the diimide nitrogens results in naphthalene derivatives possessing variable absorption 
and emission characteristics. Generally, the attractive optical properties can be attributed to 
the presence of extended aromatic π conjugated systems. NDIs free of substitution on the 
naphthalene core tend to absorb only in the UV region.
101
 Extending the π conjugation via the 
addition of extra aromatic groups on the diimide nitrogens can improve absorption 
characteristics as is the case with perinones, which have phenylene diamine substituents on 
the diimide nitrogens and have been used as dyes and pigments as early as the 1950s.
102
 The 
structure of NDIs also provides them with the ability to form supramolecular assemblies 











Figure 1.16 NDI (left) and PDI (right) basic structure. 
 
The aromatic and electron deficient characteristics render them with the ability to form 
face centred aromatic interactions. This particular property opens up avenues for 
functionalising GO via π-π stacking interactions.58 Naphthalene based organic molecules 
have been used previously for imaging via 2-photon excitation techniques owing to their 
suitable 2-photon cross-section areas. Zhang and co-workers utilised a naphthalene based 
probe that was developed by attaching a polarity sensitive naphthalene molecule (BTDAN) to 
a cyclooxygenase enzyme inhibitor (COX-2). The result was a “turn on/off” probe, whereby 
the absence of cyclooxygenase enzymes allowed for a folded confirmation of the BTDAN-
COX-2 conjugate. This led to a quenched fluorescence via photo-induced electron transfer 
between the fluorophore and recognition site of the enzyme inhibitor that were in close 
proximity to one another. Presence of the enzyme re-arranged the confirmation, thus allowing 
for the re-emergence of fluorescence in vivo/vitro. More specifically, Chou et al developed a 
series of near-infrared 2-photon absorbing NDI chromophores. By attaching and varying the 
number of triarylamine moieties to a brominated NDI core, they were able to fine tune their 
2-photon cross-sections and drive the emission to the near-infrared region.  
Previous work within the group developed a facile method for the supramolecular 
complexation of phenylalanine substituted NDI molecules to single walled nanotubes 
(SWNTs) towards applications in cell imaging and drug delivery.
98
 This work demonstrated 
that the NDI molecules could wrap around SWNTs via supramolecular host-guest 





demonstrated that the NDI molecule could retain a certain degree of fluorescence upon 




Figure 1.17 X-ray structure of NDI unit cell fragment proposed structure of a fragment of 
NDI@SWNT composite: molecular mechanics minimized representation of NDI stacks self-




Furthermore, it was demonstrated that functionalisation of SWNTs with the NDIs reduced 
the cytotoxic properties of the nanotubes and could be internalised within cancerous and non-
cancerous cell lines, thus establishing the supramolecular complexes as potential cell imaging 
probes. The use of NDI molecules has also been extended to incorporate targeting peptides 
for more specific imaging strategies for cancer (Scheme 3).  Recently within the group, an 
NDI based imaging probe for the targeted imaging of cancer cells based on RGD peptide 
sequence was developed.
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 Similar to the previous studies mentioned, the RGD sequence 
was used to more effectively target αvβ3 integrins. The over expression of αvβ3 integrins has 
been implicated in the tumour progression and metastasis in a number of cancers during 





tryptophan tagged naphthalene diimide. Probing of the fluorescent characteristics of these 
molecules in PC-3 prostate cancer and non-cancerous FEK-4 cell lines was carried out via 
confocal and fluorescence lifetime imaging strategies (Figure 1.17).  
 
 
Scheme 1.3 Synthesis of tryptophan–NDI–RGDfK.103 
 
 
Figure 1.18 Two-photon laser confocal fluorescence with λex = 810 nm. A typical 
micrograph of PC-3 cells incubated for 20 min at 37 °C with tryptophan tagged NDI (100 μM 





cytoplasm: lifetime mapping (a), the intensity image  and the corresponding average τ 
lifetime distribution curve and lifetime scale-bar.
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These studies revealed the successful uptake of the NDI-peptide conjugate within the 
cytoplasm of the exposed cells. One of the key findings was a narrowing of the excitation 
wavelength of the NDI after derivatisation with cyclic RGD to a region of the spectrum that 
avoided interfering cellular auto fluorescence. This and the aforementioned NDI works in 
particular support the notion that peptide based NDI fluorescent imaging probes can be used 
to achieve more specific tracing and characterising of a variety of intracellular organelles in 
vitro via different fluorescent modalities . 
1.7 Applications of supramolecular chemistry in NDI assemblies 
The intelligent manipulation of forces of interaction between molecules has long since 
demonstrated a capacity for the formation of highly complex nanostructures. The field of 
supramolecular chemistry has a number of mechanisms behind the molecular recognition 
processes that govern the binding of various molecules. Hydrogen bonding, Van der Waals 
and electrostatic interactions in general govern the highly specialised and effective biological 
systems that a considerable portion of research aims to emulate.
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The geometric requirements in order for one “guest” molecule to fit within a restricted 
space governed by the structural conformation of the “host” molecule is a considerable 
driving mechanism behind supramolecular binding. The extent to which a geometric 
arrangement must be altered in order to fully realise the binding event (termed “induced fit”) 
can have varying effects on the degree/strength of binding. For example, varied enthalpic and 
entropic contributions can be observed depending on the conformational nature of respective 
host-guest assemblies, and to what extent structural mobility exists within the resulting host-
guest complex. In some instances high enthalpy interactions can lead to considerable entropic 
losses. However, if host-guest complex mobility is limited via the inclusion of covalent 
bonds, the added mobility restriction can further enhance interactions driven by changes in 
enthalpy. Only in rare cases are supramolecular assemblies driven by entropy contributions. 





complexes. Any interactions characterised by significant enthalpic forces, leads to less 
degrees of freedom and hence greater losses of entropy.
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Attractive forces between molecular species of opposite charge are another driving force 
behind the mechanisms of supramolecular binding. These interactions encompass both 
stacking and hydrogen bond interactions. The stacking interactions are primarily facilitated 
by alterations in electron density created by substituents attached to aromatic moieties. 
Arguably the most significant of supramolecular interactions is the hydrogen bond. Hydrogen 
bonds are strong, highly selective and can impart a certain degree of directionality with 
respect to the formation of various hosts and complexes. Careful modification of molecular 




The significance of solvent may well prove to be the most important factor in the design of 
supramolecular systems. Polar solvents such as water can compete and effectively rob 
supramolecular systems of hydrogen bonds necessary for formation. In non-polar solvents 
that do not possess lone pairs, dipolar and hydrogen bonding effects are much more 
pronounced. It is therefore difficult to garner meaningful information when pursuing or 
attempting to characterise supramolecular systems without accounting for the effect of 
solvent. 
1.7.1 Supramolecular naphthalenediimide nanostructures 
Ryelene diimides are a class of organic compound based on a naphthalene core network. 
Particularly of interest within this work and to applications within bioimaging are the 
naphthalene diimides (NDI) and their derivatives, as well as their perylene (PDI) and 
oligothiophene analogues. The previous section demonstrated their value in the imaging of 
cancers, and the following section will discuss how their properties extend their utility to the 
development of spontaneous self-assemblies. This particular class of molecule is well suited 
for use as n-type electron acceptor molecules that can form a variety of nanostructures based 







By modification of the basic NDI structures through direct functionalisation of the 
aromatic cores as well as substitution at the imide nitrogens, a wide variety of nanostructures 
can be achieved and studied. These molecules exhibit supramolecular interactions which 
allow them to not only self-assemble into many structures but also to interact with other 
aromatic species such as graphene, principally via π-π stacking interactions which make them 
ideal for donor-acceptor systems. The development of supramolecular chemistry has allowed 
for the expansion of a variety of nanostructures using a “bottom up” approach. The 
spontaneous self-assembly of naphthalene based molecules via this method is of particular 
interest as it allows for the efficient and well controlled fabrication of a variety of 
nanostructures. This is of considerable value when attempting to incorporate graphene in 
imaging technologies as it not only allows for stabilised dispersions in biological media, but 
it also eliminates the need for covalent approaches to graphene modification which can be 
complex and time consuming. 
1.7.2 Peptide appended naphthalene diimides 
A large body of research has focused on the modification of NDI molecules to contain side 
chains that enhance their solubility. In particular, the tendency for certain shorter chain 
peptide sequences to arrange into helical and β-sheet type structures has led to their use as 
agents to drive the assembly of NDIs into twisted thread-like structures. Shao et al. 
demonstrated that it is possible to tailor the supramolecular electrostatic conditions of 
assembly by attaching peptide sequences containing lysine onto the imide regions of the 
naphthalene core.
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 They reasoned that the peptide derivatised NDI species would undergo 
electrostatic repulsion upon packing and that the inclusion of protonated lysine residues 
would diminish the self-assembly governed by the π-π NDI interactions and peptide 







Figure 1.19 Design of minimal H/P-type dipeptide-NDI sequences (Top). Assembly of 
dipeptide-NDI conjugates A and B into left-handed fibres and ribbons (Bottom). Interstrand 
distances of β-sheets and plane-to-plane distance of NDIs shown determined by XRD.107 
 
This ultimately lead to the formation of well-ordered helical or twisted nanoribbon like 
species depending on the position of free amines or dipeptide species as evidenced by TEM 
and AFM microscopy. Furthermore, circular dichroism of the peptide appended NDIs in 
water confirmed the helical arrangement of the NDI dipoles into ribbon-like assemblies due 
to the apparent negative cotton effect (220 – 260nm) and negative bisignet couplets (242 
nm).Nanotubular structures represent some of the more interesting conformations to arise 





stacking present a means of constructing 1-D n-type nanotubes. Similar studies by Shao et al. 
developed on the work of lysine containing peptides by modifying the imide groups of NDI 
species to contain amino acid sequences containing lysine head groups and demonstrated the 
formation of a stable gel phase in water. From TEM and AFM analysis it was concluded that 




Figure 1.20 Structures of lysine-based bolaamphiphiles A (R =O) and B (R =OMe) and the 
assembly of A into rings, which stack to give tubes. The blue sections of A undergo 
hydrophobic π-π stacking interactions, and the red sections electrostatic interactions. b) TEM 
image of bolaamphiphile A in water (250 μM). Blue insets: Two nanotubes and one nanoring. 
c) Tapping-mode AFM image of bola-amphiphile A in water (250 μM) on freshly cleaved 








π-π stacking was apparent from the UV-Vis investigations in which decreased absorbance 
and red shifts were observed in the primary absorption bands of the NDI units (300-400 nm 
and 236 nm). Further analysis of the XRD pattern of the bolaampiphile revealed reflections 
and d-spacings that corresponded to the length and wall thicknesses seen in the TEM 
analysis, as well as the π-π stacking distances observed from analysis of the NDI crystal 
structure. The most interesting aspect of this study was their rationalisation of the TEM and 
XRD results with respect to the overall conformation of the NDI units within the nanotube. 
They proposed that the bolampiphiles formed a monolayer lipid membrane. The chirality 
induced by the lysine headgroups resulted in a curvature of the nanotube and the greater 
proportion of hydrophobic regions minimised the extent of surface water exposure. The 
additional stacking of the NDI cores forced the hydrophobic aromatic cores to the inside of 
the nanotube and the hydrophilic lysine regions to the outer regions of the nanotube. 
The utility of peptides in the directional control of self-assembly extends beyond short 
chain linear sequences, to the employment of cyclic peptide species. Cyclic peptides 
themselves are a group of molecules that can arrange into a variety of cylindrical cavity based 
structures. It has been proposed that the employment of cyclic peptides attached via linkers to 
naphthalene diimides can be used to control the directional stacking of aromatic side chains 
to induce more long range one dimensional arrangement of self-assembly. It is possible to 
control the nature/extent of hydrogen bonding between cyclic peptide species in order to 
induce the arrangement of naphthalene diimide to favour 1 dimensional stacking and charge 
transfer. Horne et a.l investigated the ability to control the assembly of a series of cyclic 
peptides attached to NDIs through multiple NDI substitution, tuning of peptide hydrogen 









Figure 1.21 a) Schematic representation of hydrogen bond-directed dimerization of backbone 
N-methylated cyclic d,l-α-peptides with generic side chains R1–R4 .b) Calculated model of 
one possible dimer of peptide 3 viewed from the top and c) from the side d) Schematic 
illustration depicting overlap of NDI side chains (diamonds) in the four possible dimeric 
assemblies available to the C1-symmetric peptides.
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They found that multiple substitutions of NDIs onto the cyclic peptides led to monomeric 
species formation in solution that effectively halved the binding constants with respect to 
singly substituted peptides. Furthermore, it was noted that decreases in association, and hence 
greater dimer stability, were observed when the NDIs were attached further away from the 
cyclic peptides. However, fluorescence studies showed diminishing effects on charge transfer 
capacity associated with shorter linker length. NDIs that were more closely attached to the 
peptide species had less room to arrange in a suitable conformation for dimer charge transfer 
and consequently excimer formation was reduced. 
Incorporating amino acids into naphthalene diimide structures enhances the ability to 
provide multiple means of controlling self-assembly. However, the presence of π-π, Van der 
Waals and hydrogen bonding interactions in a single molecular geometry can lead to a highly 
complex system of intramolecular interactions that can be difficult to control. In order to 
tailor the self-assembly to facilitate the formation of specific nanostructures, one must 





ultimate nanostructure morphology. Eakins et al. carried out a study in which perylene 
diimides were attached to peptide sequences as a means of studying their aggregation 
behaviour in solution. The incorporation of alkyl chains into peptide sequences has 
demonstrated a capacity to form a variety of self-assembled nanostructures in solution such 
as fibres, vesicles and nanotubes. By incorporating short peptide sequences and hexyl chains 
onto the imide groups of the PDIs they demonstrated that it is possible to tailor the effects of 





Figure 1.22 General structure of the peptide-PDIs explored in the thermodynamic studies.
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Initially, the study observed the formation of fibre like nanostructures in water via TEM 
and AFM. Systematic temperature dependant spectroscopic UV-Vis studies allowed them to 
clarify the enthalpic and entropic contributions to aggregation with respect to structural 
features of the peptides and hexyl chains. They observed that varying the hydrophobicity and 
incorporation of asymmetric hexyl chain substitution had the greatest influence over the 
thermodynamic association. More favourable Gibbs free energies of association were 
observed for those PDIs appended with hexyl chains due to less charge repulsion enhancing 
the aggregation. Furthermore, by incorporating multiple glutamic acid residues they were 





contribution to association, most likely due to the repulsive effects arising from trying to pack 
a more highly charged peptide species. They also noted diminished packing with the 
incorporation of sterically bulky peptide sequences that contained phenylalanine and leucine. 
These residues not only obstructed the hydrogen bonding between peptide backbones, but 
also interfered with π-π stacking between PDI units. Choice of solvent also played a key role 
in determining aggregation characteristics. Solvents capable of π-π stacking with the PDI 
core led to lower aggregation and more monomeric species. 
The ability of PDIs to form π-π stack self-assemblies facilitates charge transport by 
increasing π-orbital overlap and crucially, that these interactions are subject to a degree of 
tunability by variation of the diimide nitrogen substituents.
111
 This variation has the effect of 
altering the self-assembly of the PDIs and therefore their physical properties. Specifically 
within this work it was found that thin films of these substituted PDIs exhibited high electron 
mobilities. Due to this, and also the solubility of PDIs in organic solvents, they have been 














Figure 1.23 N,N’-dialkylated perylene diimide. 
 
Gregg and Cormier  also studied spin coated thin films of similar N,N’-disubstituted PDIs, 
in this case by electrochemical methods. They noted that these species exhibit stronger 
intermolecular attractions when they are reduced. Furthermore they found that these reduced 
forms are stabilised by structural rearrangements undergone during reduction and that 
conductivity across the films increases by 5 orders of magnitude upon reduction of the PDI 
molecules. Crucially they noted that conductivity increased to within the semi-conducting 
range at reduction of less than 1% of the films, suggesting low doping level requirements (i.e. 





Struijk et al. reported the presence of highly ordered liquid crystalline phases of three 
N,N’-dialkylated PDIs by a combination of techniques including x-ray diffraction and 
UV/Vis spectroscopy. They were able to observe by crystallographic and computational 
methods that this order was due in particular to the π-π stacking interactions of the perylene 





  Figure 1.24  3-D packing of N,N’-dialkylated PDIs reproduced from Struijk et al.117 
 
With respect to solvent contributions, certain groups have studied how the utilisation of 
aromatic solvents such as benzene, o-xylene and metisylene can influence the association 
behaviour of similarly charged ampiphilic and bolaampiphilic NDI species. Modifying the 
imide groups of the NDIs with dodecyl or cholesterol type species allowed them study how 
solvent aromaticity affects the aggregation of NDIs in solution.
118
 Through time correlated 
single photon counting they were able to show that NDIs formed ground state charge transfer 
complexes with aromatic solvents evidenced by changes in the exponential fluorescence 
lifetime decay upon variation of solvent electron density. No observable change in absorption 
or emission spectra was seen upon variation of NDI concentration, it was thus concluded that 
the change in photophysical properties was due to exciplex (excited complex) formation. 
Ultimately, imide group substitution was not the overwhelming influencing factor when 
governing charge transfer complexation, solvent plays a larger role, unless the substituent 





Additionally, a particularly extensive study by Eakins et al. characterised how factors such 
hydrophobicity, hexyl chain length, charge, peptide length and number of stereocentres 
influenced the thermodynamic aspects of peptide driven self-assembly of a variety of PDIs.
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Increased peptide hydrophobicity led to greater entropic driving forces of aggregation. One of 
the most interesting aspects of this study was the effect that solvent played on PDI 
aggregation. By studying the assembly behaviour of the compounds in a variety of solvents 
that varied across the ET
N
 solvatochromic scale, two particular groups emerged. They 
observed a wide variety of aggregation factors across the solvatochromic scale that 
essentially demonstrated that the solvation parameters that underpin the scale are not the only 
influencing factor in aggregation. Rather, aspects such as the ability of solvents to π-π stack 
with the PDIs or solvents that have the capacity compete with hydrogen bonds tend to lead to 
more monomeric, less aggregated species. 
 
 
Figure 1.25 Selected plots of the aggregated fraction of (a) 3 and (b) 6 in various solvents 
across a wide range of solvent character (as described by the ET
N
 solvatochromic scale), 








1.7.3 Naphthalene diimides in supramolecular surface chemistry 
The extensive π conjugation through the presence of highly ordered pyrolytic graphite 
(HOPG), graphene or a variety of graphene-like poly aromatic hydrocarbons can serve to 
enhance the stacking interactions with NDI like molecules to manipulate their structural 
conformation. The following section will discuss primarily how the presence of a solid 
graphitic interface can modulate the forces of interaction to drive the direction of self-
assembly toward very particular nanostructures. 
Some studies have extended the use of naphthalene diimides towards their value as linker 
molecules for the attachment of melamine to form cavity based networks. Palma et al. 
utilised a variety of linkers to bridge malemine molecules together via hydrogen bonding and 
studied how these linkers influenced the degree of structural polymorphism and the extent of 
phase separation at the solid-liquid interface.
119
 Through scanning tunnelling microscopy 
(STM), they were able to demonstrate the formation of 2-dimensional nanoporous 
architectures when melanin was blended with naphthalene tetracarboxylic. The bicomponent 
mixture of melamine and NDI linker were mixed in trichlorobenzene and DMSO and further 
deposited onto highly ordered pyrolytic graphite to create the solid liquid interface. Mixtures 
containing melamine with NDI forced the mixture to assemble into both linear 1 dimensional 








Figure 1.26 (a), (c), (d) Constant current STM images of1+MEL. (a) Zoom in of a small 
crystalline domain showing a pentagon defect. (b) Simulated STM images at constant height: 
in white at (EF - 0.72) eV and in red at(EF + 0.83) eV. (c) Survey STM image showing a 
polygonal motif. (d)Zoom-in with superimposed molecular models; the red bar corresponds 
to 3.2 nm. Tunneling parameters: (a) average tunneling current It ) 0.5 pA,sample bias 
voltage Vt ) -500 mV; (c), (d) It ) 5 pA, Vt ) -500 mV.
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However, only hexagonal structural arrays were observed when the concentration of the 
mixture was altered to favour melamine dominance. Phase segregation and the assembly of 
different nanostructures from a bicomponent mixture are governed by enthalpic driving 
forces from hydrogen bond recognition. The presence of HOPG at the solid interface allowed 
for a competitive physisorption interaction through van der waals and π-π interactions that 
drove the bicomponenet mixture containing NDI to form a 1 dimensional linear secondary 
phase. It is expected that the role of Van der Waals type interactions to be a considerably 
smaller magnitude to that of hydrogen bonding. It was therefore necessary to decrease the 
proportion of the mixture containing NDIs in order to limit van der waals interactions at the 
solid interface and thus favour the hexagonal nanostructured phase formation. The movement 
towards surface based supramolecular methods at the solid liquid interface for nanostructured 
assembly has led to the inclusion of NDI and its congeners in order to modulate the forces 
that drive the adsorption of organic molecules onto more planar aromatic structures. Slater et 





melamine to form a triple-hydrogen bonded symmetry system that created a honeycomb 





Figure 1.27 (a) STM images of PTCDI (top), (SPr)2–PTCDI (middle), and Bu2–CTCDI 
(bottom) deposited on a graphene monolayer formed on Rh(111)/YSZ/Si(111). (b) Schematic 
of dimeric and trimeric hydrogen-bonding junctions observed. STM imaging parameters: (a) 
Top image: sample voltage, −1 V; tunnel current, 0.2 nA. Middle image: sample voltage, −1 




The combination of PTCDIs with melamine to form 3-D surface networks also extends to 
their deposition on other 2-dimesnional layered materials such as boron nitride (BN) and 
molybdenum disulphide (MoS2). Molybdenum disulphide in particular also demonstrates the 





difference in the hexagonal arrangement between depositions on graphene and MoS2 is the 
tendency for PTCDIs to form hexagonal islands of smaller dimensions.
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 These studies have 
established that the capacity of NDI like molecules to effectively adsorb onto aromatic 
surfaces is associated with the presence of a surface moiré pattern that provides multiple sites 
for self-assembly. PTCDI chains form into hydrogen bonded rows when deposited on 
graphene. However, the formations of 3-D islands are preferred when deposited on graphite, 
due to the lack of a moiré pattern. The influence of surface moiré patterns is also reflected on 
the adsorption of PTCDIs on boron nitride. Boron nitride possesses a larger moiré pattern 
periodicity; therefore the alignment of the NDI like structures with the pattern in periodicity 
effectively prevents the formation of more extended hydrogen bonding networks. This is 
supported by studies performed by Pollard et al. whereby the adsorption of variants of 
perylene diimides onto Rh (III) grown epitaxial graphene were studied. Through scanning 
tunnelling microscopy, they showed that the molecular assembly and dimensions of PDIs on 
graphene corresponded to the moiré structure that led to 1- dimensional supramolecular 
arrangement. The stabilisation of the structure arises due to NH 
.... 
O intermolecular hydrogen 








Figure 1.28 a) STM image acquired following deposition of PTCDI on agraphene monolayer 
formed on Rh(111)/YSZ/Si(111); inset: structureof deposited molecule. b) PTCDI–PTCDI 
dimer with a center–centerseparation of d stabilized by two hydrogen bonds. c) Small area 
scanshowing intramolecular double lobe contrast of PTCDI molecules ongraphene. d) 
Placement ofPTCDI rows on graphene superstructure asdepicted in Figure 1b. e) STM image 
of PTCDI on a BN nanomeshformed on Rh(111)/YSZ/Si(111) in which isolated molecules 
aretrapped in nanomesh “pores” in contrast to the rows formed ongraphene. f) Placement of 
molecules on BN nanomesh. g) Highercoverage of PTCDI (0.11 moleculesnm_2) showing 







By manipulating the PDIs to contain alkyl chain substituents at the bay areas, they were 
able to tailor the surface assembly to favour triangular arrangements over linear arrays. The 
significance of the matching NDI assembly to the surface moiré structure lies in that it 
ultimately determines whether or not the molecules can adsorb to the surface in locations 
where their surface and intermolecular interaction energies are minimised. This eventually 
establishes the presence or absence of extended surface structures.
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The use of NDIs in conjunction with small polyaromatic hydrocarbon fragments allows 
for the control of supramolecular assembly by varying the nature of charged or alkyl species 
within the complex. The fine-tuning of these factors is seen as an efficient design strategy 
towards tailored supramolecular arrangement. Kumar et al. carried out an investigation in 
which oppositely charged donor acceptor molecules were used to enhance the supramolecular 
binding of a naphthalene diimide ampiphile and a tetrapotassium salt of coronene. Three 
NDIs were synthesised based on varying the substituents on the imide groups of the NDI 
species. They were able to control the extent of assembly that was governed by electrostatic 
forces by inclusion of either alkyl chains or quaternary ammonium salts on the imide moieties 
of the NDI. A variety of solution based titrations (UV-Vis, NMR) confirmed the charge 
transfer processes, as well as the electron shielding effects upon ground state face centred π-π 
complexation.
123
 The positively charged NDI species formed stronger charge transfer 
complexes with the coronene species when compared to the neutral species. Additionally, the 
employment of assymetric NDI substitutions of alky chains and hydrophilic cationic species 
led to the growth of 1-D nanofibres. 
The combination of NDI and coronene-like polyaromatic hydrocarbons has led to 
crystalline assemblies of value to a variety of optoelectronic properties. Schmidt-Mende et al. 
combined a perylene diimide with a hexaphenyl substituted hexabenzocoronene (HBC) in a 
solution process method for the construction of a self-assembled liquid discotic crystal.
124
 Pi-
pi interactions drove the assembly of the bi-component mixture spin coated from chloroform 
into columns of disc-shaped arrangements. Varied thin film morphologies were observed via 
AFM and SEM depending on the proportion of PDI and HBC in the supramolecular blend. 
Surface smoothness, with continuous coverage was observed in equal blends, whereas more 
rough protrusions were noted in pure PDI films. Photodiodes formed from blends of the two 





either component between large interfacial areas evidenced by considerable 
photoluminescence quenching. 
1.8 Summary of Chapter 1 
The continual rise in incidence of prostate cancer has led to the expansion and 
development of technologies capable of effectively imaging cancer both in vitro and in vivo. 
The advances in imaging technologies have led to a parallel rise and progress in a variety of 
chemical strategies for the development of novel cancer imaging agents. Graphene in 
particular is a material whose study has seen an incredible escalation in its utility for a variety 
of cancer diagnostic and therapeutic strategies. Its ease of oxidation and subsequent 
functionalisation has led to the attachment of a diverse range of molecules that provide 
imaging capabilities, cancer targeting and therapy, as well as enhanced biocompatibility. 
The field of supramolecular chemistry is an area well suited to the development of 
functional graphene-based materials as it allows for the controlled modification and 
development of nanostructured self-assemblies. Naphthalene diimides are a class of 
fluorescent organic molecules that have been used for the development of a number of 
nanostructures based predominantly on van der Waals and electrostatic interactions. The 
addition of amino acids and peptide sequences into their structures has not only expanded the 
capacity to tailor the forces that govern supramolecular assembly, but has also provided 
additional opportunities for cancer targeting. 
NDIs and their peptide derivatives are capable of adsorbing onto the surfaces of allotropes 
of carbon, including graphene, as well as a variety of other polyaromatic hydrocarbons. These 
binding events occur principally via π-π stacking and demonstrate a capacity for enhanced 
supramolecular binding mediated by charge transfer processes both in a ground and excited 
state. The focus of this work is to develop amino acid and peptide derivatised naphthalene 
diimides that can be used to bind to the surfaces of graphene and polyaromatic hydrocarbons, 
as a means of developing supramolecular fluorogenic graphene assemblies that can be used to 





1.8.1 Aims of this work: 
1. To synthesise chiral naphthalene diimides (NDIs) bearing aryl halide modified 
phenylalnine moieties and investigate their optoelectronic and self-assembly 
properties in solution and solid-sate. To explore the potential of these NDIs as 
potential cancer imaging agents via laser scanning confocal microscopy (LSCFM) and 
2-photon fluorescence lifetime imaging (2P-FLIM). 
2. To investigate the formation of donor-acceptor complexes of the NDIs with C60 and 
the planar polyaromatic hydrocarbon (PAH) coronene. To utilise UV-Vis, NMR, 
fluorescence and time correlated single-photon counting (TCSPC) to investigate the 
influence of aryl halide species on the association of the complexes via ground and 
excited state energy processes. The capacity for prostate cancer cells to internalise the 
complexes will be studied and the subsequent in vitro emissive properties will be 
characterised. 
3. To synthesise and characterise reduced graphene oxide from a graphite oxide 
precursor. To study the complexation of the fluorescent NDI molecules with reduced 
graphene oxide via fluorescence titrations and TCSPC. To establish the capacity for 
internalization of the graphene complexes in prostate cancer cells and characterise the 
in vitro emissive properties via laser scanning confocal microscopy. 
4. To synthesise and functionalise the peptide sequence (Bombesin 7-13) for targeting 
prostate cancer cells via G-protein couple receptors. To evaluate the binding capacity 
of the peptide sequence to cancer cells via electrochemical impedance spectroscopy 
(EIS). To derivatise the NDI molecules synthesised herein with this peptide sequence 
and subsequently complex the bio-conjugate to reduced graphene oxide. To perform 
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Chapter 2.  Optoelectronic and self-assembly properties of chiral naphthalene 
diimides and their prostate cancer imaging potential 
 
2.1 Overview to Chapter 2 
 
The capacity to alter the optoelectronic properties of organic molecules via the strategic 
manipulation of electron withdrawing/donating substituents has been exploited in the 




 Over recent years NDIs have 
shown a tendency to assemble and fold into a variety of nanostructures in various solvents 
based predominantly on Van der Waals and electrostatic interactions. As has been alluded to 
in the literature review, diimide molecules possessing aromaticity such as NDIs, and their 
higher order homologues PDIs, extend their utility to a variety of applications. They can 





 precursors to macrocycles, as well as electrically conducting and variably 
photoactive molecules.
5
 Indeed, the synthesis of molecules that stack in a way that allows for 
extensive π orbital overlap is essential for various optoelectronic applications. 
In particular, symmetric chiral variants of these molecules are of interest in the design of 
photoactive supramolecular systems due to their optical activity coming from the chirality 
induced asymmetry of the chromophores and their interactions with one another.
6
 The nature 
of the packing of this particular class of molecules has extensive influence over the 





many cases the manipulation of substituents to tailor the type and extent of intermolecular 











 have demonstrated a 
capacity to form π stacks that exhibit helical structural arrangements. Many of these 
molecules demonstrate enhanced fluorescence quantum yields and high carrier mobilities due 
to the higher order within their molecular structure. For instance, Dehm et al. synthesised a 
perylene diimide possessing diimide phenyl substituents appended with hexyl chains that 
showed helical growth within columnar dye assemblies.
11
 This particular study was able to 
determine thermodynamic parameters associated with the self-assembly of π stacked species. 
Variable temperature circular dichroism (CD) revealed that the PDI molecules preferred a 
right handed aggregate formation at lower temperatures. Whereas at higher temperatures, left 





temperatures were observed from temperature dependent UV-Vis studies. Certain studies 
have carried out in depth investigations into what effect this helical self-assembly process has 
on vibronic coupling. These studies have utilised circular dichroism spectroscopy to study the 
vibronic coupling effects and have revealed aspects such as Davydov splitting leading to 
positive and negative CD effects.
6, 9, 15
  
Zheng et al. developed an NDI possessing a double substituted phenolic sugar bearing 
amine. Their work aimed to exploit the ability of certain chiral NDIs to undergo a reversible 
colour change upon switching of its redox state from neutral to radical anion and dianion.
16
 
Chiral environments can be constructed from the assembly of chiral supramolecular systems. 
This study therefore developed a helically stacked dye that when reduced to its radical anion 
and dianion states created an optical conduction band as a result of the excitation of π 
electrons in the stacked assembly. This resulted in reversible absorption and CD 
characteristics within the NIR region (1310 – 1550 nm). The ability to control the optical 
activity of chiral molecules within the NIR region is particularly valuable for bioimaging 
applications owing to the transparency of biological tissue in this region. 
Studies on the assembly of NDIs have led to a more general description of their assembly 
as being either H or J aggregates driven by π-π interactions. J bands occur when molecular 
aggregates of dyes present a narrow absorption peak that is red shifted away from the region 
of monomer absorption. When the absorption band is shifted to higher energies (i.e. blue 
shifted), the aggregation is described as H type.
17
 Indeed many changes in fluorescence 
properties can be observed in these types of assemblies. With some of these NDI 
chromophores exhibiting aggregation-induced enhanced emission (AIEE).
18
 The majority of 
NDI based molecules form J aggregates.
19
 However, certain studies have shown aspects of 
solvent control on J or H type aggregation,
20
 with instances of perylene-based chromophores 
exhibiting this particular dependency. Kumar et al. used detailed optical studies (UV-
Vis/Fluorescence) to show that the dynamic self-assembly of an ampiphilic NDI led to the 
assembly of different polymorphic phases/aggregates depending on the solvent.
21
 Further 
aspects of the structural arrangement dependency of the two aggregation types will be 
discussed within the chapter. 
The ability of NDIs to play extended roles in self-assembly and cancer targeting requires a 
molecule that possesses a variety of functional positions for subsequent modification. The 
attachment of amino acids to NDIs is desirable because it allows for the introduction of a 





ones disposal allows for a means of introducing and tailoring Van der Waals, π-π and/or 
hydrogen bonding interactions such as can be achieved with amino acids like lysine or amino 
acids possessing aromaticity such as phenyl alanine or tryptophan. Prior to 2006, the strategy 
for producing these molecules relied on the condensation reactions of primary amines with 
naphthalene tetracarboxylic acid dianhydride. Typically the two starting materials would be 
subjected to reflux conditions for extended periods of time in high boiling solvents. 
Furthermore, these conditions were not adaptable to free amino acids or sensitive/protected 
amines. 
 Microwave assisted organic syntheses for this particular reaction have been studied. 
Microwave irradiation results in highly efficient reaction heating conditions due to the direct 
application of microwave energy to the molecules of interest. Dipolar polarization and ionic 
conduction facilitated by the presence of dipoles (such as those provided by polar solvent 
molecules and charged species, respectively) facilitates the conversion of microwave energy 
into heat with additional losses due to molecular friction and solvent dependent dielectric 
losses. Microwave heating can reduce reaction times due to the ability to superheat solvents 
and thus eliminate the need for extended reflux conditions of high boiling solvents. 
Additionally, microwave reaction conditions can lead to cleaner more selective high yielding 
reactions due to optimised heating of temperature dependent reaction pathways.
22
 
Pengo et al. exploited a microwave dielectric method to produce symmetrical α-amino 
acid derivatised NDIs in an efficient, high yielding manner, with a broad scope of varying 
amino acid substituents.
23
 This particular methodology has been replicated to produce a series 
imide substituted NDIs possessing phenylalanine with modified aryl halide substituents. The 
following chapter discusses the synthesis, optical characterisation, solution self-assembly and 
cell imaging of the NDI chromophores with a view to assessing their viability as potential 
cancer imaging agents. 
2.2 Synthesis of chiral naphthalene diimides 
 
1,4,5,8-Naphthalenetetracarboxylic dianhydride (200 mg, 0.746 mMol) and the 
corresponding α-amino acid derivative (1.491 mmol) were suspended in 5 mL of DMF in a 
pressure-tight 20 mL microwave vial. To this suspension was added 0.2 mL of dry Et3N. The 
suspension was sonicated until the mixture became homogeneous. The reaction mixture was 





system. The solvent was removed under reduced pressure, and each reaction mixture was 
recrystallised in Acetonitrile and 1M HCl yielding the symmetrical NDI derivative product.  
 




















H NMR spectroscopy of compound 3 in CDCl3 at 298.15 K 





All of the NDIs were synthesised in high yields in a pure form characterised by single 
peaks in their HPLC chromatograms (see experimental section for retention times and 
appendices for HPLC traces).  Associated NMR assignments and spectra can be found in the 







Table 2.0 Summary of NDI 
1
H NMR resonances 
Chemical Shift (δ) in ppm 
NDI HA HB HC HD HE HF 
2 - 8.87 7.72-7.09 6.69 4.29 4.19 
3 13.11 8.63 7.36-6.78 5.81 3.56 3.27 
4 13.12 8.64 7.59-6.82 5.81 3.53 3.23 
5 13.16 8.65 7.51-6.95 5.78 3.55 3.26 
6 13.10 8.66 7.33-7.04 5.84 3.59 3.30 
7 13.10 8.62 7.22-6.97 5.86 3.59 3.31 
 
2.3 Cyclic Voltammetry 
 
The tendency of certain NDIs to form n-type structures over p-type has been exploited to 
design an extensive array of self-assembled structures. It is of particular interest in this work 
as it is essential in order to satisfy the conditions for accepting electrons in the charge transfer 
based binding mechanisms that will ultimately underpin the means by which these 
supramolecular nanostructured materials form that will be discussed in subsequent chapters. 
The electron accepting nature of the six NDI species studied was determined by cyclic 
voltammetry. A standard three electrode system comprising a platinum working electrode, a 
Ag/AgCl (in solution of KCl) reference electrode and platinum wire counter electrode and the 
ferrocene/ferrocenium (Fc/Fc
+
) redox couple as the internal standard was used. The NDIs 
were dissolved in a 0.1 molar solution of tetrabutylammonium hexafluorophosphate 
(TBAPF6) supporting electrolyte in THF to produce a 5 mmol NDI concentration. To this 
solution was added an equimolar concentration of ferrocene to act as a standard. Samples 
were purged with Argon before measurements. Experiments were conducted over a range of 
scan rates between 100 mV s
-1
 and 10 mV s
-1
. 
The voltammogram of the NDI in Figure 2.1 revealed two one-electron processes which 
can be ascribed to the sequential reduction of the two imide substituents, firstly to the anion 
and then to the dianion species. The LUMO energy levels of the six NDI species were 








𝐸𝐿𝑈𝑀𝑂 = − [(𝐸𝑟𝑒𝑑 − 𝐸1
2
 𝑓𝑒𝑟𝑟𝑜𝑐𝑒𝑛𝑒
) + 4.8]   Eq.1 
Whereby Ered is the voltage at onset of reduction and E1/2 ferrocene is the half potential of the 
ferrocene redox couple. The calculated low lying LUMO energies summarised in Table 2.1 
confirm the electron accepting nature of these NDIs and substantiate their potential for use as 
n-type electron accepting organic compounds for supramolecular complexation. 
 
Figure 2.1 Cyclic voltammogram of compound 3 in THF. Inset shows scan rate dependency 
of redox potentials situated around the half-wave potential of -0.52 V.  
















































2.4 UV-Vis molar extinction coefficients evaluation 
 
The optical properties of the synthesised NDIs have considerable influence over whether 
or not they satisfy the conditions suitable for imaging applications and for charge/energy 
transfer based binding mechanisms. The UV-Vis absorption characteristics for all of the 
NDIs were determined by performing scans across a concentration range (0.005, 0.01, 0.02, 
0.03, 0.04 and 0.05 mM) in THF. 
Figure 2.2 Concentration dependent UV-Vis absorption spectra of compound 3 in THF. 
The UV-Vis absorption spectrum for compound 3 bearing a fluorine aryl halide modified 
phenylalanine is shown in Figure 2.2. The NDI possesses three clear maxima at 
approximately 367, 347 and 328 nm. These bands appear vibronic in nature and correspond 
to the π-π* transitions of the NDI core. The largest peak at 367 is attributed to the 0-0 
evolution of the lowest electronic transition. The absorption wavelength of the vibronic peaks 
corresponds to the skeletal vibrations of the aromatic NDI core. No large deviations in the 
location of the vibronic peaks across the series of NDIs is observed in the same solvent, 
which is entirely expected as the NDIs possess no core substitutions that may lead to 
deviations in absorption from those particular core structural positions. The UV-Vis 







































absorption spectrum also shows enhancement of vibronic absorption features at elevated 
concentrations, but crucially a slight hypsochromic shift in the absorption maxima 
accompanied the increase in concentration. This suggested a transition away from a 
monomeric to a more aggregated assembly at higher concentrations. Careful examination of 
the lower energy region of the spectrum (400 – 800 nm) revelead no further regions of 
absorption as the concentration was increased. 
The fluorescence emission characteristics of the NDIs have been established in order to 
assess their suitability as imaging agents. Upon excitation of the NDIs at λexc = 367 nm 
corresponding to the naphthalene core excitation, the characteristic NDI emission curve is 
observed with a Stoke’s shift of approximately 160 nm.  
 
Figure 2.3 Normalised absorption and emission spectra of compound (3) in THF (left) and 
lifetime decay curve (right) determined via time correlated single photon counting (TCSPC). 
The fluorescence quantum yield of the NDIs were established via a comparative method in 
which the peak aborption and emission characteristics are compared to those of a known 
reference standard. In this case, the reference compound was Ruthenium trisbipy dissolved in 
water. Equation 2 is used to determine the quantum yield. 














    Eq. 2 
Where 𝜑 is the quantum yield (subscripts R and S denoting the value corresponding to the 
reference and sample under investigation), 𝐷 is the integrated area of the emission band, 𝐴 is 































Stokes shift of 160 nm 







 Raw TCSPC data
















the absorption of the solution at the excitation wavelength, 𝐼 is the maximum intensity at the 
excitation band and η is the refractive index of the solvent. S and R correspond to the sample 
and reference respectively. The quantum yield of compound 3 in THF was determined to be 
0.014, which is particularly low in comparison to its more traditional cancer imaging 
fluorophores and may therefore pose some difficulty in establishing suitable fluorescence 
intensity for cancer imaging applications. However, it is not entirely clear at this point 
whether or not such low quantum yields render the NDIs impractical for imaging. These 
aspects will be covered in more detail in the latter aspects of the chapter. The optical and 
electronic properties of the NDIs are summarised in Table 2.1 
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2 372 450-640 1.24 x 10
4 
0.023 -0.52 -0.51 -3.75 
3 372 450-640 2.15 x 10
4 
0.014 -0.62 -0.53 -3.78 
4 372 450-640 1.03 x 10
4
 0.012 -0.52 -0.52 -3.71 
5 372 450-640 1.74x 10
4
 0.019 -0.51 -0.34 -3.92 
6 372 450-640 1.15 x 10
4
 0.021 -0.55 -0.52 -3.74 
7 372 450-640 1.46 x 10
4
 0.021 -0.56 -0.65 -3.63 
 
2.5 Self-assembly in solution 
 
The UV-Vis absorption spectrum in the previous section demonstrated enhancement of 
vibronic absorption features at elevated concentrations, accompanied by a slight 
hypsochromic shift in the absorption maxima when the concentration was increased. This 
prompted a more in depth investigation into the nature of assemby in different solvents. 
Choice of solvent will ultimately play a crucial role in the geometry of aggregation, assuming 
a self-assembling system reliant on hydrogen bonding and π-π stacking interactions exists. 
The following section describes the concentration dependent solvatochromic aggregation 





The suggestion of enhanced π-π stacking interactions of the NDI chromophores within the 
aggregates is supported by the increase in absorption intensity of the primary NDI absorption 
bands as the solvent transitions towards more polar species. The increased absorbance 
intensity and band broadening for the regions corresponding to the π-π* transitions of the 
naphthalene core implies a more extended π network is present. The slight variation in 
absorption characteristics is particularly interesting in that it suggests different types of 
solvent dependent conformational assemblies. All of the NDIs demonstrated enhanced 
development of the vibronic spectral absorption features, with the peak absorbances 
becoming sharper and more pronounced as the concentration increased. However, 
accompanying these spectral changes were slight changes in the position of peak absorbances 
depending on the choice of solvent. Polar solvents such as THF, DMSO, acetonitrile and 
NMP showed hypsochromic shifts of the peak absorbances (4, 5, 6 and 3 nm respectively) as 
the NDIs transition from monomeric to aggregated concentrations. However, a bathochromic 
shift of 5 nm was observed in chloroform.  
Figure 2.4 Solvent dependent UV-Vis absoprtion spectra of compund (3) at a concentration 
of 0.05 mM. 




























Parallel stacks of mutually repelling dipoles will make it more difficult for a transition 
dipole moment to form on the absorbing chromophore. This will result in a smaller dipole 
moment and hence diminshed absorption. The aspects of hypochromism observed for the 
self-assembling NDI species across the polar solvent suggests that in these conditions the 
NDIs favour an attempt to drive mutually repelling NDI cores together as evidenced by 
aspects of diminished molar extinction co-efficients (see Table 2.2). 
The nature of chromophore assembly has been extensively studied in cyanine dyes and has 
also been identified in NDI molecules. The type of conformation these dyes can assemble 






 These aggregates are both 
formed when the stacking of parallel dye molecules occurs in a plane-to-plane or end-to-end 
fashion (for H and J aggregates, respectively) forming two dimensional crystals. Exciton 
theory explains the spectral changes with respect to their molecular arrangement.
26
 The NDI 
molecule acts as a point dipole. As the transition dipoles interact with eachother the excitonic 
state of the dye aggregate divides into two separate levels.
27
 The naphthalene cores of the 
NDI will stack in parallel conformations either in a face centred plane-to-plane fashion or an 
end-to-end arrangement. These arrangements correspond to H and J dimers, respectively.  
The difference in their optical properties is a product of the different slip angles within 
their structural packing arrangement. Exciton theory states that the parallel and perpendicular 
transition moments are accompanied by the generation  of higher and lower excitonic bands 
either side of the monomeric energy level (see Figure 2.5). In H aggregates the lower state is 




Additionally, due to the stability of the lower state in H aggregates, fast decay from the 
excited state to the ground state is observed with the majority of energy losses coming from 
non-radiative sources. This leads to the tendency for H aggregates to possess low 
fluorescence emissions (low quantum yields) and larger Stoke’s shifts.29 The opposite is true 


















Figure 2.5 Schematic representation of creation of degenerated excited states in H and J type 
aggregates. 
The various differences in optical shifts are consistent with solvent dependent molecular 
interactions that conform to a range of polymorphic phases of self-assembly. Hypsochromic 
shifts were only observed in solvents of increased polarity which could be due to the 
formation of H aggregates.  
Figure 2.6 Concentration dependent UV-Vis spectra demonstrating bathochromic and 
hypsochromic shifts characteristic of J and H type aggregation respectively. 
 











































Indeed, examination of the corresponding emission spectra showed decreases in emission 
intensity with additionally red shifting of the of peak emission position, all of which are 
signatory features of H type assembly. The solvent dependent absorption and emission 
characteristics for compound 3 are summarised in Table 2.2 including error parameters for 
the extinction coefficients (excluding the absolute external error associated with UV-Vis 
sample preparation). 
Table 2.2 Summary of solvatochromic NDI characteristics with respect to aggregation type. 
NDI Solvent 































































Figure 2.7 Solvent dependent fluorescence emission spectra of compound (3) (10 mM) 
 
It has previously been reported that the arrangement of H-type dimers in a face centred π-π 
stacking conformation can result in a decrease in distance between chromophores. This can 
lead to a broad unstructured fluorescence emission band from the lower energy state that is 
attributed to a more excimer (excited dimer) type emission, which is observed in the emission 
spectra of these NDI (see inset of Figure 2.7). This aggregation induced pre-association and 
its corresponding broad featureless fluorescence emission is not observed in solvents that 































































































2.6 Two-dimensional NMR Spectroscopy 
2.6.1 Two-dimensional Nuclear Overhauser Spectroscopy (NOESY) 
The characterisation of the molecular arrangement of the NDI assemblies is particularly 
challenging owing to their capacity to form varied arrangements depending on solvent 
composition. As has been previously observed, the conformation of the assemblies can have 
considerable influence over their optical properties. It is therefore necessary to carry out more 
detailed investigations into the manner in which NDI molecules arrange in solution. The 
ability to disperse the NMR spectrum into 2 dimensions opens up opportunities to probe 
interactions within and between molecules. These interactions can be split into those caused 
by scalar (through-bond) coupling or through-space coupling. The Nuclear Overhauser Effect 
(NOE) has proven to be a valuable tool in the characterisation of self-assembling molecules. 
NOE result from intra or intermolecular through-space interactions and, thus, they serve to 
provide a spatial reconstruction of the molecules based on their relative position to one 
another.
30
 The NOE arises as a result of through space magnetic dipolar coupling and is 
related to the distance between interacting nuclei via inverse 6
th
 power proportionality. 
Therefore, the NOE is more pronounced in protons that are spatially close to one another (< 5 
Å). Additionally, the magnitude of the NOE is associated with molecular motion. The NOE is 
positive for small molecules that “tumble” at a faster rate and negative for larger molecules.31 
A NOESY spectrum is generated by performing a 3 step pulse sequence during the NMR 
experiment. Three π/2 pulses are used in which the first generates a transverse spin 
magnetization. This magnetization precesses during time t1 which is gradually increased as 
the 2D experiment proceeds. The aim of the second pulse is to generate an equal longitudinal 
magnetization. This allows for appropriate conditions whereby cross-relaxation can occur 
between protons that are suitably close to each other. The longitudinal magnetization relaxes 
during a constant mixing time. After the magnetisation has been allowed to relax during the 
mixing time, a third pulse is applied that generates transverse magnetization from the residual 
longitudinal magnetisation, after which acquisition commences.
32
   









H NOESY NMR spectrum of compound 3. The acquisition 
was performed in CDCl3 in a 500 MHz NMR spectrometer at 298.15 K with a mixing time of 

























H NOESY NMR in CDCl3 of compound 3 showing cross-relaxation of 
phenylalanine protons with naphthalene core protons 
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From Figure 2.9 we note the diagonal line running across the 2-D spectrum that 
corresponds to the 1D spectrum of the FNDI. All of the notations either side of the diagonal 
correspond cross-relaxations between protons that are near to each other in space. By 
convention the diagonal 1D spectrum has been plotted in a positive phase. The blue notations 
are in-phase positive cross-relaxation interactions that relate to slow tumbling molecules and 
are thus indicative of cross-relaxation occurring within a large molecule.
33
 Looking first at 
the up-field region of the spectrum we note the alkyl protons of the phenylalanine (HE, HF) 
have cross-relaxation peaks with the other nearby alkyl protons (HD). Additionally there are 
interactions with one set of magnetically distinct aryl protons (HC). However, we only 
observe a single relaxation between HB and HE and no cross relaxation between HB and HF. 
This interaction is also reflected when the protons of the naphthalene core are irradiated as 
the source and the dipolar coupling transfer of magnetisation is observed in the phenylalanine 
alkyl protons of interest.  
This is particularly interesting first and foremost because it clearly suggests that in 
chloroform, the phenylalanine protons are situated in such a way that they are suitably close 
to the naphthalene core to result in a cross-relaxation of their respective magnetisations. 
However, considering the position of one set of the alkyl protons (HF) does not lead to the 
same aforementioned transfer of magnetisation implies that the through space interaction 
between the phenylalanine and the naphthalene core cannot be a parallel face-centred 
conformation. If it were, one would most likely observe a NOE between all of the 
phenylalanine protons and the naphthalene core. However, the absence of a NOE between HF 
and HB protons implies that the interaction between these particular structural moieties must 
be offset by some specific angular conformation that prevents the spatial cross-relaxation.  
Figure 2.10 displays the NOESY spectrum of compound 3 in d
6
-DMSO. The first thing of 
note is the presence of negative anti-phase cross-peaks indicative of a smaller molecule. 
Additionally, there is no through-space cross relaxation of phenylalanine protons with the 
naphthalene core. Therefore, not only do the NDIs assemble into molecular aggregates of a 
smaller size in DMSO, the phenylalanine protons are arranged in an entirely different 




























H NOESY NMR of compound 3 in d
6
-DMSO showing no cross-
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2.6.2 Diffusion Ordered NMR Spectroscopy (DOSY) 
 
Techniques based on the analysis of diffusion parameters have long been seen as a 
valuable tool for characterising supramolecular assemblies. The diffusion co-efficient of a 
particular molecule at certain temperatures and in specific solvents is governed primarily by 
its molecular weight, size and shape.
34
 The diffusion co-efficient and its associated 




The pulse field gradient spin-echo (PGSE) is the most established approach to determining 
diffusion parameters. In this particular sequence an initial π/2 pulse is applied to the sample 
leading to a net magnetisation in the transverse x-y plane. After the pulse each spin will begin 
to spread or “de-phase” throughout the x-y plane. Spin-spin interactions during transverse 
relaxation as well as any inhomogeneity in the external field will cause each spin to 
experience a variation in magnetic field.
35
 At time τ a second π pulse is applied along the y 
direction. The result is a rotation of the spins about the y-axis. Each spin is inverted and 
precesses at its frequency prior to the pulse. Therefore at time 2 τ all spins are refocused 
leading to an echo. The gradient pulse labels coherences with a phase that corresponds to 
the position and coherence order of the individual spins in the sample. The gradient is 
what causes the spins at various locations in the sample to spin differently and thus 
accentuate the de-phasing process. If the rate of spin precession varies throughout the 
gradient experiment, it means their spin positions have changed which ultimately leads to a 
decrease in spin-echo intensity.
35
 Therefore the spin echo intensity is directly related to the 
extent of diffusion that has led to the phase shift of each spin after τ2. A larger diffusion co-
efficient is typically observed for a sample characterised by poorer spin system refocusing 













Figure 2.11 Schematic representation of DOSY NMR pulse sequence (top) and 
corresponding effect on proton NMR spin phase and echo intensity (bottom).
34
 
The diffusion of a molecular species is governed by size, shape of the diffusing species, 
temperature and viscosity of solvent. If one assumes a spherical species is diffusing, the co-




     Eq. 3 
Whereby k is the Boltzmann constant, T is the temperature; η is the viscosity of the 
solvent and rs is the hydrodynamic radius of the molecule. 
The change in NMR signal intensity as a result of spin-echo is described by 
𝐼 = 𝐼0𝑒





Whereby I is the observed intensity, I0 is the reference intensity, D is the diffusion 
coefficient, γ is the gyromagnetic ratio of the observed nucleus, g is the gradient strength, δ is 
the length of the gradient and Δ is the diffusion time 
 
This can be simplified further by combining the terms that are constant. 
𝐼 =  𝐼0𝑒
−𝐷 𝑄      Eq. 5 
From equation 2.1 and 2.3 one can determine the diffusion co-efficient and the 
hydrodynamic radius of a molecular species subject to aggregate inducing intermolecular 
interactions. From Figures 2.12 and 2.13 we note that the diffusion coefficients for compound 











as the viscosities of the two solvents and substituting these values into equation 2.1 
the hydrodynamic radii of compound 3 can be determined. The values are summarised in 
Table 2.3. The results of the DOSY NMR experiments reflect the data obtained in the 
NOESY NMR experiments whereby in solvents such as chloroform the NDIs assemble into 
larger structures in comparison to polar solvents possessing lone pairs that are capable of 
competing for hydrogen bonds as evidenced by the larger hydrodynamic radius for compound 
3 in chloroform. The UV-Vis, NOESY and DOSY NMR experiments give us some 
indication of the assembly in terms of the location of naphthalene cores with respect to one 
another and on the arrangement of the appended phenylalanine units. However, these results 
are not overwhelmingly conclusive and there remains some degree of ambiguity with respect 
to the exact manner in which the NDIs are likely to interact with each other.  
The ensuing sections will cover more specific means to elucidate the structural arrangement 
of the NDIs both in solution and in the solid state. 









































Figure 2.12 DOSY NMR spectrum (left) and diffusion coefficient for selected NDI proton 













Figure 2.13 DOSY NMR spectrum (left) and diffusion coefficient for selected NDI proton 








2.7 Circular Dichroism 
 
Circular Dichroism (CD) spectroscopy is a characterisation tool that is used predominantly 
in the investigation of chiral molecules within large biological systems. It is particularly 
valuable in the study of macromolecules that possess complex secondary structures that are 
sensitive to changes in surrounding environment (i.e. solvent, temp, pH etc). It is therefore 
particularly useful for studying how these factors influence the conformation of self-
assembled molecules. 
CD functions on the premise that a chiral molecule will differentially absorb left and right 
handed circularly polarised light. Linearly polarised light possesses light oscillations that 
exist in a single plane. If one combines two linear vertically and horizontally polarised light 
waves of equal amplitude and phase, the resulting light wave is linearly polarised at 45
o
. 
However in CD, a birefringent quarter wave plate is utilised in order to vary the refractive 
indices experienced by the vertically and horizontally polarised light, so that one of the light 
waves moves at a lower speed with respect to the other. This creates a set of waves that are 
out of phase with one another that when combined lead to a circularly polarised light wave. 
During the measurement of a CD spectrum, a chiral entity will absorb left or right circularly 
polarised to a greater extent than the other. Therefore any given CD signal over a particular 
wavelength region scanned will be non-zero. 
 
Figure 2.15 Diagram illustrating generation of circularly polarised light utilised in the 






Figure 2.16 CD spectrum of compound (3) in CHCl3 (20 μM) before and after the addition of 
20μL of THF. Inset shows expanded region of spectrum highlighting the cotton effect 
characteristic of helical molecules. 
 
As the chromophores within a chiral molecule interact with one another, excitonic 





 M or lower in some cases. The intermolecular distance between 
such interacting molecules at those concentrations tends to be longer than 10 nm. Therefore, 







interaction between said molecules is considered negligible. However, this is not the case for 
this particular class of molecules and their aggregation characteristics. As mentioned in the 
section describing the solvatochromic dependency of the NDI optical properties, all of the 







when any two of the identical NDI chromophores interact with one another without bearing a 
direct conjugation (i.e. a supramolecular non-covalent interaction), either of the two 
chromophores have the same statistical likelihood of experiencing electronic excitation and 
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therefore separating into two degenerated transitions (see Figure 2.5). This is known as 
Davydov splitting and is what causes the excitonic coupling observed in the CD spectrum. 
The CD spectrum of compound (3) is shown in Figure 2.16. It shows evidence of Davydov 
splitting whereby the bands of electronic or vibrational spectra are split as a result of two or 
more interacting equivalent NDI molecules in the unit cell. If a chromophore is electronically 
excited whilst in close proximity to another chromophore, a subsequent coupling of their 
transition dipole moments may occur. An absorption spectrum consisting of exciton coupled 
chromophores that are arranged in a chiral fashion will lead a bisignate cotton effect. In 
Figure 2.16, the optical rotation observed in the CD spectrum is heavily wavelength 
dependent in the most prominent absorption bands of the NDI chromophore. As the 
wavelength decreases, the angle of rotation becomes positive until it reaches a maximum. At 
this point it starts to decrease crossing the zero axis point to produce negative ellipticity. 
After reaching a minimum, the ellipticity subsequently rises again. The maximum and 
minimum occur at the absorption maxima for the skeletal vibrations of the aromatic NDI core 
of the NDI chromophores. This is known as the cotton effect. The positive sign at lower 
energy for the first cotton effect and the negative sign for the second at a slightly higher 
energy suggest a right handed screwness of the electric dipole moments of the adjacent NDI 
chromophores commonly associated with a helical arrangement. It is interesting to note that 
after the addition of 20 μL of THF, the cotton effect disappears (red line in Figure 2.16). This 
suggests a breakdown of the helical assembly. This is not unexpected considering that THF is 
polar solvent possessing a lone pair of electrons that can compete with the NDI assembly for 
the hydrogen bonds necessary to form the helical structure. Indeed, in order to obtain the 
characteristic helical spectrum, the CD acquisition had to be performed in chloroform solvent 
that was stabilised with amylene, as opposed to ethanol. Therefore, it is a clear indication that 
any slight degree of polarity in the surrounding molecular environment leads to a set of 
conditions in which higher order helical aggregate assemblies are highly unlikely. 
The solution studies have revealed degrees of variation and complexity associated with the 
self-assembly of the NDI species, and it was therefore necessary to attempt to grow crystals 
of the NDIs to establish a more definitive picture of the structural arrangement of the NDIs 







2.8 Solid Sate Characterisation 
 
Single crystals of compound 3 suitable for X-ray diffraction analysis were obtained from 
two different saturated solutions of 3 in chloroform filtered through PTFE membrane. NDI 
solutions were then stored at –20°C or room temperature overnight to allow crystal growth. 
In both cases the same structure was obtained. 
Compound 3 crystallises in the orthorhombic system, P212121 space group, with four NDI 
molecules and four solvent molecules in the unit cell (See appendix for detailed bond 
parameters). 
 
Figure 2.17 Unit cell fragment showing the packing diagram of compound 3, which 
crystallised in the orthorhombic P212121 unit cell. Thermal ellipsoids at 50 % probability. 
There are hydrogen bonds between the carboxylic groups of neighbouring NDIs, resulting 
in an extended H-bonded plane of NDIs (Table S3 in the appendix). The planes are linked 
together through double short contact interactions between the NDIs, resulting in the stacking 
of two layers, with two solvent (CHCl3) molecules in the cavity (Figure 2.17), and leading to 






Figure 2.18 Alternative representation of a fragment of the unit cell, showing the extended π-
π network through interaction of phenyl substituents and naphthyl core. Thermal ellipsoids at 
50% probability 
 
Interestingly, the naphthalene core is not planar and this can be attributed to some 
interaction between the carbonyl C(10) and O(2) of the carboxylic acid group of the phenyl 










Figure 2.19 The asymmetric unit of 3, showing non-planar naphthyl core. Thermal ellipsoids 
at 50% probability 
 
 






X-ray diffraction analysis of p-fluoro-phenylalanine-NDI (compound 3) reveals important 
information on the spatial structure of these amino acid tagged compounds. The structure of 
compound (3) is displayed in Figure 2.19. Structural data, selected bond lengths and angles 
and hydrogen bond tables are provided in the Appendix. The torsion angles between fluoro-
phenylalanine moieties and longitudinal direction of the NDI skeleton is 73.5°. The N1, C10, 
O3, C21, O4 atoms lying 7.2(3)° and N2, C15, O5, C16, O6 atoms lying 2.4(3)° outside of 
the mean plane comprised of atoms C11, C12, C13, C14, C17, C18, C19, C20, C22 and C23. 
























Crystal structure of compound 3.C6F6 
The structure of compound 3.C6F6 is displayed in Figure 2.21. Structural data, 
selected bond lengths and angles and hydrogen bond tables are provided in Table S1, 
S2 and S3. 
 
Figure 2.21. Molecular structure of 3.C6F6. Thermal ellipsoids at 50% probability. 
Compound FNDI (3.C6F6) crystallises in the triclinic space group P1, with one NDI 
molecule and one solvent molecule in the unit cell. The dihedral angles between fluoro-
phenylalanine moieties and longitudinal direction of the NDI skeleton is 68.0° (Figure 2.22). 
Interestingly, the naphthyl core is not planar, with the N1, C10, O3, C21, O4 atoms lying 
2.3(4)° and N2, C15, O5, C16, O6 atoms lying 3.4(5)° outside of the mean plane comprised 






Figure 2.22 Tilt angle (diheadral angle) between the mean plane of C11-C23 and the axis of 
fluoro-phenylalanine moiety for 3.C6F6 
 
The two fluorophenylalanine moieties are on opposite sides with respect to the mean 
plane. The torsion angles of the fluorophenyl groups with respect to the mean plane C11-C23 
are 177.2(2)° (the phenyl ring containing the C4) and 179.8(17)° (the phenyl ring containing 
the C27). Finally, the existence of hydrogen bonds between the carboxylic groups of 
neighbouring NDIs result in an extended H-bonded plane of NDIs (Figure 2.23). The planes 
are linked together through π- π interactions between the phenyl groups from NDIs and the 
solvent molecules, resulting in the stacking of two layers, with one solvent (C6F6) molecule 
between the phenyl rings of NDIs from two different planes. The solid state characterisation 





structural arrangement of supramolecular assemblies, thermodynamics of their interaction 
and their capacity to facilitate charge/energy transfer. 
 
Figure 2.23 Crystal packing diagram of 3.CHCl3 showing the existence of hydrogen bonds 
between the carboxylic groups of neighbouring NDIs. Thermal ellipsoids at 50% probability. 
The red, purple, grey, white and yellow coloured atoms represent O, N, C, H and F, 
respectively. 












Attempts were made to obtain structures of compound 2; however the only suitable single 
crystals couldn’t be resolved with an error lower than 25 %, therefore only a partial solution 
of the crystals structure was obtained. The crystals were obtained from a 1:1 mixture of 
toluene and THF. The structure for compound 2 is shown in Figure 2.24. One of the phenyl 
alanine moieties is aligned with the naphthalene core of an adjacent NDI molecule, with a 
distance of 3.35 Å, suggesting a - interaction. Despite being performed in a different 
solvent system to the one in which the crystals were grown, these structural aspects are 
consistent with NOESY NMR experiments that showed cross-relaxation between the 
naphthalene core and phenyalanine, suggesting they were close to each other in space. 
Additionally, each phenylalanine moiety orients itself so as to allow for a network of 
hydrogen bonds between carboxylic acids that facilitates the formation of a tubular 3D 
structure (Figure 2.24). This is also consistent with the circular dichroism results discussed 















Figure 2.24 Crystal packing and solvent accessibility diagram of 2 showing the existence of 
tubular network due to hydrogen bonds between the carboxylic groups of neighbouring NDIs. 









The Van der Waals radii were used to estimate the magnitude of the pore diameters and 
these were determined to be 12.3Å and 18.3Å (see Figure 2.24). The crystal structure analysis 
was unable to solve for the interaction of the solvent. This aspect is crucial because the 
solvent system used to grow the crystals was toluene and THF and thus contained both 
aromaticity and polarity. One would therefore expect there to be significant - and/or 
competitive hydrogen bonding. It is therefore unclear to what extent this particular solvent 
system influences the supramolecular arrangement of the nanotube structure. However, the 
partial structure, taken in conjunction with the circular dichroism, DOSY and NOESY NMR 























2.9 In-vitro Laser Scanning Confocal Microscopy of NDI 
 
Laser scanning confocal microscopy has been performed on the chiral NDIs in order to 
establish their potential as cancer imaging agents. PC-3 cells were grown according to 
standard serial passage protocols and plated onto glass bottom dishes and allowed to grow  up 
to a suitable confluence (see experimental section for cell culture and plating details). Prior to 
imaging serum free medium (SFM) was removed from the plated cells and the cells were 
washed with potassium phosphate buffer solution (PBS) 3 times. 990 μL of SFM was added 
to the cells and 10 μL of the NDI compound was added to the SFM from a stock 
concentration of 10 mM to leave a final concentration of 100 μM. The cells were incubated 
for 15 minutes, after which the SFM containing the compound was removed and the cells 
washed with PBS 3 times to ensure any surface compound had been removed. Prior to 
imaging, a 1 ml volume of SFM as added to the plated cells. 
Cells were imaged using a Nikon A1Rsi Laser Scanning Confocal Microscope System 
fitted with 60X objective lens. Initially, camera images were taken of the sample with a 
standard detector. The sample was manually focused and irradiated with a 405 nm laser. The 
number of pixel setting was adjusted to 512x512 as an appropriate resolution. The pinhole, 
laser power and HV were adjusted until a suitable image was obtained, after which the image 





















Figure 2.25 Single-photon confocal direct camera acquisition: Compound 3, 50μM, 0.5% 
DMSO, at 37°C in PC-3 cells incubated for 15 minutes.  The cells were irradiated with 405 
nm light and DIC image is represented by (a) the brightfield image of the cells prior to 




Figure 2.25 shows the bright field camera image and the overlay of the emission of the 3 
channels (separated images of the individual channel emissions can be found in appendix). 
From Figure 2.25 it is clear that there is up-take of the NDI compound in PC-3 cells, with the 
majority of the emission lying within the blue and green wavelengths with some minor 
emission in the red wavelengths. Considering the successful uptake it was deemed necessary 
to perform further images with confocal settings in order to gather more information 
regarding cellular uptake and distribution. 
The microscope was switched to confocal mode. Image acquisition conditions were 
adjusted in a similar fashion to the previous camera mode. During acquisition, the pixel dwell 
time was increased to maximise the degree of laser irradiation time per pixel. Images were 
checked to ensure laser power not causing pixel saturation and the images were line averaged 






Figure 2.26 Single-photon confocal fluorescence image acquisitions. Compound 3, 50μM, 
0.5% DMSO, at 37°C in PC-3 cells incubated for 15 minutes.  The cells were irradiated with 
405 nm light and image is represented by the separated emissions across the blue, green and 
red channels (a, b & c) and the overlay of the individual channel emissions (d). 
Figure 2.26 reflects the images taken in the camera mode with a large majority of the 
emission lying in the blue and green wavelengths. However, it is much clearer that there is 
broad emission across all of the visible wavelengths including the red. This is consistent with 
the solvatochromic studies performed earlier in the chapter whereby the NDIs demonstrated 
broad emissive characteristics ranging from 400 to 700 nm of the visible spectrum. Also 
encouraging is the fact that clear and well resolved emission could still be observed despite 
the relatively poor quantum yields of the NDIs. From the confocal microscopy it seems the 
NDIs localise throughout the cell structure, however there seems to be little emission coming 





nuclear membrane. It was therefore deemed necessary to perform depth scans across the 
entire sample to confirm uniform distribution of the NDIs within the cell cytoplasm. 
A Z-series section scan was performed on the sample by adjusting the focus to set the start 
and end planes at the top and bottom of the sample in order to define the scan depth. The 
number of steps was then adjusted to define the separate scan sections for the number of 
image layers to be acquired. A z-stack was performed on the images in order to build the 
layers of the sample sections together. Smoothing function, background subtraction, gauss-
laplace filter and matric expansion were adjusted to interpolate and generate a 3-dimensional 
image of the sample. The 3-dimensional image in Figure 2.27 is generated from in-vitro 
fluorescence emission of the internalised compound. Therefore, the presence of the outline of 















Figure 2.27 Image showing the 3-dimensional render of the confocal fluorescence z-stack 
series of images for compound 3 at 405 nm laser irradiation after 15 minutes of incubation in 
PC-3 cells at the 37 
o






2.10 Two-photon Fluorescence Lifetime Imaging Microscopy (2P-FLIM) 
 
2 photon fluorescence lifetime imaging was performed on both of the substituted NDIs 
bearing bromine and iodine aryl halide phenylalanine substituents (Compounds 5 and 6). 
Each compound was incubated with PC-3 cells at a 100 µM concentration in 1 % DMSO for 


















Figure 2.28 Two-photon fluorescence lifetime map in PC-3 cells of compound 3 (top) and 
associated distribution curve (bottom left) and lifetime decay profile (bottom right) at 100 μM 




















































The 2P-FLIM cellular studies indicate that the aryl halide substituted NDIs could be taken 
up by PC-3 cells with the distribution lying predominantly in the cytoplasm. The images also 
demonstrate the presence of cavities void of fluorescence lifetime emission where the cell 
nucleus is located. This reflects the images obtained with the confocal microscope. The 
cellular studies also indicate that the decay profiles of the Br substituted NDI (compound 5) 
can be modelled to a 2 component system with both containing a short major and long minor 
component. Compound 5 possessed a τ1 of 530 ps accounting for approximately 72% of the 
decay lifetimes and τ2 of 3242 ps corresponding to 27.6% of the decay lifetimes. The 
fluorescence lifetimes for both substituted NDIs lay outside the FWHM of the control 
experiment, suggesting that the lifetimes observed can be attributed to the fluorescence of the 
substituted NDI compounds. Therefore, despite the generally poor quantum yield of the NDI 
compounds, they still possess a certain degree luminescent characteristics that can distinguish 






















2.11 Evaluation of NDI toxicity via MTT Assay 
 
In this section, cytotoxicity tests were carried out to expand the scope of these 
investigations of NDI compounds as potential therapeutic anti-cancer agents. Small 
molecules with planar heterocyclic moieties that can intercalate within DNA molecules can 
cause unwinding, lengthening and stiffening of the double helix.
36
 This can affect the DNA 
replication process and ultimately induce apoptosis. Studies by Tumiatti et al. showed that 
protonated NDI molecules can induce caspase activation and trigger a sequence of events that 
led to apoptosis.
37
 Certain classes of NDIs have been shown to be inhibitors of cancer 







 This has been largely attributed to the NDIs demonstrating the capacity to 
form DNA quadruplex-ligand complexes. These complexes interfere with the activity of the 
reverse transcriptase telomerase enzyme and thus prevent retention of telomere integrity. This 
quadruplex intercalation has been shown to induce DNA damage in vitro/vivo and has thus 
led to NDIs being seen as ideal anti-proliferative therapeutic anti-cancer agents. NDI 
compounds possessing N-methyl-piperazine groups in particular have shown remarkable anti-
proliferative effects with IC50 values between 100 and 200 nM.
41
 
MTT assays were performed on the NDI compounds to establish the extent to which the 
NDIs exhibit cytotoxic behaviour. 3x10
3
 cells per well were seeded into a sterile 96 well plate 
and incubated for 48 hours. A range of concentrations for the NDI compound were added to 
the well plates and allowed to culture for a further 48 hours. After appropriate washing 
phases with PBS, the 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) 
reagent was added. After 2 hours of incubation with the MTT reagent, the absorption at 570 






Figure 2.25 Scatter graph representing dose dependent response of cell viability with respect 
to NDI concentration for compound 5 
Figure 2.25 shows the dose response curve of the cell viability with respect to increasing 
concentration of compound (3). The IC50 value for compound 3 was calculated to be 15.95 
μM. This is an order of magnitude higher than some previously reported NDI compounds 
which possessed EC50 values of 0.2 to 2.5 μM across a variety of cell lines and is certainly 
much larger than the N-methyl-piperazine containing NDIs mentioned previously. For a large 
majority of the cytotoxicity studies performed in the literature, the capacity for DNA binding 






 Those compounds that 
bound heavily to DNA had a correspondingly larger anti-proliferative effect. The imaging 
studies performed in the previous section demonstrated that the NDI compounds do not exert 
any nuclear membrane penetrating activity. This may therefore prevent the NDIs from 
binding to DNA and causing the more severe anti-proliferative effects seen in other 
molecules of a similar structure in the literature. However, cellular apoptosis can be initiated 
by a variety of intra/extra cellular insults that trigger signalling cascades such as the 
activation of caspase proteins.
45
 These do not necessarily require nuclear membrane 
penetration to be facilitated and would represent a more general biochemical pathway for cell 
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death and anti-proliferation that is achievable for this particular class of compounds. This 
may account for the cytotoxicity observed, albeit comparatively lower with respect to 
previously published NDI compounds. Standard MTT assays were performed in order to 
investigate the effect of the phenyl alanine substituents on the cellular viability with respect 
to the unsubstituted L- and D-NDI. With the only exception of D-Br and D-Cl derivatives, 
both the L- and D- series of phenylalanine NDIs show comparable values of IC50 in a range 
of 1.10 lani
−4
 and 4.65  of 
−4
 M. Interestingly, chloro- D-phenylalanine NDI, compound 4, 
exhibited significant increment of biocompatibility reducing cytotoxicity up to a thousand 
times comparing to the fluoro-L analogue (further details can be found in the appendices). 
 
2.12 Summary of Chapter 2 
 
Chiral naphthalene diimides bearing aryl halide modified phenylalanine substituents were 
successfully synthesised via a microwave di-electric heating method. Solvatochromic studies 
demonstrated a clear solvent influence on the self-assembly and optical properties of the NDI 
molecules, with a preference of parallel stacking of naphthalene cores in solvents bearing 
lone pairs. However, more complex structures were observed in chloroform. Two-
dimensional NMR studies and circular dichroism revealed that the NDIs assembled into large 
hydrogen bonded helical structure that broke down in the presence of polar solvents. Crystal 
structure analysis revealed a tendency for phenylalanine moieties to arrange either side of the 
mean plane of the naphthalene core conformation. A partial crystal structure was obtained 
that presented supporting evidence of helical nanotube arrangement. Solid state analysis 
ultimately reflected the solution studies whereby solvent composition led to the formation of 
different structural arrangements and polymorphic phases. In vitro cancer cell studies 
revealed successful up-take and distribution of the NDI compounds throughput the cytoplasm 
at 100 μM suitable for imaging via laser scanning confocal microscopy. However, the 
compounds did not penetrate the nuclear membrane. Furthermore, fluorescence lifetime of 
the compounds was determined in PC-3 cells, with lifetime decay and distribution 
distinguishable from cellular autofluorescence. MTT assays revealed that the NDIs possess 
moderate cytotoxicity, with IC50 values orders of magnitude higher than examples of 
previously published anti-proliferative therapeutic NDI compounds. Ultimately, these 
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Chapter 3.0 Investigations into the supramolecular association of naphthalene 
diimides with polyaromatic carbon systems and their imaging in prostate 
cancer cells 
 
3.1 Overview to Chapter 3 
 
The structure of NDIs provides them with the ability to form supramolecular assemblies 
based on donor acceptor interactions. The aromatic and electron deficient characteristics give 
them the ability to form face centred aromatic interactions. This particular property opens up 
avenues for functionalising GO via π π stacking interactions.1 Water soluble NDIs are known 
to strongly interact with DNA molecules
2





 Furthermore, it has been reported that NDIs with substituents 
on the naphthalene core could serve as viable imaging probes. With respect to the interaction 
of NDIs and carbon materials, Sanders et al. demonstrated that α-amino acid functionalised 
NDIs possess the capacity to self-assemble into helical cavity-containing hydrogen-bonded 
nanotubes and act as receptors for C60 fullerenes.
5
 This particular work was able to 
demonstrate that C60 molecules were taken up into the tubular core of the NDIs and this 
overcame the poor solubility issues associated with C60 molecules.  
Different NDIs with varying substituents tagged at the periphery of the diimide moieties 
were characterised via UV-Vis and Circular Dichroism in order to test their capacity towards 
the uptake of C60 fullerenes. NDIs with methyl ester substituents that were unable to form the 
tubular structures demonstrated no improvement in the solubility of C60. This was taken as 
confirmation of the internalisation of C60 within the tubular networks of NDI molecules. 
Further to this work Sanders et al. investigated the interaction of the higher order C70 with the 
tubular networks of NDI molecules. They discovered that contrary to the tubular uptake of 










Figure 3.0 Schematic representation of the interaction of NDI molecules with C60 fullerenes 
adapted from Pantӧs et al.5 
Previous work within the group developed a facile method for the supramolecular 
complexation of iodine-substituted NDI molecules to SWNTS towards applications of cell 
imaging and drug delivery.
7
 This work demonstrated that the NDI molecules could wrap 
around SWNTs via supramolecular host-guest interactions based on π-π stacking. Two- 
photon fluorescence lifetime imaging demonstrated that the iodine substituted NDI 
(compound 6) could retain a certain degree of fluorescence upon complexation to the 
SWNTs. Furthermore, it was demonstrated that functionalisation of SWNTs with the NDIs 
reduced the cytotoxic properties of the nanotubes and that SWNTs could be internalised 
within cancerous and non-cancerous cell lines, thus establishing the supramolecular 
complexes as potential cell imaging probes. The extensive sp
2
 hybridisation of the planar 
graphitic domains opens up the opportunity for functionalisation via π-π stacking or Van der 
Waals forces in the ordered areas unaffected by the presence oxygen functionalities. 
Iverson et al. have described a model for understanding the interaction between separate 
aromatic systems
1. In general, the electron density derived from the π orbitals of aromatic 
rings creates a quadrupole moment possessing an overall partial negative and partial positive 
charge on top of aromatic faces and on the periphery respectively. When these moments 
come within a suitable distance, a face centred parallel stacking interaction can occur
8
. The 
interaction between aromatic molecules that alternate in their extent of electron density is 
sometimes referred to as aromatic donor-acceptor interactions. Although there is still 
considerable debate in regards to the driving forces behind the interactions between aromatic 
molecules in close proximity to one another
1
, it would still suffice to conclude that such 
interactions present an attractive strategy towards the construction of supramolecular 







Figure 3.1 Scheme describing electrostatic view of aromatic interactions. Images provide a 
qualitative description of quadrupole moments in the more electron rich aromatic rings 
(benzene) and the electron deficient aromatics (1,4,5,8 – Naphthalene tetracarboxylic acid) 
adapted from Iverson et al. 
1
 
Graphene, graphene oxide and its congeners vary in the size of their sheets and the extent 
of their surface functionalisation. As a result it becomes particularly challenging when 
attempting to quantify the extent of supramolecular binding considering that most 
experimental methods require a knowledge of the molecular weight of the species involved. 
In order to quantify the capacity of the aryl halide modified NDIs to bind to the surface of 
graphene a model experiment has been developed. In this system the polyaromatic 
hydrocarbon coronene is used as a representation of a nano-section of a graphene sheet. 







 Indeed previous studies have utilised carbon nanoforms such as hemi-
fullerene to investigate graphene like systems, whereby the existence of a weak charge 
transfer heterodimer with an electron donating  tetra-thiafulvene has been taken as a 
suggestion for the potential viability of the basis of organic functionalisation.
12
 The 
conjugation of polyaromatic hydrocarbons (PAHs) with electron accepting molecules of the 





applications. Schmidt et al. combined a perylene molecule with hexabenzocoronene in order 
to develop as self-organized liquid discotic crystal.
13
 The advantage of such a system lies in 
the fact that the larger organic material carrier mobility has been observed in devices 
comprised of organic crystalline materials. These studies serve as a precedent for the use of 
coronene as a basis and precursor to the understanding of the nature of organic molecular 
functionalisation of graphene materials. Furthermore, coronene has the capacity to impart 
interesting electronic and optical properties in its own right that are worthy of investigation 
for supramolecular assemblies for imaging applications The following section describes the 
series of experiments designed to establish the extent and mechanism by which the NDIs bind 
to the surfaces of polyaromatic hydrocarbons and allotropes of carbon. 
 
3.2 Fluorescence Titration Experiments 
 
NDIs are commonly considered desirable sensor candidates because of their facile 
synthesis and tuneable fluorescent properties.
14,15
  Although these particular  NDIs are 
generally weak fluorescent emitters, the synthesised molecules still exhibited luminescence 
processes that can be easily monitored using fluorescence spectroscopy. By exciting the 
NDIs cores at λexc = 380 nm, emission events were observed in the range of 470-670 nm. The 
fluorescence spectrum of the NDI in THF shows a typical emission structure characterised by 
two energetic transitions at ca. 530 and 570 nm. 
 The NDI-coronene systems were designed to explore the fluorescence quenching 
mechanism that is of particular interest in the field of chemosensors, artificial photosystems 
for solar energy and indeed is particularly relevant to fluorescent complexes designed for 
cancer imaging. The mechanism by which the interaction and quenching process occurs will 
have considerable influence over additional phenomena such as photothermal and 
photodynamic therapy which one may desire to exploit in a therapeutic imaging system. It is 
therefore necessary to establish an understanding of this mechanism to assess the viability of 





The ability of the excited state NDIs to interact with carbon based systems was therefore 
assessed via qualitative fluorescence titration experiments. A saturated solution of coronene 
in THF was prepared. The solution was sonicated for 30 minutes; the excess coronene was 
allowed to settle and the remaining solution was decanted from the top of the excess 
coronene and subsequently filtered through a PTFE membrane. To this solution was added a 
10 mM quantity of bulk NDI. The resulting solution was titrated against another 10 mM 
solution of NDI in THF. Each scan was conducted after 0.2 mL titres were removed from 
cuvette and replaced with 0.2 mL titres of 10 mM NDI solution saturated with coronene in 
order to maintain constant NDI concentration throughout the experiments. General procedure 
of fluorescence titrations are reported in the experimental section.  
Figure 3.2 Fluorescence emission titration of NDI saturated with coronene (30 mM) into 
compound 3 (10 mM in THF). Inset shows fluorescence quenching at 530 nm with respect to 
equivalence of coronene saturated NDI solution. 
 
From Figure 3.2 we note that as the guest concentration of coronene is increased a gradual 
quenching of the NDI fluorescence is observed. The fluorescence quenching can occur via 

































































several mechanisms: Fӧrster resonance energy transfer (FRET), collisional quenching, 
formation of covalent or non-covalent non-fluorescent complexes and attenuation of incident 
light.
16
 We propose that within the systems studied in this work quenching occurs via FRET. 
This is the mechanism by which an excited donor (in this case the NDI species) transfers 
energy to an acceptor (in this case the coronene) via non-radiative processes. There are four 
principal conditions that must be satisfied in order for FRET to occur, namely spectral 
overlap, orientation of transition dipoles, sufficiently high donor quantum yield and donor-
acceptor proximity.
17
 For any transfer to occur the donor species must be photoactive, i.e. 
they must absorb and emit photons efficiently. These abilities can be defined in terms of the 
molar extinction coefficient (εmax) and the quantum yield (ɸ), both of which should be high in 
order to promote FRET. Despite the relatively poor quantum yield of the NDIs in polar 
solvents such as THF, the complex still undergoes a considerable resonance energy transfer 
quenching. This is the first indication that this particular series of NDIs readily bind to 
polyaromatic carbon systems and interact with them in such a manner that their proximity to 
one another is suitably close and thus promotes the transfer of energy. This particular 
experiment has provided a qualitative understanding of the excited state binding interactions. 
If indeed there is excited energy transfer occurring between species in solution, it would be 
expected that the solutions of NDIEx-coronene and would have different fluorescence lifetime 
decay characteristics with respect to the free NDIs in solution. 
 
Time correlated single photon counting (TCSPC) is a method to probe the fluorescence 
decay characteristics of an excited molecule.
16
 This method involves the detection of single 
photons after excitation with respect to a periodic light signal. Fluorescence excited states 
will decay based on a statistical likelihood of loss of molecules in the excited state population 
within an initial nanosecond timescale. Further losses in excited species in subsequent 
nanoseconds will be subject to a similar statistical likelihood, therefore resulting in an 
exponential decay profile. These decay profiles can be fitted to multi-component exponential 
systems (τ1 and τ2) to determine the presence of different excited state species after 
complexation. Samples for TCSPC experiments were prepared by the same method as those 
for fluorescence titration experiments differing only in that the NDI concentration was at 50 
μM. A much lower NDI concentration was necessary in order to avoid any self-quenching 
processes that may occur between the NDI species that have already shown to have a high 





much lower NDI concentrations with respect to the fluorescence titration experiments 
minimises the likelihood of NDI excimer (excited dimer) formation that could have an 
influence over the exponential lifetime decay characteristics. 
 
Figure 3.3 Time correlated single photon counting decay curve of compound 3 in a free 
(uncomplexed) form (50 μM in THF) and complexed with coronene (3 eq.) saturated 
solution in THF. 
 
The fluorescence decay of the NDIs could be accurately fitted to a single component 
system when in free solution, compared to two component models that resulted in poorer chi-
squared analysis of the data fit. However, chi-squared analysis returned values that suggested 
two component systems were more accurate models of the decay profiles when coronene was 
present. This implies the presence of new emitting species as a result of complexation. 
Indeed, there is likely to be even higher aggregate species beyond the two-component model. 
However, for the purposes of this analysis, the data has been restricted to the two-component 
system.  All of the NDIs showed single lifetimes of approximately 3.3-3.7 ns when in free 
solution. Upon complexation however a shorter major lifetime component (τ1) and a longer 























minor component (τ2) was apparent. These changes in lifetime upon complexation, 
particularly the additional longer component can be attributed to photo-induced energy 









χ2 Two Component (ns) χ2 % 
 τ  τ1 τ2  a1 a2 
(2) 3.33 1.26 - - - - - 
(2) + coronene - - 0.908 3.21 1.09 76 24 
(3) 3.75 1.29 - - - - - 
(3) + coronene - - 2.24 4.9 1.29 71 29 
(4) 3.79 1.25 - - - - - 
(4) + coronene - - 1.74 4.68 1.18 75 25 
5 3.49 1.16 - - - - - 
(5) + coronene - - 1.2 4.66 1.17 69 31 
6 3.49 1.19 - - - - - 
(6) + coronene - - 1.53 4.55 1.27 73 27 
 
The diffusion length of excited electron-hole pairs is very small (10-20 nm). The 
consequence of the increased fluorescence lifetime component is that those excitons 
associated with the charge transfer species will exist for longer before recombination the 
effect of this could be an increase in the overall efficiency of photoexcited energy transfer 
contained within the NDI-coronene complexes. 
 
Despite the indication of excited state interactions there is expected to be additional 
ground state basis for the supramolecular interactions considering the low lying LUMO levels 
in proximity to the electron rich coronene molecules. The following section will describe a 





and NMR based titration experiments in attempt to establish a more definitive 
characterisation of the extent to which aryl halide modifications control the degree of 
supramolecular binding when more planar aromatic guest molecules are used. 
3.3 UV-Vis Solubility Enhancement 
A simple UV-Vis experiment was carried out to establish the presence of ground state 
charge transfer. First a UV-Vis scan of the NDI was performed in THF. To this solution a 
small quantity of coronene was added and allowed to complex overnight. The resulting 
solution was filtered through a PTFE membrane and UV-Vis scan performed on the 
subsequent NDI-coronene complex. 
 
Figure 3.3 UV/Vis spectra of compound 2 (0.01 mM), Coronene, 2+Coronene, and the 
Coronene contribution to the 1+Coronene solution (green trace) in THF. 
The enhanced solubilisation of coronene is supported by the increased absorbance at 304 
and 342 nm in UV region of spectrum. Subtracting the NDI absorbance from that of the 
complex allows us to visualise the contribution of coronene to the charge transfer complex 
which is identifiable by broadening of the shoulder between 290 and 304 nm and is caused by 
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additional sharp peak at 294 nm (green trace in Figure 3.3). The inset of Figure 3.3 shows 
the presence of new charge transfer bands not seen in either of the independent host and guest 
solutions. The appearance of low energy bands at 485 nm arises as a result of electronic 
transitions between the HOMO of the donor and the LUMO of the acceptor.
35
 These 
transitions were present after increasing the concentration of the host molecule to 1 mM in 
order to overcome the relatively poor extinction co-efficient of the complex. The choice of 
solvent for these studies was restricted due to solubility issues. Coronene is sparingly soluble 
in THF and was therefore seen as an ideal candidate to study solubility enhancement in the 
presence of NDIs.   
3.4 Mathematical modelling of supramolecular binding isotherms 
One of the more readily utilised experiments to quantify the magnitude of association 
interactions of a supramolecular nature is the titration experiment. Typically a guest solution 
is titrated into a host solution and as the experiment proceeds a particular physical property is 
monitored. This has allowed the technique to be employed in UV-Vis, fluorescence and 
NMR procedures in which optical absorption and emission or changes in δ ppm are observed. 
The magnitude of these changes is used as a means to quantify the strength of interaction. 
In order for any numbers associated with the magnitude of binding to be considered 
reliable, one has to ensure that the conditions of the titration experiment and subsequent data 
analysis can be applied to a sound mathematical model. The titration technique employed and 
data analysis model used must account for appropriate binding stoichiometry and 
concentration. There must also be some means of assessing the reliability of the data 
obtained. The simplest equilibria that govern dynamic supramolecular systems are ones that 




    Eq. 6 
The guest molecule (in this case an allotrope of carbon or a polyaromatic hydrocarbon) is 
titrated into a host solution (in this case an NDI solution), the concentration of which is held 
constant throughout the duration of the titration. This ensures that any observed changes of a 
selected physical parameter are due to the complexation of the host and guest species. A 






[𝐻]0 = [𝐻] + [𝐻𝐺]     Eq. 7 
[𝐺]0 = [𝐺] + [𝐻𝐺]     Eq. 8 
The changes of a physical parameter (Y) are representative of the sum of the contributory 
host and guest components according to equations 2 and 3 written as a function of 
concentration or molar fraction. 
𝑌 = 𝑌𝐻[𝐻] + 𝑌𝐺[𝐺] + 𝑌𝐻𝐺[𝐻𝐺]     Eq. 9 
 𝑌 = 𝑌𝐻𝑓𝐻 + 𝑌𝑎𝑓𝑎 + 𝑌𝐻𝐺𝑓𝐻𝐺       Eq. 10 
 
Combining the mass balance equations (7 and 8) with the basic association equation (6) 
yields a binding isotherm that describes the association constant with respect to changing 




      Eq. 11 
If the measured change is related to the molar fraction of the complexation, then the 
association constants can be determined if the free guest concentration is also known. This is 
difficult to determine in most practical experiments based on physical techniques. However, 
this can be overcome by separating the variables in the mass balance equations and inserting 




     Eq. 12 
Expanding the right hand side of the denominator and re-arranging to solve with respect to 




(𝐺0 + 𝐻0 +
1
𝐾𝑎





+ 4[𝐻]0[𝐺]0    Eq. 13 
It is now possible to determine solutions to equation 9 and 10 based on initial or total 
concentration of host and guest, the association constant and the changing physical 






𝑌 = 𝑌𝐻 + (
[𝐻𝐺]
[𝐻]0
) (𝑌𝐻𝐺 − 𝑌𝐻)    Eq. 14 
Which can be further reduced to 
∆𝑌 = 𝑌∆𝐻𝐺 (
[𝐻𝐺]
[𝐻]0
)     Eq. 15 
 
A nonlinear regression of the experimental data it is now possible to determine all of the 
parameters and physical changes in a supramolecular titration experiment based on equations 
6, 13 and 15. These equations can now be applied to various experiments that monitor 
different physical parameters as a means determining the strength of supramolecular binding. 
In many cases of supramolecular binding interactions, it is the propensity for higher order 
equilibria formation that can have considerable influence on the overall strength of 
association.
18
 This may occur whereby two or more guest molecules may bind to a single host 
molecule. Or the opposite may be true whereby a single guest molecule binds to multiple 
hosts. Such systems can be modelled with so called 1:2 or 2:1 equilibria. For studying the 
interactions of a Host-Guest (HG) complex, the simplest stoichiometries are 1:1, 1:2 and 2:1. 
It is reasonable to assume that at suitably excess concentration of either Host or Guest, 
binding systems of higher order than 1:1 will form provided the structural nature of either 
Host or Guest can facilitate this. It is reasonable to assume that these systems will form via 
stepwise binding processes as it would be extremely unlikely for a termolecular complex to 
form by simultaneous collision of three Host and Guest species. The formation of these HG 




H + G ⇌ HG      Eq. 16 
HG + G ⇌ HG2      Eq. 17 































Figure 3.4 Formation pathways of 2:1 Host-Guest complex. These equilibria can be 





A’B’. The relative magnitudes of these binding constants give information on 
the overall cooperativity of the system such that if K21 is greater than K11, the binding system 
can be described as exhibiting positive cooperativity.
19
 
Describing the binding constants more generally as Kmn where m and n are integers. A 
complex where m or n is greater than 1 describes a system where either the Host or Guest 
possesses more than one binding site.
19
 Consider the system where the Guest has two binding 
sites and the Host has a single binding site, as reported for NDI-coronene systems described 
within this report. Using A and B to denote the two binding sites of the Guest (AB), the 








either site A or B. These isomeric 1:1 complexes are denoted by A’B and AB’, where the site 
of the bound Host is denoted by the primed letter. The 2:1 complex A’B’ is then formed by 
the binding of a second Host to either of the 1:1 isomeric species. 
 
The binding system stoichiometries that are possible are determined by the nature of the 
Host and Guest. However the stoichiometries detectable by experimentation may be to some 
extent influenced by the experimental conditions. For example, it is reasonable to assume that 
if the Guest concentration in solution were much higher than that of the Host, that the 1:2 









Figure 3.4 Schematic representation of microscopic association constants (K1A, K2A, K1B and 





If the binding sites of the host behave in an identical way, then there is no means by which 
to distinguish between K1A and K1B. This is therefore described as non-cooperative system. 
However, in some cases the binding of a guest to the first host site can influence the capacity 
or extent to which the second guest binds to the remaining site. Such a system is described as 
cooperative. The degree of cooperativity a supramolecular system displays can be described 
by the following simple equation. 




   
 









      Eq. 22 




H NMR titration studies of the complexation of NDIs to C60  
 
One of the challenging aspects in host-guest supramolecular chemistry is to assess a 
quantitative analysis of the intra- and inter-molecular interactions between the components 
involved.
18
  The most common approach to consider the degree of association between host 
and guest species is a titration method. NMR spectroscopy can provide binding constants of 
ground state non-covalent interactions between carbon allotropes and aromatic molecules.
20
 
As mentioned before, the binding behaviour of graphene-like materials can be understood 
using coronene as a model molecule. In this 
1H NMR titration, coronene (‘guest’ molecule) is 
gradually added to the NDI (‘host’ system) solutions and selected 1H chemical resonances are 
monitored. Detailed in the following experiments are the up- and down-field progressions of 
the chemical resonances (Δppm) of naphthalene core (blue) and alkyl protons (red) of the 
NDIs respectively on the relative host-guest ratio (Figures 3.5 and 3.8). Considering that 
supramolecular binding is largely dependent on electrostatic effects, polar solvents such as 
THF can serve to disrupt the binding due to donation of electron pairs or the acceptance of 
hydrogen bonds from the NDI units. In order to overcome solubility issues for latter NMR 
studies, the solvent of choice was mixture of THF-d8. and toluene-d8. The inclusion of this 
non-polar solvent served to enhance the solubility of coronene to the intended titration extent, 
as well as aiding in the reduction of solvent-host binding interactions which have been shown 
to dramatically reduce binding associations by factors of up to 100.
21
 For studying the 
interactions of a Host-Guest (HG) complex, the simplest stoichiometries are 1:1, 1:2 and 2:1. 
It is reasonable to assume that at suitably excess concentration of either Host or Guest, 
binding systems of higher order than 1:1 will form as the structural nature of either Host or 
Guest can facilitate this. It is reasonable to assume that these systems will form via stepwise 
binding processes as it would be extremely unlikely for a molecular complex to form by 
simultaneous collision of three Host and Guest species.
19
 
Fullerenes are spherical polyenes that are subject to dispersion interactions as the primary 





structural commensurability of the respective host-guest shapes will influence the extent to 
which their surfaces can interact and hence their binding ability. Therefore, molecules that 
possess a degree of curvature or the ability to form large cavities are more favoured shapes 
for the association with fullerenes. Complementary conformation has also been suggested in 
donor-acceptor fullerene interactions between contorted molecules and their π orbitals, 
leading to a concave-convex π recognition association. This has been demonstrated by the 
synthesis of recognition motifs for the bowl shaped polyaromatic hydrocarbon (PAH) 
corannulene.
22
 Concave aromatic electron donating molecules have served as ideal 
complementary receptors for C60 that facilitate a tweezer-like binding interaction.
23
 
Furthermore, the unsubstituted phenylalanine NDI was previously shown to form a helical 
cavity inclusion complex for C60.
5
 Titrations with C60 were therefore seen as an ideal starting 
point to assess the variable binding capacity of halogenated NDIs prior to their complexation 
with more planar PAH systems. 
 
 
Figure 3.5 Schematic representation of proton resonance shifting during formation of host-
guest complexes. 
 
In the C60 titration experiment, aliquots of guest (C60) were gradually added to solutions of 
NDIs in 0.1 equivalence increments.
 1
H NMR titrations were performed to establish 
quantitative information with regard to the magnitude of the association constants and the 
order of the dynamic equilibria between the host NDIs and the guest C60 molecules. The 





overall position of the peak is the weighted average of the free host and the bound host/guest 
complex. Details on the NMR titration are reported in the experimental section.  The addition 
of C60 causes an increase of the up-field shifts of the naphthalene protons (blue in Figure 
3.5), while the chemical shifts of the alpha proton (red) are de-shielded as the titration 
progresses (red in Figure 3.5). 
Figure 3.6 NMR titration curves showing shifting of relative position naphthalene core and 
alkyl proton resonances with respect to C60 equivalence for Compounds 1 (green), 5 (blue) 
and 6 (red) performed in THF-d8/Toluene-d8 in a 9:1 mixture at 298.15 K. 
The concentration dependent shifting of the naphthalene and alkyl protons was modelled 
to assess their fit to 1:1, 1:2 and 2:1 equilibria. The resulting association constants, standard 
error, covariance of fit as well as magnitudes of cooperativity are summarised in Table 3.1. 






















Table 3.1 Summary of association constants and cooperativity values for the 1:1, 1:2, 2:1 modelled complexes and their associated error 

















































The apparent successful modelling of the NDI-C60 to 1:1, 1:2 and 2:1 systems provide association constants that suggest a complex system of 
dynamic interactions. The standard error and covariance of fit reported in Table 1 assessed the quality of the fitting and imply that the simple and 
higher order equilibria are entirely plausible interactions within this system of donor and acceptor molecules. The higher order equilibria opens 
up the opportunity for varying degrees of cooperativity. The bromine substituted NDI was the only molecule to demonstrate positive 
cooperativity (α > 1) in the 1:2 model, with the other NDIs showing negative cooperativity (α < 1). Excluding the Iodine NDI, all of the NDI 
interactions for the 2:1 system demonstrated positive cooperativity. In particular, the Bromine NDI demonstrated marked positive cooperativity 
(α = 679). This implies that there is little to no accumulation of the intermediate state whereby the host is bound to 1 guest molecule prior to 
complete binding. Ultimately, these experiments show that the NDIs interact with C60 molecules in a complex and dynamic fashion that can vary 
depending on the type of aryl substituents. However, it should be noted that considering the dynamic nature of the interactions, it is likely that all 
of these models would be occurring simultaneously during supramolecular complexation.  It was therefore deemed prudent to assess the extent 





3.6 Determination of likely binding stoichiometry between NDIs and coronene 
Fused benzene ring systems such as coronene have been suggested to be a suitable small 
model for graphene by a number of studies as they are regarded as molecular subunits of 
graphene.
24
 Indeed previous studies have utilised carbon nanoforms such as hemifullerence to 
investigate graphene-like systems. In one particular study, the existence of a weak charge-
transfer heterodimer with an electron donating tetrathiafulvene was taken as a suggestion for 
the potential viability of the basis of graphene functionalisation.
12
 The conjugation of 
polyaromatic hydrocarbons with electron accepting molecules of the rylene class has been 
used to specifically enhance the performance of photovoltaic interactions. Mende et al. 
combined a perylene molecule with hexabenzocoronene in order to develop a self-organized 
liquid discotic crystal. The advantages of such a system lay in the fact the some of the largest 
organic material carrier mobilities have been observed in devices comprised of organic 
crystalline materials.
13
 These studies serve as precedent for the use of coronene as a basis and 
precursor for the understanding of the nature of organic molecular functionalisation of 
graphene materials. Furthermore, coronene has the capacity to impart interesting electronic 
and optical properties in its own right that are worthy of investigation for supramolecular 
assemblies for imaging applications. 
One of the more popular methods for determining host-guest stoichiometries is known as 
Job’s method, also referred to as the method of continuous variation. In this particular 
methodology, host and guest solutions of equal concentrations are mixed together in varying 
volumes. At all times the concentration of the host and guest is constant, but the respective 
volumes of the host and guest vary. This leads to a series of samples of host-guest solutions 
that vary in molar fraction. As with the previous titration experiments, a change in a 
particular physical parameter is monitored as the molar fraction of the guest is varied.
19
 The 
change in property is plotted against the molar fraction of the guest and the point at which the 
maximum deviation is observed represents the more favoured stoichiometry of the host-guest 
complex. In order to determinate the binding stoichiometry of the NDI coronene complexes, Job 
plots studies were performed by running standard 
1
H NMR pulse sequences of NDI-coronene 
solutions. Stock solution of NDI and coronene (2.21x10
-3
 M) were prepared separately in a mixture of 
THF-d8 and toluene- d8 (1:9). Coronene solution was gradually added (200µL) into a 4 mL NMR tube 
containing an X-NDI solution so that the total concentration of {[NDI] + [Coronene]} for each NMR 
experiment was kept constant. The resonance of naphthyl protons was upshifted as the mole fraction 
of Coronene was progressively increased resulting in a Δδ. Job plots were obtained plotting y = 





Figure 3.7 Job plot of halogenated NDI compounds 3, 4, 5 and 6 showing the shifting of the 
relative position of naphthalene core protons(d8-THF) as a function of the increasing mol 
fraction of coronene performed at 298.15 K.  
 
Figure 3.7 shows the Job plots corresponding to the stoichiometry of the complexes of the 
NDIs with coronene. It is important to note that Job’s plot analysis assumes the sum of the 
host and guest concentrations is greater than the inverse of the equilibrium constant that 
describes their interaction. For all of the plots in Figure 3.7, a gradual approach to a limiting 
maximum shift of δppm is observed when half of the total concentration of the species in the 
complex is comprised of NDI molecules (i.e. NDI mol fraction of 0.5). This is indicative of a 
1:1 complex. What is also particularly interesting is the observation of larger maximum shifts 
of δppm for the complexes as the aryl substituents of the NDIs transition to larger more/less 
polarisable, more/less electronegative halide species. This is clearly observed in the Job plot 
of the titration of coronene with the INDI, whereby a much larger and sharper triangular 
shape of plot is evident. This is therefore an indication that supramolecular complexes 
comprised of aryl halide substituents can have a positive influence on the overall stability of 
supramolecular complexes. At this point it was necessary to conduct further titration 

























experiments to extract information regarding the association constants between the host and 
guest species. 
In a typical titration experiment, aliquots of guest (coronene) were gradually added to 
solutions of the NDIs. Details on the NMR titration are reported in the experimental section.  
The addition of coronene causes an increase of the up-field shifts of the naphthalene core 
protons (blue arrow in Figure 3.9), while the chemical shifts of the alpha proton (red arrow) 
are de-shielded as the titration progresses. 
 
 
Figure 3.8 Schematic representation of proton resonance shifting during formation of host-










Figure 3.9 Stacked plot of standard 
1
H NMR spectra (THF-d8/Toluene-d8 in a 9:1 mixture) 
showing up-filed and down-filed progression of naphthalene and alkyl protons respectively as 
the molar equivalence of coronene is increased. 
 
For the halogen series of NDI studied, a total of 3 equivalents of coronene were 
progressively added during each experiment. The Δδ data were then extrapolated to constitute 
a data collection that were analysed by Matlab m-files
18
 and the 1:1, 2:1 and 1:2 binding 
isotherm were fitted to the data affording values of association constants. A typical up- and 
down-field progression of the chemical resonances of naphthalene core (blue) and alpha 
protons (red) of the NDIs respectively on the relative host-guest ratio is reported in Figure 
3.10. In figure 3.10, Δδppm is plotted versus the equivalent of guest added upon titration . 
 
The formation of a 1:1 NDI-coronene complex was also suggested by Jobs plot analysis. 
The association constants of the NDI-coronene complexes for (3), (4), (5) and (6) are 
reported in table 3. The series of halogenated NDI fit a 1: 1 and a 2: 1 isotherm binding 
system in which a molecule of coronene interact with one or two molecules of NDI 





simulations gave physically non-sensible results suggesting that a 1 :2 model is not plausible 
for the NDI-coronene complexes while 1 : 1 and a 2 : 1 are more likely systems. Due to the 
complimentary sizes of the NDI cores with the coronene molecule and their tendency to form 
face-centred complexes, it is unlikely that aggregates higher than two orders would be 
present. 
 1 : 1 host guest complexes involving NDI molecules have been previous described with 
Ka
1:1
  ranging between 13 and 110 M
-1 
for system involving NDI and Zn(II) metallated 
porphyrins.
25
 In regards to the latter system, Ka
1;1 
 of phenylalanine tagged NDIs (3), (4), (5) 





suggesting that coronene is a better guest system for NDIs supramolecular assembly.  
 
Figure 3.10 NMR titration curves showing shifting of relative position naphthalene core and 
alkyl proton resonances with respect to coronene equivalence for Compound 3 performed at 
298.15 K. 
 
Comparing the values of Ka
1:1 
of the series, it is interesting to note that a relationship 
between binding constants, atomic radius and electronegativity of the halogen group exist. 
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The values of Ka
1:1 
follows the halogen trend in which the higher constant is associated with 
the iodine substituent. These Association constants increase from the top to the bottom of the 
halogen group with Ka(6)
1:1
 being approximately one order of magnitude smaller (Ka(6)
1:1









Figure 3.11 Association constant dependencies on covalent radius (left) and electronegativity 
(right) of halide substituent. 
A similar trend is also seen in the 2 : 1 NDIGr – coronene complexes in which higher 
binding constants fit bigger atomic radii and lower electronegativity (Figure 3.11). 2 : 1 
isotherm fitting reveal very low values of Ka1
2:1
 for all the halogen substitutes ranging 




were found to be significantly higher (Ka2(3)
2:1





  = 20200 M
-1




 has been previously 







 values unequivocally describe a cooperative system consisting of two dynamic 
events in solution characterised by different kinetics. Firstly, a molecule of NDI interacts 
with a molecule of coronene via π-π stacking resulting in a HG complex. As the association 
constant of this first event is particularly small, the concentration of this supramolecular 
complex [HG] in solution at a given time is low. Once the [HG] is formed, immediately a 
faster second event occurs resulting in the interaction of a second equivalent of NDI with the 
1 : 1 - NDI : coronene complex. Values of Ka2
2:1
 suggests that the second event generates a 
complex [H2G] that is kinetically stable and the formation of which is driven by a positive 









 (α >> 1), therefore the supramolecular interactions 
between NDI and coronene in the [H2G] are more favourable than in the intermediate. the 






















































considerably larger value for the second association constant imply that the [HG] complex is 
a  relatively short lived population and “all-or-nothing” behaviour is observed.27 
 
Table 3.2 Summary of association constants and cooperativity values for the 1:1 and 2:1 
modelled NDI-Coronene complexes and their associated error parameters. 
 1 : 1 (H:G) 2 : 1 (H:G) 
NDI Ka
1:1




 SEy Covfit 
(3) 240 0.002 0.001 10 20200 0.002 0.0006 
(4) 260 0.002 0.001 10 20400 0.002 0.0005 
(5) 550 0.003 0.001 10 25600 0.002 0.0003 
(6) 2000 0.009 0.006 10 40450 0.004 0.001 
 
Many research groups have described the implications of halogen substituents in the 
design of supramolecular constructs.
28
 Both computational and experimental investigations 
have established that the spread of electron density around halogen substituents in organic 
halides conforms to an anisotropic distribution.
29
 
In a covalent halogen substituent, the atomic radius along the halogenated C-X bond axis 
is smaller with respect to the radius perpendicular to the axis. This creates an area of positive 
electrostatic potential across the covalent bond. This has the effect of pushing the lone pairs 
closer towards the halogen atom.
30
 Studies have shown that generally speaking, as the 
polarisability of the halogen atom increases, so too does the positive potential across the C-X 
axis as the halogen substituent transitions from fluorine to iodine. There is a consistent 
negative electrostatic potential around the fluorine atom. However, a positive region of 
charge appears for chlorine, bromine and iodine substituents. The size of the positively 










Figure 3.12 The molecular electrostatic potential (in Hartrees) at the isodensity surface with 
0.001 electrons Bohr
-3
: CF4 (top left), CF3Cl(top right), CF3Br (bottom left), CF3I (bottom 




This is what accounts for the tunability in halogen bonded supramolecular materials and 
may explain the trend observed in the association constant between coronene and the NDIs. 
However, as of yet it has been difficult to obtain suitable co-crystals of the donor acceptor 
interactions to verify this effect. If one were to obtain crystals, we would expect the distance 
between the electrophilic halogen atom substituent and the nearby electron density donor 
(D
….
X-Y) to be shorter than the sum of the Van der Waals radii of the atoms involved. 
Despite the rather neat manner in which the aforementioned halogen aspects explain the trend 








3.7 Characterisation of binding isotherms in an alternative solvent system 
 
All of the previous titration experiments have been performed in THF or a mixture of THF 
and Toluene, which are capable of competing solvent interactions either by aromatic stacking 
or hydrogen bond acceptance/lone pair donation. In the previous chapter a larger helical 
supramolecular network was observed in chloroform. It was therefore deemed necessary to 
investigate what effect changing the solvent composition to one without lone pairs to see if 
the diminished solvent interaction could enhance the binding interaction between coronene 
and the NDI molecules. UV/Vis Titrations of NDIs with coronene were carried out in 
chloroform. The binding constants of the host-guest NDI-coronene system were determined 
in order to establish if there is a greater likelihood for higher order equilibria in an alternative 
non-competitive solvent system.  
A 1 mM solution of NDI in CHCl3 was prepared. To this solution was added a 2 mM 
quantity of coronene. The solution was then sonicated until the mixture became 
homogeneous. After which it was filtered through a PTFE membrane.  Another 1 mM 
solution of NDI in CHCl3 was prepared. Both solutions were then diluted to 50 µM with 
respect to NDI concentration. The resulting solutions were titrated against each other. The 
absorption range scanned was 200-900 nm. Suspension containing NDI at 50 µM 
concentration in CHCl3 was added to the cuvette and the absorption spectrum scanned. 
Subsequent scans were conducted with 75 µL titres removed from cuvette and replaced with 
75 µL titres of 50 µM NDI solution containing 100 µM coronene concentration in order to 
maintain constant NDI concentration throughout the experiments. 
From the spectrum contained within figure 3.13 and the inset graph it can be seen that the 
maximum absorption at 380 nm increases with increasing concentration of the guest species 
(coronene). A parallel stack of mutually attracting allows for improved formation of a 
transition dipole moment on the absorbing chromophore (NDI). Therefore, the 
hyperchromism observed between 350 and 390 nm in Figure 3.13 is consistent with an 
electron poor (NDI) – electron rich (coronene) face centred π-π interaction. The binding 
isotherms were then fitted to a mathematical model derived from the assumed equilibria to 
obtain the association constants of the binding interactions of the NDIs and guest species by 
use of MATLAB
®








Figure 3.13 UV-Vis titration of coronene into compound 3 (30 μM) in CHCl3. Inset shows 
gradual hyperchromism of the naphthalene core skeletal vibrations upon increasing 
concentration of coronene (up to 2 eq.). 
 
The binding constants of the Host-Guest complexes were determined by fitting of the 
UV/Vis binding isotherm data through non-linear regression methods outlined by Thordarson 
et al.
18
 using the relationship between the change in the absolute concentration dependant 
physical property (i.e. the absorption maximum at 380 nm) and the molar extinction 
coefficients of the Host-Guest complexes as determined by the experimental data.  
 
This relationship is described by the following equation 23 and leads to the calculation of 





1 + K11[H]+ K11K21[H]2
   Eq.23 
 
























































Where ∆Aobs is the change in absorption upon titration, [G]0 is the absolute Guest 
concentration (coronene) and ε∆HG and ε∆H2G are the molar extinction coefficients of the Host-
Guest complexes.  
 
Table 3.3 Summary of association constants and cooperativity values for the 2:1 modelled 
NDI-Coronene complexes and their associated error parameters 
2:1 (H:G) 
NDI K11 K21 SEy Cov fit α2:1 
(2) 3300 8400 0.003 0.0025 2.58 
(3) 1600 350 0.002 0.0540 0.21 
(4) 1300 4200 0.002 0.0138 3.12 
(5) 200 3500 0.001 0.0012 16.35 
(6) 1500 2100 0.005 0.0312 1.37 
(7) 3000 1500 0.003 0.0097 0.52 
 
   
The NDI-coronene systems studied all fitted the 2:1 binding model. The experimental data 
fitted the computational binding method well as evidenced by the consistently low values for 
standard error and covariance of fit. The series of NDIs synthesized exhibit varying 
cooperativity values (α) suggesting differing binding characteristics.  
The positive correlation was not seen for all NDI species. The NDI bearing an O-Methoxy 
electron donating group as the aryl substituent on the phenylalanine displayed negative co-
operativity. This further substantiates the significant role of the electron withdrawing group 
in enhancing the binding as well as the potential involvement of halogen bonding as a means 
of added stabilisation of the complex. These experiments provide supporting evidence for the 










3.8 In vitro Laser Scanning Confocal Microscopy of NDI-Coronene complexes 
 
Laser scanning confocal microscopy has been performed on the NDI-coronene complexes 
in order to establish if they can be successfully up-taken into prostate cancer cells and 
subsequently used for the purposes of imaging. Imaging experiments were performed on PC-
3 cells according to the procedure outlined in the previous chapter and described in detail in 
the experimental section. 
 
 
Figure 3.14 Single-photon confocal direct camera acquisitions. NDI- coronene complex of 
compound 3, 50μM, 0.5% DMSO, at 36 °C in PC-3 cells incubated for 15 minutes at 36 oC. 
The cells were irradiated with 405 nm light and DIC image is represented by the compound 
emission across the blue, green and red channels (a, b and c) and the bright field image of the 






Figure 3.14 shows the bright field camera image and the overlay of the emission of the 3 
channels and the separated channel emissions. From the image of the PC-3 cancer cells it is 
clear that there is up-take the NDI compound in PC-3 cells, with the majority of the emission 
lying within the blue and green wavelengths with some minor emission in the red 
wavelengths. This was a promising result as there was anticipation that it would be 
considerably difficult to obtain suitable fluorescence emission due to the quenching effects of 
the coronene on the NDI fluorescence. Coupled with the low lying quantum yields due to H-
aggregate formation in polar protic media, the ability to observe suitable fluorescence 
emission in vitro was seen as an encouraging result that warranted further investigation. 
The microscope was switched to confocal mode. Image acquisition conditions were 
adjusted in a similar fashion according to the method described in the previous chapter and 
detailed in the experimental section. During acquisition, the pixel dwell time was increased 







Figure 3.15 Single-photon confocal fluorescence image acquisitions. NDI-coronene complex 
of compound 3, 50μM, 0.5% DMSO, at 37°C in PC-3 cells incubated for 15 minutes at 36 oC. 
The cells were irradiated with 405 nm light and image is represented by the separated 
emissions across the blue, green and red channels (a, b & c) and the overlay of the individual 
channel emissions (d). 
 
Figure 3.15 shows that the broad emission characteristics observed in the in vitro studies 
of the uncomplexed NDIs is still retained when PC-3 cells are exposed to the NDI-coronene 
complex. As of yet it is unclear whether this is due to the complex retaining broad emissive 
characteristics, or because the complex is unstable in-vitro and what we observe is purely 
emission from the NDI alone. Further studies utilising a broader range of excitation 
wavelengths will be necessary to try and isolate emission deriving from the charge transfer 





acceptor nanoparticle supramolecular assembly targeting the absorption region of the charge 
transfer complex resulted in fluorescence emission not observed in the uncomplexed 
species.
32
 Such a study would establish the preservation of the charge transfer mechanism in 
vitro. Nevertheless, a z-stack series was performed to characterise the emission profile across 
the entire cell structure. 
Figure 3.16 displays the 3-dimensional rendered image of the z-stack series. Close 
investigations of the micrographs show that the complex distributes throughout the cell 
structure. It is also clear that consistent with the studies performed in the previous chapter the 
fluorescence emission is localised to within the cytoplasm and does not penetrate the nuclear 
membrane. Figure 3.16 shows cross sections in the xyz plane and xy plane. They show 
cavities within the cell structure where the complex has not penetrated the nuclear membrane. 
The general distribution throughout the cell cytoplasm is ideal if one is to exploit the energy 
transfer processes for applications such as photothermal therapy. The ability to irradiate the 
sample and instigate energy transfer processes throughout the cell structure will allow for 






































Figure 3.16 3-dimensional render of the confocal fluorescence z-stack series of images for 
NDI-coronene complex of compound 3 at 405 nm laser irradiation after 15 minutes of 









3.9 Summary of Chapter 3 
 
The chiral naphthalene diimides were successfully complexed to relative electron rich C60 
and coronene polyaromatic carbon systems. UV-Vis studies supported the enhancement of 
solubility of the carbon systems by the NDIs and the formation of a ground state charge 
transfer complex. NMR and UV-Vis titrations demonstrated the enhancing role aryl halide 
species had on the propensity for the NDI molecules to form dynamic and varied association 
equilibria. This was dependent on the halogen atoms electronegativity and overall 
polarisability and implicates a potential halogen bonding mechanism in the overall 
stabilisation of the supramolecular complexes. Fluorescence titrations demonstrated evidence 
of a binding process mediated by a Fӧrster resonance energy transfer mechanism. Additional 
time-correlated single photon counting experiments revealed exponential decay 
characteristics that could be successfully modelled to two component systems with extending 
lifetimes suggesting the existence of new emitting species in solution after addition of 
coronene attributed photo-induced excited state energy transfer. In vitro fluorescence imaging 
of the complexes in PC-3 prostate cancer cells revealed broad fluorescence emission across 
the blue and green region of the spectrum, with a minor contribution from the red emission 
wavelengths. However, it was unclear if this was due to the disassociation of the complex. 
Ultimately when placed in a donor acceptor conjunction with electron withdrawing organic 
molecules, planar carbon systems such as coronene demonstrate the capacity to facilitate 
binding processes that are mediated by charge and dynamic excited state energy transitions. 
Additionally, the aspects of halogen atom size and electronegativity allow for a certain degree 
of control and tunability within the surface chemistry of nanomaterials. The inclusion of 
halogenated species as part of the design opens up opportunities for further manipulation of 
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Chapter 4.0 Synthesis of complexes incorporating NDIs and thermally reduced 
graphene oxide and their imaging in prostate cancer cells 
4.1 Overview to Chapter 4 
 
Graphene is a one-atom thick carbon allotrope material comprised of sp
2
 bonded carbon 
atoms arranged in a regular honeycomb like lattice structure
1
, that was first isolated in 2004 
by Andre Geim and Dimitri Novosolev. Graphene and its functionalised congeners such as 
graphene oxide and its reduced variants is a material that has garnered considerable interest 
owing to its abundance of valuable properties that have led to it being seen as a revolutionary 





 This is in large part due to its many impressive properties 











 high Young’s modulus (1.0 TPa)6 and high optical 
transmittance (97.7%).
7
 One of the key challenges of advancing graphene based 
technologies remains in the area of effective surface functionalisation and the 
formation of stable hybrid graphene materials.  
The difficulties surrounding the controlled functionalisation of graphene are 
associated with its considerable structural and atomic variability. Popular methods of 
surface modification rely on covalent approaches that require oxidised variants of 
graphene as a prerequisite to introducing various oxygen groups such as epoxides, 
tertiary alcohols and peripheral carboxylic acids.
8
 These strategies have previously 









 Modifying the surface of graphene in such a manner 
introduces defects into the planar graphitic layers that can ultimately serve to diminish 
the valuable aforementioned properties. A potential solution to this problem is the 
exploitation of supramolecular methods towards the development of hybrid graphene 
nanostructures.
13
 This can provide the benefit of a facile approach to modifying 
graphene surfaces that relies primarily on electrostatic and van der Waals interactions. 
Furthermore, it eliminates the need for using graphene oxide and covalent methods 
that can be complex and time consuming. 
Despite its numerous advantageous properties, graphene is limited in its utility 
owing to its zero band-gap characteristics.
14





been used to effectively dope the surface of graphene to render it with p or n type 
semi-conducting properties, as well as interesting optical and magnetic 
characteristics.
15-17
 One of the benefits of using organic molecules as the dopant lies in 
the ability of organic molecules to be readily tuneable with respect to their electronic 
and optical properties. Combining graphene with organic molecules allows the field of 
supramolecular design to exploit the best of both materials and organic chemistry 
research disciplines towards the development of novel functional nanomaterials. 
A basic and fundamental example of efforts to deposit organic molecules onto 
graphene lies in the area of ultra-high vacuum (UHV) processing.
18
 These methods 
exploit the thermal evaporation of different small organic molecules onto the surface 
of graphene in a UHV chamber. As alluded to in the literature review perspective, 
methodologies have already been established whereby small organic molecules form 
highly ordered 2-dimensional nanostructures when deposited on flat sp
2
 hybridised 
surfaces. Recent studies have shown that perylene molecules bearing carboxyl groups 
can interact with graphene via π-π interactions to form continuous uniform layers that 
align themselves in a parallel fashion to the graphene surface.
19
 Indeed, modulating the 
electron accepting capacity of the organic molecules has demonstrated the ability to 
enhance the binding efficacy with graphene Salzman et al. used a perfluoropentacene 
to produce a π stacked array of co-planar molecules with an incredibly low π stacking 
distance of 3.07 Å.
20
 Phthalocyanine molecules have also been shown to align 
themselves in a face centred orientation on CVD grown graphene.
21
 Furthermore, iron 
(II)-phthalocyanine was adsorbed onto a single sheet of monolayer graphene.
22
 These 
molecules arranged themselves according to the surface moire pattern and thus 
demonstrated the capacity of graphene to act as a template for the self-assembled 
growth of regular lattice structures.  
Ultimately, the overall arrangement of the self-assembled nano-construct is going to 
be governed by a mixture of non-covalent intermolecular interactions and the 
molecule-substrate interactions at the solid interface. Considering organic molecules 
can be readily modulated to contain side-groups possessing different functionality, 
these aspects can work in tandem or in opposition to the π-π interactions to drive a 
variety of self-assembled pathways. Ab initio studies have revealed that three types of 
molecule-molecule or molecule-substrate interactions govern the way in which 





repulsive π-π interactions (0.1 – 0.3 eV), medium range attractive π-π* interactions 
(0.3 – 0.6 eV) and short range hydrogen bonding (0.6 – 0.8 eV).23 The hydrogen 
bonding in particular imparts great directional control that allows for the tailoring and 
prediction of the arrangement and general position of organic molecules. Ultimately, 
nucleation, orientation, packing, degree of intermolecular interactions and the extent 
of available solid-liquid interface complete a complex set of influencing factors that 
govern the assembly of organic molecules onto the surface of graphene that is 
markedly different to the interactions that govern the more traditional doping of 
semiconductor substrates such as silicon. 
From a viable large scale application perspective, graphene is likely to be used in 
some form of liquid-phase processing. Therefore soluble organic-graphene composite 
solution processed systems hold and advantage over CVD based methodologies.
24
 A 
whole host of molecules have been used to facilitate the liquid-phase exfoliation of 
graphene in organic solvents via ultrasonication treatment.
25-27
 The dispersion and in 
essence doping of graphene in organic molecule solutions has interesting effects on the 
optical properties of the resulting hybrid materials. Doping with large aromatic ring 
systems such as anthracene and pyrene results in wider splitting of the G-band phonon 




Graphene demonstrates the capacity to quench fluorescence via charge and energy 
transfer mechanisms. A variety of organic fluorescent emitters have been shown to 
bind to graphene, graphene oxide and reduced graphene oxide mediated by energy, 









 have all induced energy transfer processes that have led to 
quenching, photocatalysis, self-assembly and improved optical efficiency.
34
 The 
quenching in particular has been noted in instances where the organic molecule is up 
to 30 nm away from the surface of graphene. This is a much larger distance for typical 
energy transfer based mechanism such as Forster resonance energy transfer (<10 nm). 
Indeed the interactions between graphene and organic molecules can occur via phonon 
energy transfer as well. Considering phonons are quantum mechanical 
characterisations of vibrational motions, improving energy transfer via phonon modes 





been demonstrated between sulphonated pyrenes and reduced graphene oxide and is of 
particular value to photothermal therapeutic applications.
34
 
Lying firmly in the class of fluorescent, electron withdrawing molecules, α – amino 
acid derivatised naphthalene diimides synthesised in this work demonstrate an 
incredible opportunity as functional organic dopants for graphene and its congeners. 
The features of the resulting composite have the potential to be more than the sum of 
the individual properties of the constituent molecules. The following section describes 
the synthesis, reduction and characterisation of graphene oxide. Experiments have 
been carried out to establish the nature and extent of fluorescence quenching with the 
dye molecules as surface dopants. The chapter concludes with cell imaging studies to 
assess the viability of the fluorogenic composites as prostate cancer imaging agents. 
 
4.2  Synthesis and reduction of Graphene Oxide 
 
Graphene oxide was synthesised according to modified Hummers method. This method 
has been extensively employed in the literature in which a diamanganese heptoxide species is 
generated as the prime oxidant in the reaction. Attempting to precisely control the extent and 
nature of the oxidation is a considerable challenge owing to the amorphous nature of the 
berthollide graphite source. The modification to the Hummer’s method used herein allows for 
the adjustment of the rate at which the diamanganese heptoxide speed is generated. Adjusting 
the total volume of water, the duration of stirring and the time at which hydrogen peroxide is 
added allows for a more controlled oxidation and reaction termination. 5 g of flake graphite 
was added to 115 ml of conc. H2SO4 and 2.5 g of NaNO3 under stirring in an ice bath for 30 
minutes. 15 g of KMnO4 was slowly added to the flake graphite suspension over the course 
of one hour. The dark brown suspension was stirred for an additional hour ensuring the 
temperature did not rise above 5 
O
C. The temperature was then raised to 45 
O
C and stirred for 
a further hour. 230 ml of distilled water was added and stirred for 30 minutes at 45 
O
C. The 
reaction was then terminated via the addition of 600 ml of distilled water and 150 ml 
hydrogen peroxide (3%). The resulting brown/yellow suspension was centrifuged (3000 rpm, 
5 minutes) and the supernatant decanted to leave wet solid GO. The GO was then put through 
repeated cycles of washing and centrifugation with distilled water to remove residual salts 





50 mg of GO was dispersed in a 2:1 mixture of ethanol and water and sonicated for 3 hours in 
30 minute intervals with additional 5 minute resting periods to exfoliate the graphite oxide in 
order to pry apart sheets of GO. After sonication the GO suspension was centrifuged and the 
supernatant collected containing a stable dispersion of sheets of GO. Supernatant was 
deposited onto lacey carbon grids for TEM characterisation and left in a desiccator overnight 
prior to microscopy. Thermal treatment in a furnace was employed to reduce the graphene 



























4.3 Solid state analysis of Graphene Oxide 
 
Transmission Electron Microscopy (TEM) was performed on the stable dispersions of 
graphene oxide in order to confirm the presence of sheets of graphene oxide and to 
characterise their surface morphology. The TEM analysis of the graphite oxide after 
sonication indicates the presence of discrete sheets of graphene oxide ranging in size from 
200 nm length to 2 microns. Therefore cavitation induced by sonication was sufficient to pry 
apart the platelets of graphene oxide. A large majority of the sheets demonstrate a high 
degree of surface wrinkling due to extended defects on the surface of the graphene sheets. 
Selected Area Electron Diffraction was also performed and revealed hexagonal diffraction 
pattern corresponding to 6 membered rings of the graphitic domains, suggesting the presence 
of a coherent crystalline structure. 
In addition, elemental analysis was performed on the sample to assess the degree of 
oxidation. The results indicate that the modified Hummers method applied in this particular 
manner was capable of producing sheets of graphene oxide containing a Carbon: Oxygen 
ratio of 55.22:16.57. Ultimately, the TEM analysis indicates that the material is not an 








































Figure 4.0 TEM micrographs of graphene oxide displaying varied sheet size distribution 







4.4 FT-IR Analysis of Graphene Oxide 
 
Fourier Transform Infra-red Spectroscopy was performed in order to extract information 
regarding the nature of the oxygen functional groups introduced into the graphite. The 
corresponding FT-I.R. spectrum is shown in Figure 4.1 below. 
 
Figure 4.1 FT-IR spectrum of graphene oxide 
A broad band is present at 3330 cm
-1
 that is attributed to v(O-H) stretching vibrations of 
hydroxyl groups on the graphene surface. Sharp band at 1620 is attributed vibrations 
corresponding to aromatic carbon double bonds due to unoxidised graphitic domains. The 
peaks at 1106 and 1270 are attributed to alkoxy and epoxy species respectively. Despite the 
GO possessing partial carboxyl groups and a number of hydroxyl and epoxide species, it still 
retains a certain degree of crystallinity as evidenced by the selected area electron diffraction 
pattern. Therefore the oxygen groups must exist primarily on the edge or intercalated in 
between the spaces of the sheets. The nature of the oxygen functionality can be probed 
further with Raman spectroscopy 
 




























4.5 Raman characterisation of Graphene Oxide and thermally reduced Graphene Oxide 
 




 hybridisation of 
the graphitic structures in order to gain some insight into the degree of order and disorder 
within the structure of graphene oxide. Figure 4.2  displays the solid state Raman spectrum of 
both the flake graphite precursor and that of graphene oxide obtained with a 532 nm laser 
irradiation. 
Figure 4.2 Raman spectra of bulk graphite starting material and graphene oxide after 
sonication showing evolution of G and D bands. 
 
The unit cell of single layer graphene is shown in Figure 4.3 to illustrate the origin of 
graphene Raman modes. The prominent characteristic present in the Raman spectrum of 
graphite is the G band situated at 1580 cm
-1
. This feature is characteristic of all sp
2
 bonded 
carbon structures and exists due to the in plane stretching vibrations of C-C bonds. The G 
band arises due to first order Raman scattering processes, whereby only 2 specific directions 
of vibrational modes are possible. One direction lies parallel to the A and B atoms and the 
other direction lies perpendicular to them. The phonon modes responsible for these vibrations 



























are the in plane longitudinal optic (iLO) and the plane transverse optic at the centre of the 1
st
 
Brillouin zone that corresponds to the E2g symmetry.
35
 The D band is the second notable 
feature for the graphite sample, situated at 1380 cm
-1
. This band appears as a result of second 
order double resonant scattering processes. During this process, excited electrons are 
inelastically scattered by defects in the graphitic material. This is then followed by a 
secondary inelastic scattering event of the electrons by an in plane transverse optic phonon 
near the K point in the Brillouin zone. In order for the peak to be more prominent, the sample 
requires a significant degree of defects. 
The Raman spectrum of graphene oxide also shows a broader G band situated around 
1600 cm
-1
 and a much more prominent and broad D band blue shifted to its graphite 
counterpart centred around 1350 cm
-1
. The greater intensity and broadening of the D band is 
observed as result of the existence of new bands at shorter wavelengths attributed to the 
additional epoxy and hydroxyl groups introduced to the graphitic domains leading to a rise in 
the number of surface defects. The ratio of the intensity of the D to G band is correlated to 
crystal size by the Tuinstra-Koenig relation and is very close to 1 for the prepared sample of 
graphene oxide. The increase in this parameter upon oxidation corresponds to an increase in 
the size and number of sp
2
 hybridised carbon clusters.
36
 
The frequency and intensity of the G peak is known to be sensitive to layer number. The 
frequency and its corresponding intensity shifts to a higher wavenumber as the graphene 
oxide transitions from few layer graphene to bi-layer and single layer sheets.
37
 The 
bathochromic shifting of the G band can also be attributed to the emergence of Raman active 
bands at 1620 cm
-1. This D’ band tends to be Raman inactive, but is activated due to phono 
confinement by the defects introduced into the graphene material. Additionally, the higher 


















Figure 4.3 Unit cell of single layer graphene indicating inequivalent atoms A and B and 
associated lattice vectors 𝑎1⃗⃗⃗⃗ , 𝑎2.⃗⃗⃗⃗  ⃗⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗    B corresponds to the Brillouin zone of single layer 
graphene, whereby Γ, K, K’ and M correspond to centre and edge symmetry points and 𝑏1⃗⃗  ⃗ 
and 𝑏2⃗⃗⃗⃗  are the reciprocal vectors. 
Figure 4.4 Raman spectra of the graphene oxide precursor and the thermally reduced 
derivative (532 nm laser irradiation) 
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The Raman spectrum of the thermally reduce graphene oxide after complexation also 
presents the characteristic D and G bands of highly disordered graphene structures. However 
the ID/IG ratio for the TRGO is 1.2, which is far greater than its GO parent material, which 
possesses an ID/IG ratio of 0.8. This is not entirely unexpected as the thermal shock 
exfoliation used during the preparation of the TRGO introduced further defects into the sp
2
 
planar structure that was already heavily disordered due to extensive oxidation. One might 
also expect the D peak intensity to decrease due to the removal of the disorder associated 
with oxygen functionality. The observed increase in relative D peak intensity suggests that 
there is partial restoration of sp
2
 sites. However, the aggressive temperature conditions 
utilised to remove oxygen forced the creation of strains and surface defects that can lead to 
the isolation and formation of segregated sp
2
 domains of a smaller size. The drop in oxygen 
content from the EDX analysis in tandem with the Raman data implies that thermal reduction 
process does not restore the ordered structure of the graphene. The heating process causes 
pressure build up and the release of CO2 as oxygen functionality is removed, during which 
further vacancies, defects and imperfections are introduced into the basal plane of the 
graphene structure contributing to further disorder.  
Furthermore, the Raman G band is typically produced as a result of a superposition of 3 
different peaks derived from the various functionality introduced into the graphitic structure. 
O-H bending vibrations present at 1640 cm
-1





 graphite carbon band occurs at 1590 cm
-1
 all of which contribute to the overall 
position and intensity of the G band. After annealing it is evident from the Raman spectrum 
that the G band shifts to a lower wavenumber. This is to be expected because the loss of 
moisture for instance, during the heating process, would lower the intensity of the Raman 
features at higher wavenumbers which would ultimately cause an overall downshift in 




 Furthermore, during thermal reduction the hydroxyl 
groups will require a carbon source to decompose into CO gas. This carbon source can be 
derived from either the ordered aromatic C=C structure or from the disordered C
_
C bonds. 
The increased D band intensity post thermal treatment, therefore implies a propensity for 
C=C bond removal during reduction. This also supports the notion that the majority of the 
oxygen functionality exists in a well-developed central basal plane interlayer space. The 
general change in the Raman spectrum can be ascribed to an overall graphitization of the GO 
material upon annealing in which the Raman features are predominantly caused by the sp
2
 





position and its co-current drop in relative intensity and further defect induced D band 
enhancement as a result of annealing.  
4.6 Powder X-ray diffraction of Graphene Oxide and thermally reduced Graphene 
Oxide 
 
X-ray diffraction (XRD) was performed on the graphene oxide and its thermally reduced 
counterpart to extract information regarding the extent to what affect the thermal treatment 
influenced the structure of the graphene layers. The X-ray powder diffraction data was 
collected with a BRUKER AXS D8 Advance, equipped with a Vantec-1 detector, using 
CuKα radiation (λ= 1.5418 Å).  
 
Figure 4.5 Powder XRD spectra of the graphene oxide precursor and the the thermally 
reduced product 
 





 respectively. The line broadening of the diffraction peak in the TRGO 
sample is indicative of a graphene bearing crystallites of greater thickness according to the 
Scherrer equation. Indeed, the line broadening and the higher diffraction angle of (002) plane 


























of TRGO is also an indication of the reduction in the interplane distance between graphene 





     Eq. 24 
 
𝜆 = 2𝑑ℎ𝑘𝑙𝑠𝑖𝑛𝜃     Eq. 25 
 
Whereby D is the graphene thickness, K is the warren constant used as an estimate for the 
size of crystallite shape, λ is the x-ray wavelength, B is the full width at half the maximum 
(FWHM) of the diffraction peak of interest, θ is the scattering angle and d is the interplane 
distance. 
This is entirely consistent with a sample that has had intercalated water molecules and 
oxygen functionality along the basal plane removed, thus allowing for a greater stacking 
amongst the reduced graphene layers. Ultimately, the material characterisation methods 
describe sheets of graphene of a semi-crystalline nature with a high degree of defects and 





















4.7 Donor-acceptor excited state interactions between TRGO and NDIs 
4.7.1 Fluorescence titration of TRGO dispersions with NDIs solutions 
 
Overlap of the donor emission spectrum and the acceptor absorption spectrum is required, 
such that energy emitted by the excited donor to the ground state may excite the acceptor 
species. TRGO exhibits broad absorption characteristics around the emission band of the  
NDIs and so FRET may be facilitated in this way. Two-dimensional fluorescence contour 
plots were recorded for both free (6) (Figure S64 in the appendix) and its complex with 
TRGO. Apart from the fluorescence peak of NDI, a strong Rayleigh scattering line is 
observed from NDI 2D fluorescence contour plot, arising from the NDI in solution. Peaks 
characteristic of free NDI are absent in the NDI-TRGO complex emission-excitation contour 
plot (see appendix for details and additional TEM/SEM microscopy of the complexes).  
Figure 4.6 Fluorescence titration of thermally reduced graphene oxide with the bromine 
substituted NDI (compound 5-10 mM) in THF.  
 
Fluorescence titrations were carried out on the halogenated series of NDIs with TRGO. A 
10 mM solution of NDI was prepared in THF. To this solution was added a saturating 
quantity of TRGO. The resulting saturated suspensions were then sonicated to promote layer 
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separation and until a stable dispersion of TRGO had been achieved. The excess TRGO was 
allowed to settle. The resulting suspension supernatant was titrated against another 10 mM 
solution of NDI in THF. Full details of the exact titration procedure can be found in the 
experimental section. 
 
Fluorescence titrations demonstrated a reduction in emission intensity upon addition of the 
TRGO. This could be due to a static quenching process mediating the formation of a ground 
state complex that is weakly emitting. It could also be caused by the collision of TRGO with 
NDI molecules that are in an excited state. This would result in intermolecular dynamic 
quenching in which excited state energy is dissipated through a radiative pathway. This 
radiation of a dynamic nature is capable of shortening fluorescence lifetime, unlike its static 
counterpart. Considering the extent of aromaticity in the host guest species, it is reasonable to 
assume the complexation arises through the stacking of multiple and varied stoichiometries. 
A simple representation of these complexation equilibria can be described by substituting the 
terms into equations (12), (13) and (14). 
𝑛𝑁𝐷𝐼 + 𝑇𝑅𝐺𝑂 ⇌ [𝑁𝐷𝐼]𝒏 − 𝑇𝑅𝐺𝑂     Eq. 26 
[𝑁𝐷𝐼]𝑛 − 𝑇𝑅𝐺𝑂 + 𝑇𝑅𝐺𝑂 ⇌ (𝑇𝑅𝐺𝑂 − [𝑁𝐷𝐼]𝑛 − 𝑇𝑅𝐺𝑂)  Eq. 27 
(𝑇𝑅𝐺𝑂 − [𝑁𝐷𝐼]𝑛 − 𝑇𝑅𝐺𝑂) + 𝑇𝑅𝐺𝑂 ⇌ ([𝑁𝐷𝐼]𝑛 − (𝑇𝑅𝐺𝑂)𝑛)  Eq. 28 
Equation 26 describes the simplest arrangement of a single TRGO sheet with a single or 
stacked set of NDI. Equation (13) corresponds to a sandwich like complex, whereas equation 
(14) is a complex of the NDI with a TRGO dimer-like species. Upon reaching the point 
whereby all NDI molecules have been complexed by TRGO in equation 26, further additions 
of TRGO will likely cause the complexation events in equations  27 and 28 and other higher 
TRGO aggregates and complexes. If the quenching process occurs primarily via a pathway 






= (1 + 𝐾1[𝑇𝑅𝐺𝑂])      Eq. 29 
 
F0 refers to the initial fluorescence intensity, while F1 refers to the intensity of a given 





would imply that the dynamic higher order quenching processes described in equations (13) 
and (14) are not occurring. In this case, only the simplest complex [NDI–TRGO] would then 
be formed. Indeed, this seems to be the case upon inspection of the fluorescence titration in 
Figure 4.6. This is the first indication that there are no higher order aggregates of NDI and 
TRGO forming via mechanisms of photo induced energy transfer. However, this is unlikely 
due to the NDIs demonstrating a propensity to aggregate with themselves via π-π interactions 
coupled with graphenes tendency to stack. This suggested some uncertainty associated with 
the suggestion of a lack of higher order aggregates mediated photo induced energy transfer. It 
was therefore necessary to perform additional TCSPC experiments to resolve the 
discrepancies across the titration experiments. 
 
4.7.2 Time correlated single photon counting of the NDI-TRGO complexes 
 
 
Figure 4.7 TCSPC decay traces of fluorine (compound 3) substituted NDI (50 μM in THF)  
and its complex with TRGO.  
 
The fluorescence decay of the NDIs could be fitted to a single component system when in 
free solution However, as with the complexes with coronene described in the previous 























chapter, two component systems were more accurate models of the decay profiles when 
TRGO was present This implies the presence of new emitting species as a result of 
complexation. All of the NDIs showed single lifetimes of approximately 3.5 - 3.8 ns when in 
free solution. Interestingly, the major component for the TRGO-NDI complexes was reduced 
quite dramatically (46-329 picoseconds) and the minor contributions to lifetime components 
were extended to a far greater degree than there minor counterparts. This suggests that two 
processes are occurring. Firstly, a collisional quenching that forms a complex that does not 
undergo radiative emission processes and secondly and dynamic quenching whereby energy 
is being transferred after excitation leading to extended lifetimes. These changes in lifetime 
upon complexation photo-induced excited state electron transfer occurring between the 
closely bound donor-acceptor systems within the NDIEx-TRGO complexes. In particular the 
picosecond lifetime component latter suggests that TRGO is a more severe quencher than 
coronene.  All fluorescence lifetime decay parameters for the NDI-TRGO complexes are 
summarised in table 4.0. 
 
Table 4.0 TCSPC fluorescence lifetime data for free NDIs and their TRGO complexes. 
 Single Component (ns) χ2 Two Component (ns) χ2 % 
 τ  τ1 τ2  a1 a2 
(2) 3.33 1.26 - - - - - 
(2) +TRGO - - 0.307 3.24 1.27 72 28 
(3) 3.75 1.29 - - - - - 
(3) + TRGO - - 0.329 4.16 1.08 73 27 
(4) 3.79 1.25 - - - - - 
(4) + TRGO - - 0.069 3.48 1.21 76 24 
(5) 3.49 1.16 - - - - - 
(5) + TRGO - - 0.046 3.76 1.15 74 26 
(6) 3.49 1.19 - - - - - 
(6) + TRGO - - 0.054 3.70 1.20 70 30 
 
 
The clear and dramatic reduction in fluorescence lifetime of all of the NDI-TRGO 





reduced graphene species and the NDI chromophores. It would therefore seem that the 
discrepancies in the results of the fluorescence titrations have been resolved. The lack of two 
separate linear regions of quenching that should exist in species undergoing static and excited 
state quenching has are more reasonable explanation whereby the NDI concentration with 
respect to the TRGO in the fluorescence titration experiment was not suitably low for the 
higher order TRGO equilibria to form. As TRGO is a more severe quencher, coupled with the 
poor quantum yields of the NDI species in polar solvents, higher concentration of NDIs were 
required in order to detect a suitable fluorescence signal. This meant that it was far less likely 
for the TRGO species to be at a suitably high enough concentration with respect to the NDI 
to observe excited state quenching via a fluorescence titration. Additionally, the discrepancies 
between the relative concentrations between the two complexing species were not of concern 
in TCSPC experiments. as they were performed at a much lower concentration of NDI (50 
μM) in order to avoid the self-aggregation influences on the fluorescence lifetime. Therefore, 
the bi-exponential decay characteristics are more likely to be indicative of TRGO facilitating 
excited state photo induced dynamic quenching. 
Choice of solvent can play a significant role in the structural arrangement of 
supramolecular assemblies, thermodynamics of their interaction and their capacity to 
facilitate charge/energy transfer.
41, 42
 As discussed in the literature review section, a number 
of studies have shown that graphene and its congeners can serve to act as a template for self-
assembly whereby the organic molecules arrange themselves according to the surface moire 
pattern. The synthesis of thermally reduced graphene oxide has led to the production of 
sheets of graphene that vary quite widely with respect to their nanostructured dimensions. 
Therefore, it is expected that will be a considerable competitive van der Waals physisorption 
interaction as a result of the varied number of solid interfaces at any given moment within a 
stabilised NDI-TRGO complex suspension. This additional π-π and/or Van der Waals 
interaction may serve to disrupt the helical arrangement observed in the free and NDI-




















Figure 4.8 Circular dichroism spectra of coronene complex of compound 3 (30 μM) in 
CHCl3 stabilised with amylene and when complexed to TRGO.  
What is interesting to note is the bisignate cotton effect observed in the supramolecular 




 with coronene is not retained with TRGO. 
TRGO has the capacity to form much larger sheets of aromaticity which can lead to  a more 
competitive physisorption  component through Van der Waals and π-π interactions  at the 
solid interface that makes it impossible for the hydrogen bonds to form the helical 
assembly.
46
 The majority of the studies carried out in this investigation have been performed 
in a mixture of THF and toluene. The combination of polarity and solvent aromaticity and 
significant π-π interaction derived from the graphene surface makes it highly unlikely that 
such a helical arrangement would exist in solution. But it is still interesting to observe such 
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4.8 Two-photon fluorescence lifetime imaging microscopy (2P-FLIM) of NDI-TRGO 
complex 
 
The purpose of utilising graphene in a complex with the NDIs is to primarily exploit the 
fluorescent properties of the NDIs to image the cells whilst simultaneously maintaining the 
charge and energy transfer processes that are essential for applications such as photothermal 
therapy. In order to achieve this, the complex must obviously be stable in vitro, but it must 
also impart a suitable fluorescence signal that is not completely quenched by the close 
proximity of the TRGO material. Two-photon fluorescence lifetime imaging was performed 
on the substituted NDI bearing bromine aryl halide phenylalanine substituent (Compounds 5). 
The compound was incubated with PC-3 cells at a 100 µM concentration in 1 % DMSO for 














Figure 4.9 Two-photon fluorescence lifetime map in PC-3 cells of compound 5 complexed 
with TRGO (top) and associated distribution curve comparison of the control and compound 
5 in free and complexed state (bottom left) and associated lifetime decay profiles (bottom 
right) at 100 μM after 810 nm laser irradiation. 


















































Figure 4.9 shows the lifetime distribution and exponential decay curves of the NDI in a 
free and complexed state in comparison to the control experiments. From the distribution we 
see that the lifetime of the complex is shifted away from that of the free NDI species. The 
presence of a larger proportion of shorter lifetimes for the complex suggests that the NDIs 
undergo quenching of fluorescence in vitro in as when in solution. However, the lifetime 
profile does not completely overlay with that of the control experiments performed with 
DMSO. Therefore, the lifetime observed cannot be attributed entirely to autofluorescence or 
the free NDI. Rather, there is an additional lifetime contribution derived from the complex. 
The existence of independent emissive lifetime characteristics and a certain degree of 
fluorescence quenching indicates that the interaction between the NDI and TRGO is still 
stable in vitro. The lifetime data are summarised in Table 4.1 






















Control 0.31 2.16 1.19 70.8 29.2 
5 0.53 3.24 1.08 72.4 27.6 
5 + TRGO 0.45 2.62 1.08 69.2 30.8 
 
The retention of a certain degree of fluorescence and stability of the complex substantiates 
the potential of the NDI-TRGO complexes as imaging agents that can impart dynamic energy 
transitions in vitro. This warranted further in vitro investigation of the complex fluorescence 

























Figure 4.10 Single-photon confocal direct camera acquisition: Compound 5, 50μM, 0.5% 
DMSO, at 37°C in PC-3 cells incubated for 15 minutes.  The cells were irradiated with 405 
nm light  with the separated individual blue, green and red channel emissions (a, b & c).The 
DIC image is represented by (d) the brightfield image of the cells prior to excitation (d) and 

























Figure 4.11 3-dimensional render of the confocal fluorescence z-stack series of images for 
NDI-TRGO complex of compound 5 at 405 nm laser irradiation after 15 minutes of 






Figure 4.12 Single-photon confocal fluorescence image acquisitions. NDI-TRGO complex of 
compound 3, 50μM, 0.5% DMSO, at 37°C in PC-3 cells incubated for 15 minutes.  The cells 
were irradiated with 405 nm light and image is represented by the separated emissions across 
the blue, green and red channels (a, b & c) and the overlay of the individual channel 






Figure 4.12 reflects the images taken in the camera mode with a large majority of the 
emission lying in the blue and green wavelengths. However, it is much clearer that there is 
broad emission across all of the visible wavelengths blue channel (417-477 nm), green 
channel (500-550 nm) and in the red filter channel of the spectrum (570 – 1000 nm) . Also 
encouraging is the fact that clear and well resolved emission could still be observed despite 
the relatively poor quantum yields of the NDIs coupled with the previous TCSPC data 
demonstrating that TRGO is rather significant energy sink for fluorescence emission. From 
the 3-D z stack series and their associated cross-sections it is clear that the complex does not 
penetrate the nuclear membrane in a similar manner to the previous cellular imaging studies 
performed on the free NDIs and their coronene complexes. Considering the complexes were 
stable in vitro and retained a considerable degree of fluorescence that could be monitored via 
laser assisted confocal microscopy it was deemed necessary to perform a preliminary study to 
assess the cytotoxicity of the NDI-TRGO complexes. 
 
 
4.9 Evaluation of NDI-TRGO toxicity via MTT assay 
 
The final objective in this study was to establish the effect the NDI-TRGO complexes had 
on the cell viability. Various polyaromatic hydrocarbons and ultrafine particulate matter have 
been shown to induce oxidative stress upon their uptake in epithelial cells and macrophages. 
Indeed, a particular study by Li et al. demonstrated that fine particulate matter that readily 
penetrates the cell membrane localises in the mitochondria, where they induce structural 
damage and oxidative stress. Establishing the toxicity of the TRGO complexes exposes the 
therapeutic potential of incorporating graphene in the imaging probe. 
 
MTT assays were performed on the compound (3) that had been fully complexed to 
TRGO in DMSO (see experimental for full details on complexation procedure) in order to 
establish the extent to which the NDI-TRGO complexes exhibit cytotoxic behaviour. 3x10
3
 
cells per well were seeded into a sterile 96 well plate and incubated for 48 hours. A range of 
concentrations for the NDI compound were added to the well plates and allowed to culture 
for a further 48 hours. After appropriate washing phases with PBS, the 3-(4,5-





hours of incubation with the MTT reagent, the absorption 570nm monitored with respect to 
















Figure 4.13 Scatter graph representing dose dependent response of cell viability with respect 
to NDI concentration for complex 5 (left) and TRGO on its own (right) 
 
 
From the dose response of the thermally reduced graphene oxide there is a clear indication 
of a significant degree of toxicity and anti-proliferative cellular effects with the IC50 value 
calculated as being 2.92 μg. Previous studies in the literature have shown conflicting results 
with regard to the extent of the cytotoxic effects of graphene and its oxides. Studies that 
incorporated molecules that enhanced the stable dispersion of graphene oxide demonstrated a 






 However, studies in which the graphene was highly 
aggregated demonstrated higher levels of cytotoxicity. The use of NDI like molecules serves 
to enhance the solubilisation of polyaromatic hydrocarbon systems, therefore aiding in the 
enhanced dispersion of thermally reduced graphene oxide. The results of this are shown in 
the MTT assay of the NDI-TRGO complex. The IC50 value for the complex is calculated as 
being 122 μM of NDI in a TRGO complex. This is an order of magnitude higher than the 
toxicity of the free NDI species discussed in Chapter 2. Clearly the addition of thermally 
reduced graphene oxide in an NDI complex does not lead to similar levels of cytotoxicity 
despite the complex distributing itself throughout the cell cytoplasm. However, due to the 
variable nature in the size of the TRGO sheets and their extent of oxidation, it is difficult to 
determine the precise quantity of TRGO in the complex. It is therefore unclear to what extent 
the NDI molecules can aid in preventing rapid cytotoxicity and further in depth studies will 







 TRGO complex of 5



































































be necessary to fully evaluate the biocompatibility of the thermally reduced graphene oxide 
complexes. 
 
Compound 4 was selected to investigate how the NDI functionalization of PCSs such as 
coronene and TRGO affects the cellular viability with respect to free coronene and TRGO. 
Cell viability in the presence of free coronene, TRGO, 4・coronene and 4・TRGO were 
carried out over a 48 h observation period. Experimental details of MTT assays are available 
in the Appendices.  
 
 
Figure 4.14 IC50 in PC-3 cells after 48 h treatment of pristine coronene and TRGO, 4-
coronene, and 4・TRGO complexes. Coronene IC50: 1.20x10
−5





 M ± 2.03x10
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Assays showed that the pristine coronene and TRGO had an important effect on the 
viability of cells, leading to IC50 values of 1.20 × 10
−5
 and 2.92 × 10
−5
 M, respectively. 
Interesting, the functionalization of TRGO and coronene with compound 4 significantly 
modulates the biocompatibility of carbon-based materials showing reduced level of toxicity 
for 4-coronene and 4-TRGO. Remarkably, the IC50 values of 4-TRGO is significantly 
increased, while the viability of cells is enhanced 588 times in the presence of the 4-coronene 
complex (Figure 5.11). It is known that graphene family of nanomaterials such as graphene, 
GOs, reduced GOs are cytotoxic and/or genotoxic. Although the mechanisms for their 













While pristine carbon based materials tend to accumulate in physiological solution due to 
electrostatic interactions and nonspecific bindings to proteins, surface-modified graphene-like 




 Our results are consistent with these 
observations. These results demonstrate that the functionalization of coronene and TRGO 
with d-phenylalanine NDIs considerably improves the in vitro biocompatibility of the pristine 
PCSs presented in this work. 
 
 
4.10 Summary of Chapter 4 
 
Presented in this chapter is a detailed study of the interactions between halogenated amino-
acid tagged fluorescent NDIs and thermally reduced graphene oxide. The inclusion of 
peripheral substituents influences the degree of surface binding to the carbon surface which 
should be of relevance in the quest of designing tailor made functional nanomaterials. When 
a part of a donor-acceptor complex, and placed within the environment created by an 
acceptor, (i.e. an electron withdrawing organic molecule such as a substituted NDI), nano-
dimensional thermally reduced graphene oxide (TRGO) demonstrate the capacity to 
participate in supramolecular binding processes that are mediated by charge and dynamic 
excited state energy transitions. Additionally, the size and electronegativity tunability created 
by the presence of a differing halide substituent at the periphery of the phenyl alanine moiety 
of the NDI allows for a certain degree of control over the surface chemistry of the resulting 
nanohybrid materials. In vitro cellular imaging studies revealed successful uptake of the 
complex and the retention of its stability due to in vitro charge transfer within the complex. 
Both single and two photon studies demonstrated the ability of the complex to image prostate 
cancer cells. The inclusion of halogenated species as part of the design opens up 
opportunities for further manipulation of luminescent properties and tailoring of the materials 
directionality and strength of the aromatic interaction. These aspects will most certainly 










4.11 References for Chapter 4 
1. A. H. Castro Neto, F. Guinea, N. M. R. Peres, K. S. Novoselov and A. K. Geim, 
Reviews of Modern Physics, 2009, 81, 109-162. 
2. G. Eda and M. Chhowalla, Advanced Materials, 2010, 22, 2392-2415. 
3. F. Bonaccorso, Z. Sun, T. Hasan and A. C. Ferrari, Nat Photon, 2010, 4, 611-622. 
4. S. V. Morozov, K. S. Novoselov, M. I. Katsnelson, F. Schedin, D. C. Elias, J. A. 
Jaszczak and A. K. Geim, Phys. Rev. Lett., 2008, 100, 016602. 
5. A. A. Balandin, S. Ghosh, W. Bao, I. Calizo, D. Teweldebrhan, F. Miao and C. N. 
Lau, Nano Letters, 2008, 8, 902-907. 
6. C. Lee, X. Wei, J. W. Kysar and J. Hone, Science, 2008, 321, 385-388. 
7. Y. Zhu, S. Murali, W. Cai, X. Li, J. W. Suk, J. R. Potts and R. S. Ruoff, Advanced 
Materials, 2010, 22, 3906-3924. 
8. D. R. Dreyer, S. Park, C. W. Bielawski and R. S. Ruoff, Chem. Soc. Rev., 2010, 39, 
228-240. 
9. Z. Liu, J. T. Robinson, X. Sun and H. Dai, J. Am. Chem. Soc., 2008, 130, 10876-
10877. 
10. S. Y. Lim, J. Ahn, J. S. Lee, M.-G. Kim and C. B. Park, Small, 2012, 8, 1994-1999. 
11. L. Zhang, J. Xia, Q. Zhao, L. Liu and Z. Zhang, Small, 2010, 6, 537-544. 
12. X. Shi, H. Gong, Y. Li, C. Wang, L. Cheng and Z. Liu, Biomaterials, 2013, 34, 4786-
4793. 
13. Q. Chen, T. Chen, G.-B. Pan, H.-J. Yan, W.-G. Song, L.-J. Wan, Z.-T. Li, Z.-H. 
Wang, B. Shang, L.-F. Yuan and J.-L. Yang, Proceedings of the National Academy of 
Sciences, 2008, 105, 16849-16854. 
14. H. Liu, Y. Liu and D. Zhu, J. Mater. Chem., 2011, 21, 3335-3345. 
15. A. Nourbakhsh, M. Cantoro, B. Li, R. Müller, S. De Feyter, M. M. Heyns, B. F. Sels 
and S. De Gendt, physica status solidi (RRL) – Rapid Research Letters, 2012, 6, 53-
55. 
16. P. Lazar, F. Karlický, P. Jurečka, M. Kocman, E. Otyepková, K. Šafářová and M. 
Otyepka, J. Am. Chem. Soc., 2013, 135, 6372-6377. 
17. A. K. Manna and S. K. Pati, Chemistry – An Asian Journal, 2009, 4, 855-860. 
18. C. Coletti, C. Riedl, D. S. Lee, B. Krauss, L. Patthey, K. von Klitzing, J. H. Smet and 
U. Starke, Physical Review B, 2010, 81, 235401. 





20. I. Salzmann, A. Moser, M. Oehzelt, T. Breuer, X. Feng, Z.-Y. Juang, D. Nabok, R. G. 
Della Valle, S. Duhm, G. Heimel, A. Brillante, E. Venuti, I. Bilotti, C. Christodoulou, 
J. Frisch, P. Puschnig, C. Draxl, G. Witte, K. Müllen and N. Koch, ACS Nano, 2012, 
6, 10874-10883. 
21. X. Zhang, Y. Feng, S. Tang and W. Feng, Carbon, 2010, 48, 211-216. 
22. J. Mao, H. Zhang, Y. Jiang, Y. Pan, M. Gao, W. Xiao and H. J. Gao, J. Am. Chem. 
Soc., 2009, 131, 14136-14137. 
23. A. Rochefort and J. D. Wuest, Langmuir, 2009, 25, 210-215. 
24. K. S. Novoselov, V. I. Falko, L. Colombo, P. R. Gellert, M. G. Schwab and K. Kim, 
Nature, 2012, 490, 192-200. 
25. F. Torrisi, T. Hasan, W. Wu, Z. Sun, A. Lombardo, T. S. Kulmala, G.-W. Hsieh, S. 
Jung, F. Bonaccorso, P. J. Paul, D. Chu and A. C. Ferrari, ACS Nano, 2012, 6, 2992-
3006. 
26. E. B. Secor, P. L. Prabhumirashi, K. Puntambekar, M. L. Geier and M. C. Hersam, 
The Journal of Physical Chemistry Letters, 2013, 4, 1347-1351. 
27. Y. Xu, M. G. Schwab, A. J. Strudwick, I. Hennig, X. Feng, Z. Wu and K. Müllen, 
Advanced Energy Materials, 2013, 3, 1035-1040. 
28. X. Dong, D. Fu, W. Fang, Y. Shi, P. Chen and L.-J. Li, Small, 2009, 5, 1422-1426. 
29. X. Dong, Y. Shi, Y. Zhao, D. Chen, J. Ye, Y. Yao, F. Gao, Z. Ni, T. Yu, Z. Shen, Y. 
Huang, P. Chen and L.-J. Li, Phys. Rev. Lett., 2009, 102, 135501. 
30. L. Gaudreau, K. J. Tielrooij, G. E. D. K. Prawiroatmodjo, J. Osmond, F. J. G. de 
Abajo and F. H. L. Koppens, Nano Lett., 2013, 13, 2030-2035. 
31. H. S. S. Ramakrishna Matte, K. S. Subrahmanyam, K. Venkata Rao, S. J. George and 
C. N. R. Rao, Chem. Phys. Lett., 2011, 506, 260-264. 
32. Y. Xu, Z. Liu, X. Zhang, Y. Wang, J. Tian, Y. Huang, Y. Ma, X. Zhang and Y. Chen, 
Adv. Mater., 2009, 21, 1275-1279. 
33. K. Xiao, W. Deng, J. K. Keum, M. Yoon, I. V. Vlassiouk, K. W. Clark, A.-P. Li, I. I. 
Kravchenko, G. Gu, E. A. Payzant, B. G. Sumpter, S. C. Smith, J. F. Browning and D. 
B. Geohegan, J. Am. Chem. Soc., 2013, 135, 3680-3687. 
34. X. Pan, H. Li, K. T. Nguyen, G. Grüner and Y. Zhao, The Journal of Physical 
Chemistry C, 2012, 116, 4175-4181. 
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Chapter 5.0 Functionalisation of a prostate cancer homing peptide for sensing and 
targeted bioimaging applications 
5.1 Overview to Chapter 5 
 
The role of bioimaging is to serve as a means of visualising and characterising biological 
environments in a variety of living organisms. The rising rates of cancer incidents, prostate 
cancer in particular, has led to a drive to develop comprehensive imaging molecules that can 
expose the nature of the cancer via multiple modalities.
1
 This has led to plenty of research 
into the development of imaging agents that exploit single photon emission computed 





 With respect to fluorescence imaging of cancerous environments, a 
significant advantage lies in the ability to detect traces of fluorescent compounds at sub-
nanomolar concentrations in high resolution with reasonably high sensitivity.
4, 5
 
The features that unite molecular probes regardless of their imaging modality are the 
constituent components that make up a viable imaging probe. The probe typically consists of 
a molecule capable of imparting a signal (in this case a fluorescent NDI molecule), a 
targeting molecule that serves to impart a certain degree of specificity, and finally a linking 
molecule to attach the fluorophore to the biomolecule. Generally speaking, receptors that are 
over-expressed on cancer tumour/cell surfaces are seen as attractive regions for site directed 
targeting of cancerous growths.
6
 Consequently, a great degree of effort has been dedicated to 
developing imaging probes that target cancers via receptors such as somatostatins, integrins, 
endothelins, epidermal growth factor receptors, folate and gastrin releasing peptide receptors 
(GRPRs). The latter class of GRPRs have typically been targeted with a peptide sequence 
known as bombesin. Peptide sequences are seen as an alternative to antibody based targeting 
strategies due to their considerably smaller size in relation to their antibody counterparts used 
for similar applications. The large molecular weights of antibodies tend to result in 
difficulties when targeting large tumour masses and there are also issues associated with their 
non-specific uptake by the liver, spleen and bone marrow which further limit their 
effectiveness.
7
 Bombesin is a 14-amino acid peptide originally isolated from the skin of the 




 residues of the 14 amino acid 
sequence) have been identified as having a role in autocrine and paracrine growth factors and 






G-Protein coupled receptors (GPCR) are a large family of proteins that traverse cellular 
membranes and are responsible for converting external stimuli into intracellular signals. 
GPCR are known to respond to a variety of external factors such as light, neurotransmitters, 
peptide sequences, proteins and lipids. There are 6 major classes of GPCR that due to their 
predominant distribution across a variety of cellular species have been seen as attractive 
avenues for drug targeting therapy. 10 % of GPCR are known to be viable drug targets with a 
large number of marketed drugs targeting such receptors
9
. Within the family of GPCRs there 
exist three known sub-types that bind to bombesin. These are BB1 (Neuromedin B receptor), 
BB2 (Gastrin releasing peptide receptor) and BB3 (Bombesin like receptor 3). These 
particular sub-types have been identified in wide distributions amongst human prostate 
carcinoma
10
. Studies have been performed in order to determine the density of GPCR on the 
surface of prostate cancer cell lines using differential prostatic carcinomas possessing varied 
degrees of severity with respect to metastasis. The most significant conclusion was the 
indication that GCPRs are highly expressed in invasive prostatic carcinoma, as well as in 
prostate cancer cell lines that are in the beginnings of neoplastic transformation. The amount 
of gastrin-releasing peptide (GRP) receptor expression, which recognize BBN, is correlated 
to the severity of the prostate cancer type.
11
 One way to evaluate the malignancy of a cancer 
is based on its capability to reject the hormonal stimuli that are intended to repair the cells. 
Tumours that have this ability are called (AR) insensitive tumours and are characterised by 
having a worse prognosis with respect to the AR sensitive types. A characteristic of AR 
insensitive tumours is the high density of GRP receptor expression on their cellular surface. 
The metastatic cancer cell line PC-3 derives from the prostatic small cell neuroendocrine 
carcinoma (SNCN) and is an example of AR insensitive tumour. It is therefore characterised 
by having a high expression of GRP receptors which, in turn, provides a higher probability 
for BBN to bind the cellular membrane. The high selectivity and affinity between BBN and 
GRP receptors encouraged researchers to exploit their strong interaction for radiolabelling 
techniques and chemotherapy. Indeed, labelled-BBN can be used for both imaging of prostate 
cancer cells
12
 and for therapy by target the receptor subtypes with a greater accuracy.
13
 In 
addition, the affinity of BBN for the GRP receptors opens opportunities for detecting 











Figure 5.0 Radiolabelled peptide derived agonists and antagonists capable of binding 
to cell surface receptors
6
 
Furthermore, it has been noted that the distribution of GPCR is considerably lower in non-
neoplastic carcinoma
11
. The differential distribution GPCR may provide some indication 
about the particular types of cancer in regards to their malignancy and hence aid in the 
diagnosis, as well as treatment with the targeting of such receptors via the bombesin peptide.  
The majority of established literature focusing on the bombesin peptide sequence has been 







studies have reported the successful conjugation of such a peptide to a variety of multi-modal 
imaging probes to facilitate the uptake and subsequent in-vitro/vivo imaging of prostate 
cancer. This chapter will describe the synthesis of a shortened sequence of bombesin (7-13) 
and the study of its binding ability to prostate cancer cells. The peptide sequence will then be 
conjugated to the NDI fluorophore and subsequent supramolecular complexation with 
thermally reduced graphene oxide will conclude the formation of a targeted fluorogenic 
nanocomposite that will be tested in vitro for its cancer targeting and imaging efficacy. 
5.2 Solid Phase Peptide Synthesis for the Bombesin fragment isolation 
There are two methods used for the synthesis of peptides, namely solution and solid phase 




this short review will focus primarily on the protection strategies and various coupling 
reagents. 
Generally, in SPPS methodologies a N
α
 derivatised amino acid is attached to polymeric 
resinous support. The protecting group is removed and the support material is then 
subsequently washed with an appropriate solvent. The next amino acid is then attached after 
being pre-activated or activated in situ. The deprotection and coupling steps are repeated until 
the appropriate amino acid chain length is achieved. The peptide sequence is then cleaved 
from the solid support
18
. 
There are two main types of protection chemistry utilised in SPPS. The first involves the 
use of tertiary-butyloxycarbonyl (Boc) as the protecting group on the N
α
-amino acid. The 
Boc protecting group can be removed via trifluoroacetic acid, with the use of a tertiary amine 
to subsequently neutralise the N-terminus. A strong acid can then be used to cleave the 
peptide from the resin. The primary disadvantage of this method is the use of strong acid such 
as TFA which can lead to the degradation of peptide sequences
18
. 
Another protection strategy involves the use of 9-fluorenylmethoxycarbonyl (Fmoc) as the 
protecting group. The removal of the Fmoc protecting groups is usually facilitated via the use 
of piperidine in DMF. Fmoc strategies tend to involve milder conditions and are therefore 
generally favoured in terms of peptide synthesis. Fmoc strategies are favoured because the 
highly electron withdrawing nature of the fluorine ring system allows the hydrogen on the β-
carbon to be removed by relatively weak bases due to its acidic nature. After the removal of 
the β-carbon proton a dibenzofulvene intermediate is produced after β elimination at the 9 
position of the cyclic fluorine structure
19
. The Fmoc group can be removed at varying rates 
by the addition of primary, secondary and tertiary amines in polar media such as DMF. 
There are a number of coupling reagents typically used in SPPS in excess as a means of 
facilitating the sequential addition of protected amino acids. Choice of coupling reagent 
largely depends on the necessity to avoid side reactions and the importance of achieving a 
highly efficient coupling strategy. Again, the use of carbodiimide coupling reagents such as 
DCC and DIPCDI are ubiquitous within the field of peptide synthesis. The use of HOBt in 
tandem with carbodiimide coupling reagents suppresses racemisation and accelerates the 
coupling step. Phosphonium and aminium salts such as HBTU, HATU, TBTU and BOP have 
also been use in tandem with tertiary amines such as DIEA or NMM to achieve the most 




product hexamethyl phosphoramide. As such, PyBOP, a modified version of BOP is used as 





Figure 5.1 Structures of selected coupling reagents widely used in SPPS protocols. 
Side reactions are of particular concern in all SPPS protocols, as they can cause 
racemisation, deletion, termination or amino acid sequences that have been modified in some 
manner. However, the most common side reactions tend to be the formation of 
diketopiperazine, which normally occurs with cis forming amino acids Glycine, Proline, N-
methylamino acids or D-amino acids. The 2-chlorotrityl in Fmoc suppresses this side reaction 
due to stearic crowding
18
. 
Other serious side reactions are the formation of aspartimide species and the racemisation 
of cysteine amino acids. However, the benefit of utilising a peptide such as bombesin beyond 
its ability to target cancer cells lies in the fact that it contains minimal amino acid residues 




procedures. As such, the synthesis of such a peptide can be achieved with a relatively generic 

























5.3 Peptide synthesis strategy applied  
Synthesis of the G-Protein Coupled Receptor targeting peptide Bombesin was performed 
using α-fluorenylmethoxy carbonyl (Fmoc) amino acids onto rink amide resin (0.3 mmol/g) 
following protocols of Fmoc solid phase peptide synthesis. The resin was first swelled in 
DCM for 30 minutes. After swelling, the resin was initially deprotected by treatment with 20 
% piperidine in DMF for 3 cycles (12 minutes and 2 rounds of 3 minutes). After each cycle 
the reagent was removed and washed with DMF for 1 minute. Coupling of the first amino 
acid onto the resin was performed in the presence of 3 equivalents (0.9 mmols) excess Fmoc-
Leu-OH, 3 equivalents of HATU and 6 equivalents (1.8 mmols) of DIPEA in DMF. The 
mixture was added to the resin and left agitating for 45 minutes. After agitation the resin was 
dried via a manifold pump and suspended in DMF for 2 minutes for 3 repeated cycles. The 
resin was the dried again and the washing cycle repeated with DCM. The Kaiser test was 
performed to confirm the initial amino acid coupling step in order to test for the presence of 
free amines on the resin. To a small amount of the resin, a few drops on ninydrin, ethanol and 
KCN in pyridine was added. Gentle heating with a heat gun resulted in the resin beads 
turning a purple colour and confirmation of no free amines. The subsequent additions of 
amino acids in the sequence were performed via an automated peptide synthesiser. Coupling 
of each Fmoc-amino acid was performed with 3 equivalents of each Fmoc amino acid with 
25 % piperidine, 0.2 M PyBop and 0.4 M DIEA all performed in DMF. After synthesis, 
cleavage of the peptide from the resin performed by mixing a small amount of the resin with 
a cocktail of TFA/TIS/Water 95:2.5:2.5 in around bottom flask for 2 hours. The solution was 
then collected, filtered and DCM added to the product and further extraction with diethyl 
ether was performed.  





.Reverse phase HPLC Rt = 6.8 minutes (see 










Figure 5.1 Final structural representation of the desired fragment of the bombesin peptide 






Figure 5.2 HPLC chromatogram of purified bombesin peptide sequence.(HPLC method A) 
 
5.4 Circulating tumour cells in prostate cancer screening  
 
Screening in order to characterize the levels of Prostate Specific Antigen (PSA) has long 
been the mainstay of biomarkers for the understanding of metastatic progression for a large 
majority of those afflicted with prostate cancer. This biomarker is not only used as a 
predictive assay for those at higher risks of  developing PCa, but it is also used as a post-
therapy tool to assess and identify the effectiveness of a particular treatment strategy. 
However, recent phase 3 trials studying the survival benefit of the PCa drug docetaxel 
showed that post-therapy changes in PSA levels gave no indication that PSA response is an 
accurate indicator of long-term benefit.
21
 The biggest problem with a considerable number of 
post-therapy screening methodologies is the incongruity between symptoms, PSA levels and 
scans via various imaging modalities that ultimately leads to dilemmas for clinicians and 
patients in establishing the right course of therapeutic action.
22
 This obviously has significant 




























implications with regards to the patient’s likelihood of survival. Furthermore, the Food and 
Drugs Administration (FDA) requires the establishment of the overall survival benefit as a 
prerequisite to drug/treatment approval. Therefore, the lack of accurate means of 
characterizing post-therapy effectiveness remains a significant barrier to the introduction of 
new treatments that may be of great benefit to those diagnosed with PCa. 
One potential alternative biomarker to solve this problem is through the detection of 
circulating tumour cells (CTCs) themselves. It has been shown that tumours begin to shed 
their cells that are in the midst of neoplastic transformation.
23
 CTCs have been identified in 
patients with a relatively good prognosis possessing little likelihood of developing a 
metastatic variant of the disease. Immunochemistry methods have also detected cancer cells 
derived from the bone marrow in patients with a site specific tumour.
24
 The indication that 
the detachment and distribution of cells into the bloodstream is an early feature of 
tumorigenesis suggests promise for methods of cell enumeration as a means of effective 
screening and vindication of treatment post-therapy. 
The FDA has recently approved a technology known as CellSearch
®
 as a means of 
capturing, isolating and quantifying CTCs with a high degree of selectivity and sensitivity.
25
 
In this system a ferrofluid containing magnetic nanoparticles are functionalised with cell 
adhesion targeting antibodies. The nanoparticles are then used to separate the cells from a 
sample of the patient’s blood. Stains derivatised with antibodies are then used to distinguish 
the cancerous CTCs in the blood stream. This particular technology has demonstrated its 
ability to enumerate CTCs in patients with metastatic prostate, breast and colorectal cancer 




In regards to the work presented in this chapter, the purpose of performing cellular binding 
experiments with bombesin serves two goals. The first is to determine whether or not the 
shortened sequence of bombesin is a suitable biomolecule for the derivatisation of the NDI 
fluorophores in order to enhance their cancer targeting potential. The second is to establish if 
there is some value in utilising bombesin as a cell binding agent for the differentiation and 
enumeration of prostate cancer cells. 
The broad fields within the area of PCa Theranostics have led to the drive towards the 
development of point of care devices for the fast, specific and reliable diagnosis of PCa. With 




behaviour to probe for information regarding the significance of changes in electrochemical 
parameters such as resistance and capacitance. A biosensor can be defined as a device which 
contains an immobilised bio-targeting agent capable of detecting a specific change in the 
surroundings based on an appropriate method of transduction. Previous discussions in this 
review have focused on optical methods of transduction. However, methods that transform 
the application of complex cancer-related assays based on modern electrochemical sensors, 
such as DNA or immunosensors, have recently demonstrated considerable potential with 
regard to the detection of bio-recognition events in a fast, highly specific and sensitive to as 
low as picomolar concentrations.
26
 
5.4.1 Electrochemical Impedance Spectroscopy and its relevance to current work 
Electrochemical Impedance Spectroscopy (EIS) is a technique that allows for the 
characterisation of chemical processes based on electrical measurements. The technique 
facilitates the measurement of the impedance of an electrochemical system in response to an 
applied voltage as the environment surrounding the bio-recognition layer changes. For 
impedance measurements to have any chance of success, the bio-recognition layer must be 
sensitive, specific and possess a highly conductive surface. Consequently, materials such as 
graphene and its beneficial electronic properties, as well as gold are developing into ideal 
candidates for surface materials suited to impedance based bio-sensing.
27
 
The major advantage of EIS is the label free mechanisms used for detection. Traditionally 
electrochemical based biosensors utilise the labelling of probes and targets with electro-active 
species. This tends to result in complex preparation procedures that can hinder the bio-
affinity of the targeting molecule. EIS functions based on measuring the charge transfer 
resistance using a particular redox probe. EIS can be used to monitor the binding, viability 
spread and apoptosis of cancer cells using a variety of diagnostically relevant analytes, 










 Cancer tumours tend to demonstrate 
abnormalities such as receptor density (Folic and G-protein coupled receptors) depending on 




Such tumour markers are seen as 
viable targets for the development of specific and sensitive cytosensors. 
In EIS, a small sinusoidal voltage signal of a particular frequency range is applied to an 
electrode. 




Whereby, Et is the potential at time t, E0 is the signal amplitude, 𝜔 = 2πf is the radial 
frequency and f is the frequency. The response of the electrochemical system is measured in 
which 
𝐼𝑡 = 𝐼0. 𝑆𝑖𝑛(𝜔. 𝑡 + 𝜑)     Eq. 31 
Whereby, It is the time dependent current intensity, I0 is the signal amplitude, w = 2πf is 
the radial frequency and ϕ is the phase angle between Et and It. The amplitude and phase 
angle of the measured current are determined by the system’s impedance. The impedance is 










   Eq.32 
This equation allows for the measured impedance to be expressed as a vector in the 
complex plane, whereby the impedance is determined by Z0 and the phase shift ϕ. This is 
represented as a Nyquist plot, whereby the imaginary part of the impedance, Zi is plotted 








Figure 5.3 Schematic example of a Nyquist plot.
27
 
EIS allows for the monitoring of charge transfer resistance, which with respect to 
biosensors can be influenced by the occurrence of bio-recognition binding events. 
Wider use of self-assembling monolayers (SAMs) in biomedical research is growing in 
popularity with many utilising SAMs as the interface layer between metal surfaces and 
solutions.
36




surfaces via adsorption mechanisms. SAMs consist of a functional head group (such as thiols) 
that has strong binding characteristics to a particular substrate, an n-alkane acid tail groups 
with and a functional end group. SAMs form via the chemisorption of the head group onto a 
substrate followed by the ordered arrangement of the tail groups
37
. Instances of EIS being 
used for biosensor applications have been reported in which primarily gold surfaces have 
been used to develop the basis of self-assembling monolayers.
38
 A large majority of 
functional surfaces for electrochemical devices have relied heavily on the formation of SAMs 
via the use of alkane thiols
39
. Generally speaking, gold is seen as an ideal candidate for the 
formation of SAMs because it is easily obtainable in a colloidal form, its thin film preparation 
via physical vapour deposition, sputtering and electro-deposition is well established, it is 
relatively easy to pattern and it is also relatively inert in that does not react with atmospheric 
O2 or most other chemicals.
40
 
Gold readily attaches to thiols with particularly high affinity to form highly stable bonds 
(100 kJ/mol) across a variety of solvents, temperatures and potentials. The most established 
method for the preparation of SAMs on gold involves the submersion of the metal in 
organosulfur solutions of thiols. The sulphur end of the molecule is linked to gold through the 
formation of S-Au bond, whilst a functional group, (typically an amine or carboxylic acid) is 
responsible for the surface chemistry of the adhesive component. 
3-Mercaptopropionic acid and 11-mercaptoundecanoic acid are some of the more 
prevalent molecules used in the development of ordered structures for electrochemical 
applications. Use of these alkanethiols for the formation of SAMs is desirable as they possess 
terminal carboxylic acid that can be used to form covalent interactions with biomolecules 
based on popular carbodiimide activation protocols that utilise EDC/NHS chemistry. Studies 
have shown that SAM molecules possessing longer chain lengths produce more ordered 
assemblies
41
, with fewer defects and greater electrode surface coverage.
41, 42
  However, MPA 
is known to demonstrate less resistance to electron transfer than SAMs formed from MUA 
and therefore tends to result in higher detection sensitivities.
43
 
In a study by Wang et al. folate receptors on cancer cells were targeted by folic acid 
molecules covalently attached to modified gold nanoparticles via EDC/NHS protocols.
44
 The 
authors aimed to exploit the ability of gold nanoparticles to facilitate the shuttling of electrons 
between its surface and immobilised biomolecules. The modified gold electrodes were then 




cell line. The immobilised folic acid bound to the cells and blocked the effective transfer of 
charge, thus increasing the impedance of the system. Linear relationships between the 
magnitude of impedance observed with respect to the concentration of HeLa cells were noted 
in concentrations from 1x10
6
 cells/ml to as low as 6 cells/ml. 
Similar studies by Liu et al. have utilised folic acid covalently bound to SWNTs mounted 
onto a gold substrate to detect HeLa cells. By utilising Bovine Serum Albumin attached to the 
Au/SWNT/FA electrode surface, this study was able to eliminate incidents of non-specific 
surface binding and detect cells in concentrations as low as 10 cells/ml.
45
 Other works have 
also used carbon nanofibres 
46
 and RGD peptides on SWNTs to detect cells in similarly low 
concentrations. 
In conclusion, recent work has shown that various carbon based platforms can be used to 
develop bio-recognition surfaces for the sensitive detection of diagnostically relevant 
analytes. To date no studies have been performed that utilise bombesin in such an 
electrochemical fashion for the detection of cells and to date the only electrochemical 




5.4.2 Experimental setup for the EIS measurements 
All cells were grown according to protocols used in the previous sections and described in 
detail in the experimental section. Briefly, cells were cultured at 37 
o
C in 5 % CO2 
atmosphere and diluted once a suitable confluency had been obtained. PC-3 and LnCAP cells 
were cultured in RPMI 1640 containing 10 % heat activated foetal calf serum (FCS), 0.5 % 
penicillin/streptomycin (10000 mg/ml) and 200 mM L-glutamine. Excess supernatant 
containing dead cell constituents and excess proteins and metabolites was aspirated. The 
viable live adherent cells were washed with 2x10 ml aliquots of PBS to remove residual 
media containing FCS. Cells were counted with a haemocytometer and then re-suspended in 
10 ml PBS  Bombesin was synthesised according to the aforementioned protocol or 
purchased from EZBiolab (USA). Gold macroelectrodes were used for the measurements. 
For the SAM formation, an amine-terminated linker molecule, namely 11-amino-1-





The electrodes were incubated overnight in a solution of AUT/MCH in a ratio 1:200 
followed by a further 1 hour backfilling step using a solution of 1 mM MCH. In order to 
confer better antifouling properties to the SAM, polyethylene glycol 2-aminoethyl ether 
acetic acid (amine-PEG-carboxylic acid) was also used as an intermediate compound 
between the formed structure and the BBN. An incubation step using a mixture of amine-
PEG-carboxylic acid and sulfo-EDC elongated the SAM by n-chains of PEG molecules 
keeping the amine termination exposed for further immobilisation steps. By using this 
strategy the carboxylic acid of amine-PEG-carboxylic acid is involved in binding the amine 
termination of AUT whilst the final structure still presents a free amine termination for 
successive immobilisation steps. The inability to bind the cells when BBN was immobilised 
on the SAM in the opposite orientation (hence using a carboxyl-terminated SAM) was 
confirmed by EIS experiments that showed a signal change lower than 0.5 % for a 
concentration of 3 × 10
5
 PC-3 cells/ml. 
On the other hand, by using sulfo-EDC chemistry for the PEG-ylation of the SAM, the 
exact amount of amine-PEG-carboxylic acid molecules that will bind cannot be accurately 
controlled. In order to prevent an excessive PEGylation, a short incubation time (10 minutes) 
was used, followed by stabilisation in the measurement solution. An ideal measurement 
scenario exists whereby a certain n-number of PEG chains are present that ensure bombesin 
can bind to the GRP receptors of the cells whilst simultaneously ensuring that the binding 
does not occur too far from the electrode surface. 
The BBN immobilisation was successively performed incubating the electrodes with a 
mixture of 35 μM BBN and 80 mM sulfo-EDC in aqueous solution for 20 minutes. The 
electrodes were then rinsed and left in measurement solution for 1 hour before the first set of 
EIS measurements. The cells used for the binding assay were suspended in PBS 0.1 mM with 
addition of 0.05 % of Tween20 that helped to reduce the non-specific interaction with the 















Figure 5.4 Cartoon schematic representation of recognition surface used in EIS 
measurements 
5.4.3 Non-Faradaic EIS measurements for the detection of cancerous and non-
cancerous cells 
For testing the affinity reaction, three cell lines were used: PC-3, LNCaP and FEK-4. The 
first two cell lines derive from bone metastasis of a prostate cancer but the metastatic 
potential of PC-3 cells is demonstrated to be higher than LNCaP.
48
 The PC-3 line is 
considered to be a later stage of prostate cancer as well as more aggressive than LNCaP due 
to its AR insensitive nature.
49
 As a result the GRP expression density on the cellular surface, 
as demonstrated in previous studies
50
 is much higher in PC-3 compared to LNCaP cells. In 
addition, a confirmation of the non-specific binding nature of LNCaP to BBN was 
demonstrated by a fluorescence study performed by Reile et al.
51
 Therefore, the use of PC-3 
aimed to produce significant signal shift while LNCaP and FEK-4 cells (non-cancerous cells 
from normal human dermal fibroblasts tissues) were used as negative controls. 
The EIS response was studied for concentration of cells between 30 and 3 × 10
5
 cells/ml. 
Non-Faradaic EIS measurements were performed both in PBS 10 mM diluted 100 times 
(ionic strength equal to 1.62 mM) and 1000 times (ionic strength equal to 0.162 mM) to study 
the effect of the buffer. The signal response obtained for the PC-3 cell line is illustrated in 
Figure 6.17 and shows that the highest dilution of PBS results in an average higher signal 
change. On the other hand, using a more diluted measurement solution also increases the 








lower reproducibility and the probability of cell damage using a very dilute measurement 
solution a dilution of 100 times was chosen as a suitable condition for further binding studies. 
 
Figure 5.5 Comparison of the sensor response using PBS 10 mM diluted 100 times (ionic 
strength equal to 1.62 mM) and 1000 times (ionic strength equal to 0.162 mM) as a 
measurement solution. Standard deviations are only reported on one side for clarity. 
The dose response obtained for the three cell lines is reported in Figure 5.6. The inset of 
Figure 6.18 illustrates the positive shift in capacitance response in the linear scale with a data 
fitting that follows with a good approximation the Hill equation. The R
2
 values were 0.999, 
0.990 and 0.963 while the kd values were 1207, 11363 and 4271 cells/ml for PC-3, LNCaP 
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Figure 5.6 Dose responses for PC-3, LNCaP and FEK-4 living cell lines. In the inset the 
capacitance change is plotted vs. the linear scale of the concentration where the lines are fits 
of the data to a Hill dose response. 
Although the sensor demonstrated the capability of discriminating cells having a high 
density of GRP receptors expressed on the cell membrane, a full characterisation and 
optimisation of the sensor could not performed. The characterisation of the sensor is 
important to ensure that the SAM formation is reproducible from experiment to experiment. 
In particular, the way the SAM is currently immobilised does not allow for the accurate 
determination of the exact amount of amine-PEG-carboxylic acid molecules binding onto 
AUT. Therefore, a further optimisation of the sensor, which includes the development of a 























































5.5 Peptide coupling to naphthalene diimides 
 
The previous section established the capacity of the shortened sequence of bombesin to 
enhance the binding to prostate cancer cells over their healthy (FEK-4) counterparts. This 
substantiated the use of the peptide sequence as a homing agent that could serve to improve 
the selectivity and uptake of the NDI chromophore. The following section describes efforts to 
synthesize the NDI-Bombesin conjugate based on carbodiimide activation protocols. 
NDI (Compound 5) and N-Hydroxysuccinimide were dissolved in DMF whilst stirring in 
an ice bath for 15 minutes. 6 eq. of EDC.HCl was dissolved in DMF and added to the 
solution of the NDI and NHS and allowed to stir for a further 15 minutes. The ice bath was 
subsequently removed and the solution was left to stir for a further 15 minutes. The ice bath 
was subsequently removed and the solution was left to stir at room temperature for a further 8 
hours. The solvent was removed under low pressure evaporation and the resulting product 
was dissolved in a small amount of acetonitrile. The solution was added to double distilled 
H2O under vigorous from which a precipitate formed. The precipitate was collected via 
filtration and a fine powder was formed by adding pentane to the precipitate followed by 










Scheme 5.2 Synthesis of NHS-Ester of compound 5 for subsequent derivatisation with 



























H NMR (top left), 
13
C NMR (top right) and HMQC (bottom) of NHS Ester of the 
chlorine substituted NDI (compound 5) See experimental section for full assignments. 





NDI-OSu (2 mM, 5.5 mg) and Bombesin (4 mM, 9.7 mg) were dissolved in DMF. 2 
equivalents of triethylamine were added to the mixture. The solution was stirred under N2 for 
8 hours at room temperature. Solvent was removed and acetone added to the residue. The 
resulting solution was added in dropwise manner to a vigorously stirring volume of 1M HCl. 
The precipitate was collected by filtration and dried in vacuo. The product was characterised 
by a single peak in HPLC chromatography. Mass spectrometry calculated mass of compound 
13 was calculated to be 2213.87929 and MALDI-TOF performed at the University of Oxford 
revealed a peak at m/z ratio of 2277.55224 corresponding to the[ M+ACN+Na]
+
 ion of the 
product (See appendix for details). 
 





5.6 Confocal microscopy of fluorescent bioconjugate complexed to TRGO 
 
Laser scanning confocal microscopy has been performed on the bombesin-NDI conjugate 
complexed with TRGO in order to establish if they can be successfully up-taken into prostate 
cancer cells and subsequently used for the purposes of imaging. Imaging experiments were 
performed on PC-3 cells according to the procedure outlined in the previous chapter with 
each compound incubated at 36
O
C (50μM, in 5 : 95 DMSO : serum free medium) and 
acquisitions taken with the blue channel (417-477 nm), green channel (500-550 nm) and red 













Figure 5.8 Single-photon confocal direct camera acquisition: Compound 3, 50μM, 0.5% 
DMSO, at 37°C in PC-3 cells incubated for 15 minutes.  The cells were irradiated with 405 
nm light and DIC image is represented by (a) the brightfield image of the cells prior to 
excitation and (b) overlay of the compound emission across the blue, green and red channels. 





















Figure 5.9 Single-photon confocal fluorescence image acquisitions. Compound 3, 50μM, 
0.5% DMSO, at 37°C in PC-3 cells incubated for 15 minutes.  The cells were irradiated with 
405 nm light and image is represented by the separated emissions across the blue, green and 
red channels (a, b & c) and the overlay of the individual channel emissions (d). 
The images taken with the camera and confocal settings are consistent with previous 
chapters in which the fluorescent molecule distributes itself throughout the cell structure apart 
from the cell nucleus. There is broad emission across all of the channels. However, in both 




the cell membrane. This could be attributed to a cellular localisation effect facilitated by the 
bombesin. Further co-localisation studies would be necessary to confirm this supposition.  
The amino acids that can contribute to the fluorescence emission are Tryptophan, Tyrosine 
and Phenylalanine. In large folded proteins, the fluorescence tends to derive from aromatic 
residues. Generally speaking, most of the fluorescence is as a result of the emission from 
Tryptophan residues. Tryptophan has a much higher fluorescence intensity and greater 
quantum yield than its other aromatic amino acid counterparts. The intensity of emission, 
quantum yield and its maximum emission wavelength is largely dependent on solvent 
polarity. Greater polarity in the surrounding environment leads to bathochromic emission 
shifts and greater emission intensity.  
The bombesin peptide sequence used in this work contains Tryptophan, which could be 
contributing to the emission profile of the probe in the more violet region of the spectrum. 
The quantum yields of all of the aromatic amino acids are known to decrease when they are 
part of a larger polypeptide chain. Folding of the peptide structure can lead to both enhancing 
and diminishing effects on the quantum yield and so the intensity of the emission observed is 
not particularly informative. It would therefore be of more value to carry out circular 
dichroism studies to probe the structural nature of the conformers that may exist in 
equilibrium in a folded structure and to correlate these with fluorescence lifetime studies both 
in solution and in vitro. 
The NDI molecules discussed in this work have been derivatised with a peptide sequence 
and then further complexed to thermally reduced graphene oxide. The NDI molecules still 
retain a large degree of their intrinsic fluorescence despite the relatively complex construction 
of the probe with multiple facets that can serve to quench the fluorescence. This is supported 
further by the 3-dimensional z-stack series which demonstrates strong and broad emission 





























Figure 5.10 3-dimensional render of the confocal fluorescence z-stack series of images for 
compound 14 complexed with TRGO at 405 nm laser irradiation after 15 minutes of 




5.8 Summary of Chapter 5 
A seven amino acid sequence known as Bombesin has been synthesised according to 
solid-phase peptide synthesis protocols. The peptide was purified and characterised via semi-
prep HPLC and ESI-MS. The purpose of utilising the peptide was to enhance the targeting 
capacity of the fluorescent complexes synthesised in the previous chapters. The Bombesin 
peptide is a well-established homing sequence for imaging agents that employ a variety of 
imaging modalities owing to its capacity to bind to G-protein coupled receptor sub-types that 
are known to be up-regulated on the cell surfaces of prostate cancers. The bombesin sequence 
used in this work was unusual in that differed from the sequence typically seen in the 
literature that possess an extra methionine as the last amino acid in the sequence. 
Electrochemical impedance spectroscopy experiments established that the smaller peptide 
sequence could not only bind to prostate cancer cells, but it could also be used as a means of 
enumerating and discriminating between healthy cells and prostate cancer cells that varied in 
their metastatic potential. This is a particularly promising result in regards to the potential of 
bombesin and electrochemical techniques as a means of quantifying circulating tumour cells 
for pre and post therapy screening of prostate cancer. These results also validated the use of 
the peptide as a prostate cancer targeting sequence for the NDI-complexes. 
The NDIs were therefore derivatised with the peptide sequence via carbodiimide mediated 
activation protocols. The products were purified via semi-prep HPLC and characterised using 
MALDI-TOF. Laser scanning confocal microscopy was performed on targeted NDI after it 
had been complexed with thermally reduced graphene oxide. Images of the compound after 
incubation in PC-3 cells showed retention of broad fluorescence emission across the visible 
region of the electromagnetic spectrum with cellular localisation throughout the cell structure 
with the exception of the nuclear membrane. The probe retained fluorescence emission 
despite multiple quenching agents (via energy transfer from TRGO and peptide interactions). 
This was therefore seen as an encouraging and promising result for the future utility of 
imaging probes designed using supramolecular methods with building block comprised of 
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Chapter 6.0 Conclusions and future work 
 
The aim of this work was to develop a series of fluorescent organic molecules having the 
ability to form complexes with polyaromatic carbon systems, resulting in supramolecular 
agents which may find applications as imaging and/or sensing agents for prostate cancer 
cells. The capacity for the systems synthesised to undergo, at the molecular level, ground- 
and excited-state energy transitions were established, and this demonstrates their binding 
potential in donor-acceptor interactions. These interactions may well also have implications 
in vivo as they can impact upon the overall therapeutic benefit of the small molecules studied, 
as well as of their associated complexes. 
A series of electron-withdrawing α-amino acid derivatised chiral naphthalene diimides 
bearing aryl halide phenyl alanine substituents were synthesised via a facile microwave di-
electric heating method. The NDIs were found to assemble into various structural 
arrangements depending on solvent composition. Concentration dependent UV-Vis and 
fluorescence studies revealed the tendency for the naphthalene cores to arrange themselves 
according to H (THF, DMSO, NMP, MeCN) and J (CHCl3) type aggregates depending on the 
nature of the solvent. These studies provided an explanation for the most likely packing 
arrangement of the naphthalene cores, specifically, with polar solvents inducing a preference 
for the parallel face-centred orientations of the NDI cores. Two-dimensional NOESY NMR 
in chlororform and DMSO provided additional information in regards to the arrangement of 
the aryl halide substituents and DOSY NMR indicated the propensity for the supramolecular 
assembly of large structures in solvents such as CDCl3. This finding was supported by 
circular dichroism and the single crystal X-ray diffraction structure analysis that revealed the 
presence of extended 3-dimensional networks or large helical nanotubular cavity containing 
structures. 
The type of aggregation was found to have considerable influence over the optical 
properties of the molecules. In vitro studies of the NDIs substantiated their potential as cancer 
imaging agents based on excited state lifetime decay and fluorescence emission that was 
distinguishable from cellular autofluorescence. Initial studies into their cytotoxicity revealed 
comparatively smaller anti-proliferative effects with respect to some previously published, 
simpler NDIs, which were investigated primarily for their anti-cancer properties. The 




lengthening and is largely seen as the primary reason behind the NDIs therapeutic potential. 
The relatively low toxicity of the NDIs synthesised in this work was attributed to their 
tendency to not penetrate the nuclear membrane and thus fail to facilitate the DNA binding 
aspects. 
The more in depth biological screening to assess the cytotoxic molecular mechanism 
would be warranted to fully validate their efficacy as anticancer agents. Future work 
performing activity studies on caspase proteases will establish whether or not the NDIs can 
activate caspase proteins and trigger apoptosis. Extending these studies across a variety of 
healthy and cancerous cells of the prostate will help determine the cytotoxic selectivity of the 
molecules. 
The electron-withdrawing nature of the NDIs made them suitable candidates for their 
complexation with relatively electron rich polyaromatic donor carbon systems mediated by π-
π interactions. NMR, UV-Vis and fluorescence titrations were used to quantify the extent of 
the interactions between the NDI molecules and C60 or coronene. NMR titrations also 
revealed varied possible stoichiometries within the supramolecular complexes. Indeed, some 
of the complexes displayed positive cooperativity whereby the binding of one donor molecule 
to the NDI enhanced the binding of the second donor molecule. Fitting the data to a series of 
mathematical models of binding isotherms revealed the degree of supramolecular association 
to be dependent on the size, electronegativity and overall polarisability of the aryl halide 
substituent. The association constants were concomitant with the aforementioned halogen 
properties and thus implicated a potential halogen bonding mechanism as a factor behind the 
stabilisation of the supramolecular complexes. Further attempts to grow single crystals 
suitable for the structure determinations of the complexes will be necessary in order to fully 
corroborate this claim. 
The ground state binding interactions were also supported by an additional excited state 
interaction. Fluorescence titrations and time correlated single photon counting revealed a 
quenching of fluorescence and extension of the fluorescence excited state lifetime that was 
attributed to photo-induced energy transfer. Despite the quenching effects of the carbon 
systems, in vitro cellular imaging studies on PC-3 cells revealed a capability to visualise the 
fluorescence emission of the complexes as a means of imaging prostate cancer cells. 
The use of coronene was employed as a model molecular system for the understanding of 




systems. The varied and successful binding of the NDIs to coronene prompted investigations 
into their interaction with thermally reduced graphene oxide (TRGO). The graphene material 
was successfully synthesised from a graphite oxide precursor and subsequently reduced via 
thermal heat treatment. Transmission electron microscopy, powder x-ray diffraction and 
Raman spectroscopy revealed the graphene sheets to be of a semi-crystalline nature that 
transitioned to a more closely stacked species upon removal of intercalated water molecules. 
Fluorescence titrations and time correlated single photon counting exposed TRGO as a 
superior energy sink in comparison to coronene. Despite this quenching, the fluorescence 
emission of the graphene complexes could still be used to image prostate cancer cells via 
laser assisted confocal microscopy. Crucially, fluorescence lifetime imaging microscopy 
(FLIM) investigations revealed the lifetime of the imaging agent to be consistent with a 
fluorophore in a partially quenched state, thus confirming the retention of complex stability in 
vitro. This has considerable implications for potential therapeutic benefits of the NDI-TRGO 
complexes. Photodynamic and photothermal therapy relies not only on the heat associated 
with the absorption and emission of light, but also on the heat generated as a result of the 
energy transitions within the complex. Therefore, the stability of the NDI-TRGO complex 
that has been shown to be a considerable energy sink is particularly promising with respect to 
the photo-ablation of cancer cells and thus the overall therapeutic potential of the complexes. 
The latter aspects of this work were concerned with the synthesis of a homing peptide 
known as bombesin that targets G-protein coupled receptors that are known to be upregulated 
on the outer membrane of certain prostate cancer cells. The intention was to use the peptide 
as a means of enhancing the cancer targeting capacity of the fluorescent molecules and their 
complexes. The peptide sequence was successfully synthesised via solid phase peptide 
synthesis protocols and purified and characterised via semi-prep HPLC and ESI-MS. 
 The ability of the peptide sequence to bind to cancer cells was evaluated with 
electrochemical impedance spectroscopy (EIS). Self-assembled monolayers (SAM) of 
alkanethiols bearing PEG chains were attached to the peptide sequence via EDC-NHS 
carbodiimide activation protocols. EIS studies revealed an increase in capacitance upon 
binding of cells to the targeted functional SAM layer. Importantly, the SAM surface bearing 
the peptide sequence was capable of differentiating healthy and cancer cells, but also between 
prostate cancer cells that varied in their metastatic potential. This verified the use of the 




promising implications for the future development of techniques and functional surfaces used 
for purposes of circulating tumour cell (CTC) enumeration. Quantifying CTCs is seen as a 
viable pre and post therapy prostate cancer prognostic indicator. However, future work will 
require the optimisation of the electrode construction to ensure that the detection of CTCs is 
viable at the really low concentrations that are of significance when discussing the 
implications of CTCs. 
The NDIs were subsequently derivatised with the bombesin peptide sequence and 
complexed to TRGO. Laser assisted confocal microscopy revealed that the targeted 
fluorogenic nanocomposite could impart fluorescence emission characteristics capable of 
imaging prostate cancer cells. Interestingly, the localisation of the imaging probe seemed to 
demonstrate an enhanced capacity to bind to the cell membrane. Further co-localisation 
studies would be necessary to fully understand the extent to which the peptide sequence 
drives the NDI-TRGO complex into certain regions of the cell. Additional MTT cytotoxicity 
studies would also be needed to establish what this specific cellular localisation effect has on 
the overall toxicity and anti-proliferative effects of the imaging probe; however the more 






Chapter 7.0 Experimental 
 
7.1 General Information & Procedures 
 
All purchased starting materials were used without further purification. All solvents were of 
reagent grade quality and purchased commercially. 
Mass Spectrometry data was acquired on a Bruker Daltonics ESI-TOF and carried out in 





C chemical shifts are referenced to tetramethylsilane (TMS). 
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C chemical shift 
assignments were made by using standard COSY (cosygpqf) and HMQC (hmqcgpqf) pulse 
sequences outlined within the Bruker library. 
NOESY NMR was performed at 298.15 K on a Bruker Avance 500 spectrometer. NOESY 
spectra were run on pure samples at similar concentrations to standard 
1
H NMR scans. 
Samples were run in at least 0.6 mL volumes in high quality NMR tubes after filtering 
through a pasteur pipette inserted with a plug of cotton wool. NOESY pulse sequences 
contained within the Bruker library was applied to samples that were well shimmed with a 
strong a stable lock. The number of scans for each NOESY spectrum was set at 16. Delay 
values for D1 and D8 were set at 4 and 0.5 seconds respectively. 
DOSY NMR was performed at 298.15 K on a Bruker Avance 500 spectrometer. Prior to 
every DOSY experiment, normal1D1H NMR spectrum was recorded using pulse programme 
zg30 (Avance version 12/01/11). The gradient was changed from 2 to 95% using longitudinal 
eddy current delay bipolar gradient pulse (ledbpgp2s1d), where16 scans were performed with 
an acquisition time of 3.0s, a relaxation delay of 3.0s,and a line broadening of 0.3Hz. Based 
on the signal attenuation, the parameters were selected, and the DOSY experiment was 
performed using pulse programme ledbpgp2s. The gradient pulse and the diffusion time were 
varied depending on the sample under investigation. 
 





Cyclic Voltammetry data was recorded using a BASi Epsilon potentiostat fitted with a BASi 
C3 cell stand. Analysis was carried out using a standard 3 electrode system comprising a 
platinum working electrode, a Ag/AgCl (in solution of KCl) reference electrode and platinum 
wire counter electrode and the ferrocene/ferrocenium (Fc/Fc
+
) redox couple as the internal 
standard was used. 
UV-visible spectra were obtained using a Perkin-Elmer Spectrometer, Lamda 35 and data 
processed using UV Winlab 3 software. Fluorescence spectra were measured in a 1.00 cm 
quartz cuvette using a Perkin-Elmer LS55 luminescence spectrophotometer. Circular 
Dichroism experiments were performed with an Applied Photophysics Chirascan Circular 
Dichroism Spectrophotometer using a quartz cuvette with a 1 cm path length. 
Crystal structure determination by X-ray diffraction were performed using an Agilent 
Supernova Dual diffractometer equipped with an EosS2 CCD plate detector using a mirror 
monochromator (Cu Kα radiation, λ = 1.54184 Å). The suite of programs WINGX-1.70 was 
used for space group determination, structure solution and full-matrix least-squares 
refinement. (Farrugia, L. J. J. Appl. Crystallogr. 1999, 32, 837−838). All non-hydrogen 
atoms were refined with anisotropic displacement parameters. CH were positioned 
geometrically after each cycle of refinement. All hetero atom hydrogen atoms have been 
located in the difference Fourier map and were refined with bond length restraint. 
 
HPLC method A was carried out using a Symmetry® C-18 column (4.6 x 260 mm) 
with UV/visible detection measured at λobs = 200 nm, 300 nm, 400 nm, 450 nm, 500 nm, 
600 nm, 700 nm and 800 nm. The gradient elution was 1.1 mL/minute, with 0.1% TFA 
MilliQ water as solvent A and 0.1% TFA MeCN as solvent B. Start 95 % A reverse 
gradient until 5% A at 7 minutes, isocratic until 18 minutes, reverse gradient until 
21 minutes 95% A, then hold to 24 minutes. 
 
HPLC method B was carried out using a Symmetry® C-18 column (4.6 x 260 mm) 
with UV/visible detection measured at λobs = 200 nm, 300 nm, 400 nm, 450 nm, 500 nm, 
600 nm, 700 nm and 800 nm. The gradient elution was 0.8 mL/minute, with 0.1% TFA 
MilliQ water as solvent A and 0.1% TFA MeCN as solvent B. Start 95 % A reverse 
gradient until 5% A at 7.5 minutes, isocratic until 15 minutes, reverse gradient until 





Semi-Preparative HPLC was carried out using a Phenomenex® Gemini C-18 column 
(10 x 250 mm) with UV/visible detection measured at up to four λobs = 214 nm, 220 nm, 
254 nm, 280 nm, 300 nm and 400 nm. The gradient elution was 1.0 mL/minute, with 
0.1% TFA MilliQ water as solvent A and 0.1% TFA MeCN as solvent B. Start 95 % A 
reverse gradient until 5% A at 15 minutes, isocratic until 22.5 minutes, reverse gradient 
from 22.6 minutes 95% A, then hold to 25.5 minutes. 
 
Two-photon excitation experiments were performed at the Rutherford Appleton Laboratory 
following the methodology described by Botchway et al. 2008.
47
 An optical parametric 
oscillator was pumped by a mode locked Mira titanium sapphire laser (Coherent Lasers Ltd), 
generating 180 fs pulses at 75 MHz and emitting light at a wavelength of 580-630nm nm. 
The laser was pumped by a solid state continuous wave 532 nm laser (Verdi V18, Coherent 
Laser Ltd), with the oscillator fundamental output of 915 ± 2 nm or 810 ± 2 nm. The laser 
beam was focused to a diffraction limited spot through a water immersion ultraviolet 
corrected objective (Nikon VC x60, NA1.2) and specimens illuminated at the microscope 
stage of a modified Nikon TE2000-U with UV transmitting optics. The focused laser spot 
was raster scanned using an XY galvanometer (GSI Lumonics). Fluorescence emission was 
collected without de-scanning, bypassing the scanning system and passed through a coloured 
glass (BG39) filter. The scan was operated in normal mode and line, frame and pixel clock 
signals were generated and synchronised with an external fast microchannel plate 
photomultiplier tube used as the detector (R3809-U, Hamamatsu, Japan). These were linked 
via a Time-Correlated Single Photon Counting (TCSPC) PC module SPC830. Lifetime 
calculations were obtained using SPCImage analysis software (Becker and Hickl, Germany) 
or Edinburgh Instruments F900 TCSPC analysis software.  
 
Cell culturing and cell plate preparation were carried out according to modified serial 
passage protocols. Cells were cultured at 37 
o
C in 5 % CO2 atmosphere and diluted once a 
suitable confluency had been obtained. PC-3 and LnCAP cells were cultured in RPMI 1640 
containing 10 % heat activated foetal calf serum (FCS), 0.5 % penicillin/streptomycin (10000 
mg/ml) and 200 mM L-glutamine. FEK-4 (epithelial fibroblast) cells were cultured in 
Dulbecco’s Modified Eagles Medium (DMEM) with 15 % heat activated FCS and similar 




dead cell constituents and excess proteins and metabolites was aspirated. The viable live 
adherent cells were washed with 2x10 ml aliquots of PBS to remove residual media 
containing FCS. Cells were then re-suspended in 10 ml PBS with additional 2-5 ml Trypsin 
and incubated for a further 5 minutes at 37 
O
C. After trypsinisation, 5 ml of medium 
containing 10 % serum was added to inactivate the trypsin and the suspension centrifuged for 
5 minutes (1000 rpm) to remove residual dead cell constituents. The resulting supernatant 
was aspirated and 5 ml of medium was added. Cells were counted using a haemocytometer 
and seeded as appropriate. 
 
Cell Freezing was performed on excess cells after the cell splitting during the culture 
preparation. 0.5 – 1.0 million cells were stored in 2 ml vials containing a mixture of 50 % 
serum medium, 40 % foetal calf serum and 10 % DMSO. Cells were placed in a 2 ml freezing 
container and stored in a -80 
o
C freezer overnight. The cells were ready to be stored in liquid 




MTT assays were performed by culturing cells according to the method described above. 




) and left for 48hrsto fully adhere. All steps were 
performed in culture media absent of phenol red. For MI50 estimations by MTT assays, cells 
were incubated with each compound for 48hrs at 37 
o
C. Concentrations used were 1 nM, 100 
nM, 1 μM, 10 μM, 50 μM, 100 μM and 250 μM (1% DMSO, 99 % Eagles Modified Essential 
Medium containing FCS at the standard concentration of the cell line. Subsequently cells 
were washed three times with PBS and 100 mL of MTT reagent was added (0.5 mg mL
-1
, 10 
% PBS: SFM) followed by a 2 hr incubation period. Following aspiration, 100 mL of DMSO 
was added and 96 well plates were read with an ELISA plate reader, Molecular Devices 
Versa Max (BN02877). Data was obtained from five consistent results and the MI50 was 
using Origin 8 to determine the half th height of the fitted curve for each compound and for 
each individual experiment. 
Confocal Microscopy was performed using a Nikon A1Rsi Laser Scanning Confocal 
Microscope System fitted with 60X oil objective lens. The microscope was also fitted with a 
motorized piezo z-stage, halogen lamp and mercury lamp for visual fluorescence microscope. 
All images were processed using functions within the NIS elements software package. 
The microscope was fitted with a camera head, motorized tilt quadrocular eyepiece, two eye 




condenser. The microscope also possessed FL/DIC analyser sliders, diaphragm levellers and 
centering screws for the field and aperture diaphragm.  
Colour images via the standard detector were acquired by observing the sample through the 
microscope and setting the optical path to acquire through the standard detector. Image 
acquisition conditions were adjusted by altering excitation wavelength, pinhole size, image 
resolution (in pixel size settings), scan speed, laser application timer per pixel, laser power 
and HV 
Initially, camera images were taken of the sample with a standard detector. The sample was 
manually focused and irradiated with a 405 nm laser. The number of pixel setting was 
adjusted to 512x512 as an appropriate resolution. The pinhole, laser power and HV were 
adjusted until a suitable image was obtained, after which the image acquisition was initiated. 
After acquisition the microscope was switched to confocal mode and image acquired under 
similar settings. 
A z-stack series of images for 3-dimensinal rendering was acquired by setting the top and 
bottom focal planes of the sample. Image acquisition conditions (in terms of laser power and 
detector sensitivity) were adjusted to the brightest focal plane to prevent image saturation 
across the entire sample. The number of pixels was set to an appropriate resolution and the 
pixel dwell time adjusted to produce an appropriate degree of laser irradiation time per pixel 
for a suitably bright image. Line averaging was applied to increase the signal to noise ratio 
and the z-stack series was subsequently acquired. Smoothing function, background 
subtraction, gauss-laplace filter and matrix expansion were adjusted to interpolate and 
generate 3-dimensional image of the sample. 
Two-photon fluorescence lifetime imaging microscopy (2P-FLIM) experiments  
Stock solutions of the NDI molecules (100 mM) were prepared in DMSO. Cells were 
cultured as described previously and plated in glass bottom dishes to an approximate 60 % 
confluence and incubated for 48 and 72 hrs for the PC-3 cell lines. Prior to imaging cells 
were washed 3 times with PBS prior to the addition of serum free medium (2 ml). After 
removal of a small volume of medium the NDI compounds were added to obtain a final 
volume of 1 ml (10 µM, 1 % DMSO). After 15 minutes incubation the cells were washed 







Tryptophan-tagged naphthalenediimide, [TrpNDI], (1) 
 
 
For compound 1, 1,4,5,8-Naphthalenetetracarboxylic dianhydride (200 mg, 0.746 mmol) and 
the corresponding α-amino acid derivative (1.491 mmol) were suspended in 5 mL of DMF in 
a pressure-tight 20 mL microwave vial. To this suspension was added 0.2 mL of dry Et3N. 
The suspension was sonicated until the mixture became homogeneous. The reaction mixture 
was heated for 10 min at 140 °C (direct flask temperature measurement) under microwave 
irradiation using a dedicated microwave system. The solvent was removed under reduced 
pressure, and each reaction mixture was recrystallized in acetonitrile and 1M HCl yielding 
the symmetrical NDI derivative product. 
   1
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Phenylalanine naphthalenediimide, [HNDI], (2). 
 
For compound 2, 1,4,5,8-Naphthalenetetracarboxylic dianhydride (200 mg, 0.746 mmol) and 
the corresponding α-amino acid derivative (1.491 mmol) were suspended in 5 mL of DMF in 
a pressure-tight 20 mL microwave vial. To this suspension was added 0.2 mL of dry Et3N. 
The suspension was sonicated until the mixture became homogeneous. The reaction mixture 
was heated for 10 min at 140 °C (direct flask temperature measurement) under microwave 
irradiation using a dedicated microwave system. The solvent was removed under reduced 
pressure, and each reaction mixture was recrystallized in acetonitrile and 1M HCl yielding 
the symmetrical NDI derivative product 
1
H NMR (500MHz, 298 K, dmso-d6) δ = 13.10 (bs, HA, 2H), 8.66 (s, HB, 4H), 7.33-7.04 (m, 
HC, 8H), 5.84 (dd, HD, 2H, 
3
JDF = 9.33HZ, 
3
JDE = 5.5Hz), 3.59 (dd, HE, 2H, 
2
JEF = 14Hz), 
3.30 (dd, HF, 2H) ppm. 
13
C NMR (500MHz, 298 K, dmso-d6) δ = 170.5 (NCO), 162.8 
(COOH), 131.8, 131.4, 128.6, 126.6 (aromatic C within phenyl rings and naphthalene core), 









p-fluoro-phenylalanine naphthalenediimide, [FNDI], (3). 
 
 
For compound 3, 1,4,5,8-Naphthalenetetracarboxylic dianhydride (200 mg, 0.746 mmol) and 
the corresponding α-amino acid derivative (1.491 mmol) were suspended in 5 mL of DMF in 
a pressure-tight 20 mL microwave vial. To this suspension was added 0.2 mL of dry Et3N. 
The suspension was sonicated until the mixture became homogeneous. The reaction mixture 
was heated for 10 min at 140 °C (direct flask temperature measurement) under microwave 
irradiation using a dedicated microwave system. The solvent was removed under reduced 
pressure, and each reaction mixture was recrystallized in acetonitrile and 1M HCl yielding 
the symmetrical NDI derivative product 
1
H NMR (300MHz, 298 K, dmso-d6) δ = 13.10 (bs, H
a
, 2H), 8.63 (s, H
b
, 4H), 7.21-6.88 (m, 
H
c




Jdf = 9.9HZ, 
3




Jef = 14.4Hz), 3.30 
(dd, H
f
, 2H) ppm. 
13
C NMR (125MHz, 298 K, dmso-d6) δ = 170.5 (NCO), 162.4 (COOH), 
131.7, 131.3, 131.2, 126.4, 126.0 (aromatic C within phenyl rings and naphthalene core), 54.9 
(NCH
d
COOH), 33.8 (NCCPh) ppm. 
19
F NMR (CDCl3, 470.4 MHz, 298 K): δ = -115.7 (m, 









For compound 4, 1,4,5,8-Naphthalenetetracarboxylic dianhydride (200 mg, 0.746 mmol) and 
the corresponding α-amino acid derivative (1.491 mmol) were suspended in 5 mL of DMF in 
a pressure-tight 20 mL microwave vial. To this suspension was added 0.2 mL of dry Et3N. 
The suspension was sonicated until the mixture became homogeneous. The reaction mixture 
was heated for 10 min at 140 °C (direct flask temperature measurement) under microwave 
irradiation using a dedicated microwave system. The solvent was removed under reduced 
pressure, and each reaction mixture was recrystallized in acetonitrile and 1M HCl yielding 
the symmetrical NDI derivative product. 
1
H NMR (300 MHz, 298 K, dmso-d6) δ = 13.12 (bs, H
a
, 2H), 8.64 (s, H
b
, 4H), 7.59-6.82 (m, 
H
c
, 8H), 5.81 (dd, H
d
, 2H, 3Jdf = 8.8HZ, 
3




Jef = 14.1 Hz), 3.23 
(dd, H
f
, 2H) ppm. 
13
C NMR (75.5 MHz, 298 K, dmso-d6) δ = 170.5 (NCO), 162.4 (COOH), 
138.1, 137.3, 131.8, 131.7, 126.5, 126.0, 92.65 (aromatic C within phenyl rings and 
naphthalene core), 54.7 (NCHdCOOH), 34.2 (NCCPh) ppm. HPLC (Method A) Rt = 8.1 





p-bromo-phenylalanine naphthalenediimide, [BrNDI], (5). 
 
 
For compound 5, 1,4,5,8-Naphthalenetetracarboxylic dianhydride (200 mg, 0.746 mmol) and 
the corresponding α-amino acid derivative (1.491 mmol) were suspended in 5 mL of DMF in 
a pressure-tight 20 mL microwave vial. To this suspension was added 0.2 mL of dry Et3N. 
The suspension was sonicated until the mixture became homogeneous. The reaction mixture 
was heated for 10 min at 140 °C (direct flask temperature measurement) under microwave 
irradiation using a dedicated microwave system. The solvent was removed under reduced 
pressure, and each reaction mixture was recrystallized in acetonitrile and 1M HCl yielding 
the symmetrical NDI derivative product 
1H NMR (500MHz, 298 K, dmso-d6) δ = 13.16 (bs, H
a
, 2H), 8.65 (s, H
b
, 4H), 7.51-6.95 (m, 
H
c
, 8H), 5.78 (dd, H
d
, 2H, 3JDF = 8.9HZ, 3Jde = 5.2Hz), 3.55 (dd, H
e
, 2H, 2Jef = 14.3Hz), 3.26 
(dd, H
f







), 131.5 (CBr), 138.5, 131.8, 126.6, 126.2 (aromatic C 
within phenyl rings and naphthalene core), 55.2 (NCH
d
COOH), 34.4 (NCCPh) ppm. HPLC 




p-iodo-phenylalanine naphthalenediimide, [INDI], (6). 
 
For compound 6, 1,4,5,8-Naphthalenetetracarboxylic dianhydride (200 mg, 0.746 mmol) and 
the corresponding α-amino acid derivative (1.491 mmol) were suspended in 5 mL of DMF in 
a pressure-tight 20 mL microwave vial. To this suspension was added 0.2 mL of dry Et3N. 
The suspension was sonicated until the mixture became homogeneous. The reaction mixture 
was heated for 10 min at 140 °C (direct flask temperature measurement) under microwave 
irradiation using a dedicated microwave system. The solvent was removed under reduced 
pressure, and each reaction mixture was recrystallized in acetonitrile and 1M HCl yielding 
the symmetrical NDI derivative product  
1
H NMR (300MHz, 298 K, dmso-d6) δ = 13.10 (bs, H
a
, 2H), 8.66 (s, H
b









Jdf = 9.3HZ, 
3




Jef = 14Hz), 3.30 
(dd, H
f
, 2H) ppm. 
13







), 137.5, 126.6, 126.1 (aromatic C within phenyl rings 
and naphthalene core), 54.9 (NCH
d
COOH), 34.1 (NCCPh) ppm. HPLC (Method A) Rt = 6.9 










p-chloro-phenylalanine naphthalenediimide -tagged hydroxysuccinimidyl 











NDI (Compound 5) and N-Hydroxysuccinimide were dissolved in DMF whilst stirring in an 
ice bath for 15 minutes. 6 eq. of EDC.HCl was dissolved in DMF and added to the solution of 
the NDI and NHS and allowed to stir for a further 15 minutes. The ice bath was subsequently 
removed and the solution was left to stir for a further 15 minutes. The ice bath was 
subsequently removed and the solution was left to stir at room temperature for a further 8 
hours. The solvent was removed under low pressure evaporation and the resulting product 
was dissolved in a small amount of acetonitrile. The solution was added to double distilled 
H2O under vigorous from which a precipitate formed. The precipitate was collected via 
filtration and a fine powder was formed by adding pentane to the precipitate followed by 
drying in vacuo. 
1
H NMR (500MHz, 298 K, dmso-d6) δ = 8.73 (s, HB, 4H), 7.58-7.02 (m, HC, 8H), 5.82 (m, 
HD, 2H, 
3
JDF = 8.8HZ, 
3
JDE = 5.7Hz), 3.68 (dd, HE, 2H, 
2
JEF = 14.1Hz), 3.34 (dd, HF, 2H), 
2.74 (bs, 8H, Hl) ppm. 
13
C NMR (500MHz, 298 K, dmso-d6) δ = 170.5 (NCO), 162.8 
(COOH), 131.8, 131.4, 128.6, 126.6 (aromatic C within phenyl rings and naphthalene core), 




Bombesin analogue peptide (7-13) (11) 
 
Synthesis of the G-Protein Coupled Receptor targeting peptide was performed using α-
fluorenylmethoxy carbonyl (Fmoc) protected amino acids onto rink amide resin (0.3 mmol/g) 
following protocols of Fmoc solid phase peptide synthesis. The resin was first swelled in 
DCM for 30 minutes. After swelling, the resin was initially deprotected by treatment with 20 
% piperidine in DMF for 3 cycles (12 minutes and 2 rounds of 3 minutes). After each cycle 
the reagent was removed and washed with DMF for 1 minute. Coupling of the first amino 
acid onto the resin was performed in the presence of 3 equivalents (0.9 mmols) excess Fmoc-
Leu-OH, 3 equivalents of HATU and 6 equivalents (1.8 mmols) of DIPEA in DMF. The 
mixture was added to the resin and left agitating for 45 minutes. After agitation the resin was 
dried via a manifold pump and suspended in DMF for 2 minutes for 3 repeated cycles. The 
resin was the dried again and the washing cycle repeated with DCM. The Kaiser test was 
performed to confirm the initial amino acid coupling step in order to test for the presence of 
free amines on the resin. To a small amount of the resin, a few drops on ninydrin, ethanol and 
KCN in pyridine was added. Gentle heating with a heat gun resulted in the resin beads 
turning a purple colour and confirmation of no free amines. The subsequent additions of 
amino acids in the sequence were performed via an automated peptide synthesiser. Coupling 
of each Fmoc-amino acid was performed with 3 equivalents of each Fmoc amino acid with 
25 % piperidine, 0.2 M PyBop and 0.4 M DIEA all performed in DMF. After synthesis, 
cleavage of the peptide from the resin performed by mixing a small amount of the resin with 
a cocktail of TFA/TIS/Water 95:2.5:2.5 in around bottom flask for 2 hours. The solution was 




ether was performed. The white powder was characterised via ESI/MS: m/z 809.45 [M+H]
+
 
and reverse phase HPLC (Method C) Rt = 6.8 minutes. 
 
NDI-OSu (2 mM, 5.5 mg) and Bombesin (4 mM, 9.7 mg) were dissolved in DMF. 2 
equivalence of triethylamine was added to the mixture. The solution was stirred under N2 for 
8 hours at room temperature. Solvent was removed and acetone added to the residue. The 
resulting solution was added in dropwise manner to a vigorously stirring volume of 1M HCl. 
The precipitate was collected by filtration and dried in vacuo. The product was characterised 
by a single peak in HPLC chromatography. Mass spectrometry calculated mass of compound 




revealed a peak at m/z ratio of 2277.55224 corresponding to the[ M+ACN+Na]
+
 ion of the 
product 
Synthesis of Graphene Oxide 
Graphene oxide was synthesised according to modified Hummers method. 5 g of flake 
graphite was added to 115 ml of conc. H2SO4 and 2.5 g of NaNO3 under stirring in an ice 
bath for 30 minutes. 15 g of KMnO4 was slowly added to the flake graphite suspension over 
the course of one hour. The dark brown suspension was stirred for an additional hour 
ensuring the temperature did not rise above 5 
O
C. The temperature was then raised to 45 
O
C 
and stirred for a further hour. 230 ml of distilled water was added and stirred for 30 minutes 
at 45 
O
C. The reaction was then terminated via the addition of 600 ml of distilled water and 
150 ml hydrogen peroxide (3%). The resulting brown/yellow suspension was centrifuged 
(3000 rpm, 5 minutes) and the supernatant decanted to leave wet solid GO. The GO was then 
put through repeated cycles of washing and centrifugation with distilled water to remove 
residual salts until the supernatant was clear. The resulting material was dried in vacuo to 
leave solid GO. 50 mg of GO was dispersed in a 2:1 mixture of ethanol and water and 
sonicated for 3 hours in 30 minute intervals with additional 5 minute resting periods to 
exfoliate the graphite oxide in order to pry apart sheets of GO. After sonication the GO 
suspension was centrifuged and the supernatant collected containing a stable dispersion of 
sheets of GO. Supernatant was deposited onto lacey carbon grids for TEM characterisation 
and left in a desiccator overnight prior to microscopy. 10 mg of GO powder was obtained by 
freeze drying the GO suspension overnight. GO powder was kept in a glove box fed with argon gas 
for two days to remove oxygen adsorbed on surface of solid GO. Solid GO was placed in a quartz 
tube (9 mm diameter) and immobilised with quartz wool at both sides. The sample was then put in the 
middle of quartz tubes in a furnace. The sample was kept under argon for 30 min. The furnace was 
gradually heated to 900°C (15 °C min
-1
). GO powder was then thermally exfoliated and reduced in a 
tubular furnace under N2 flow (300 mL min
−1
). After 2 h thermal treatment, the furnace was switched 









2 mM concentration of coronene  was dispersed in  CHCl3, THF and  DMSO via  
ultrasonication (50/60 Hz) and mild heat treatment. To this  dispersion, a 1mM 
concentration of NDI compounds 2, 3 4, 5 and 6 of NDI were added as a solid. The 
mixture was then sonicated for another 5 min and left stirring overnight. Then, the 
solution was filtered through a 0.22 µm PTFE membrane and the deposited solid was 
redispersed in the desired solvent.  
 
NDI-Thermally Reduced Graphene Oxide Complexation 
10 mg quantity of TRGO  was dispersed in  CHCl3, THF and  DMSO via  ultrasonication 
(50/60 Hz). To this  dispersion, a 10 mM concentration of NDI compounds 2, 3 4, 5 and 6 
of NDI were added as a solid. The mixture was further sonicated for 6 rounds of ten 
minutes min and left stirring overnight. Then, the solution was filtered through a 0.22 µm 
















7.3 General Procedural Methods 
Determination of Molar Extinction Coefficient & Solvatochromic Self-Assembly Studies 
(εmax) by UV/Vis 
Suspensions of (3), (4), (5) and (6) in chloroform, acetonitrile, DMSO, THF and NMP were 
prepared at a range of concentrations (0.05, 0.04, 0.03, 0.02, 0.01, 0.005 mM). The 
absorption spectra of these suspensions were then obtained using a Perkin-Elmer 
Spectrometer, Lambda 35. The maximum absorption of these suspensions at 370 nm was 
then plotted against concentration and the Molar Extinction Coefficient calculated using the 
equation A = εcl, where l is equal to path length 0.01 m.  
 
Determination of Relative Quantum Yield 


















Whereby 𝜑 is the quantum yield, 𝐷 is the integrated area of the emission band, 𝐴 is the 
absorption of the solution at the excitation wavelength, 𝐼 is the maximum intensity at the 
excitation band and η is the refractive index of the solvent. S and R correspond to the sample 
and reference respectively ([Ru(bipy)3]Cl2 in water). 
 
Cyclic Voltammetry and estimation of LUMO levels 
The NDIs were dissolved in a 0.1 molar solution of Tetrabutylammonium 
hexafluorophosphate (TBAPF6) in THF to produce a 5 mmol NDI concentration. To these 
solutions were added equimolar concentrations of ferrocene to act as the standard. Samples 
were purged with Argon before measurements. Experiments were conducted at a range of 
scan rates between 100 mV s
-1
 and 10 mV s
-1
. A standard 3 electrode system comprising a 
platinum working electrode, a Ag/AgCl (in solution of KCl) reference electrode and platinum 
wire counter electode and the ferrocene/ferrocenium (Fc/Fc
+
) redox couple as the internal 
standard was used. The LUMO energy levels of the six NDI species were determined using 




𝑬(𝑳𝑼𝑴𝑶) = [(𝑬𝒓𝒆𝒅 −  𝑬𝟏
𝟐  𝒇𝒆𝒓𝒓𝒐𝒄𝒆𝒏𝒆 
) + 𝟒. 𝟖] 
Where Ered is the voltage at onset of reduction and E1/2 ferrocene is the half potential of the 
ferrocene redox couple. 
 
Fluorescence Titrations with coronene and TRGO 
A 10 mM solution of NDI was prepared. To this solution was added a saturating quantity of 
coronene. The resulting saturated solutions were then sonicated for 30 minutes and 
subsequently filtered through a PTFE membrane. The excess coronene was allowed to settle. 
The resulting supernatant solution was decanted and filtered through a PTFE membrane and 
titrated against another 10 mM solution of NDI in THF. Experiments were conducted using a 
Perkin-Elmer LS55 luminescence spectrophotometer. Excitation wavelength was set at 380 
nm for all experiments. Emission range 420-700 nm was scanned at 300 nm min-1 for all 
experiments. Titrations were conducted in a 1.5 mL cuvette. Solutions containing NDI at 10 
mM concentration in THF were added to the cuvette and the emission spectrum scanned. 
Subsequent scans were conducted with 0.2 mL titres removed from cuvette and replaced with 
0.2 mL titres of 10 mM NDI solution saturated with coronene in order to maintain constant 
NDI concentration throughout the experiments. Fluorescence titrations with TRGO were 
prepared by the same method mentioned above. TRGO suspensions were sonicated in 6 half 
hour batches to promote layer separation of the TRGO. To this suspension a 10 mM quantity 
of NDI was added and the resulting suspension subjected to a further 6 rounds of 30 minute 
sonication to promote layer separation for enhanced complexation. The excess TRGO was 
then allowed to settle and the supernatant was decanted and filtered. 
 
Preparation of samples for TCSPC Experiments 
Samples for TCSPC experiments were prepared by the same method as those for 
fluorescence titration experiments differing only in that NDI concentration was at 50 μM. A 
10 mM solution of NDI was prepared. To this solution was added a saturating quantity of 
coronene. The resulting saturated suspensions were then sonicated until the mixtures became 
homogeneous (6 rounds of 30 mintues). The coronene was allowed to settle and the 
supernatant was filtered through a PTFE membrane. The concentration of the resulting 




Samples for TCSPC experiments with TRGO were prepared by the same method as those for 
the coronene experiments differing only in the degree of sonication time. A 1.0 mg quantity 
of TRGO was added to 2 ml of solvent and sonicated for 6 rounds of 3 minutes to promote 
layer separation To this suspension a 10 mM quantity of NDI was added and the solution 
sonicated for further 6 rounds of 30 minutes. Non-complexed TRGO was allowed to settle 
and the supernatant was filtered through a PTFE membrane. The concentration of the 
resulting complex was then diluted down to 50 μM with respect to the NDI concentration. 
 
Job’s Plot Analysis 
In order to determinate the binding stoichiometry of the X-NDI-C24H12 complexes, Job plots 
studies were obtained by running standard 
1
H NMR pulse sequences of X-NDI-C24H12 
solutions. Stock solution of X-NDI and C24H12 (2.21*10
-3
 M) were prepared separately in a 
mixture of THF-d8 and toluene- d8 (1:9). Coronene solution was gradually added (200µL) into 
a 4mL NMR tube containing an X-NDI solution so that the total concentration of {[X-NDI] + 
[C24H12]} for each NMR experiment was kept constant. The resonance of naphthyl protons 
was upshifted as the mole fraction of C24H12 was progressively increased resulting in a Δδ. 
Job plots were obtained plotting y = Δδ*{[C24H12]/[X-NDI] + [C24H12]} against x = {[C24H12] 
/[X-NDI]+[C24H12 
 
NMR titration experiments were carried by running standard 
1
H NMR pulse sequences of 
X-NDI-C24H12 solutions. Stock solution of X-NDI and C24H12 (2.21*10
-3
 M) were prepared 
separately in a mixture of THF-d8 and toluene- d8 (1:9). One solution contained the NDI 
compounds whilst the other contained the same NDI concentration with an additional 3 
equivalence. 0.1 equivalence of the independent NDI solution was removed from the nmr 
tube and replaced with 0.1 equivalenceof the NDI solution containing the complexed species. 
Proton NMR spectra were recorded over 16 accumulation scans and the shifting of NMR 
resonances were plotted as a function of complexing agent concentration. The data sets were 
then fitted to 1:1, 1:2 and 2:1 binding isotherms in Matlab mfiles using binding isotherm 
equations outlined by Pall Thordarson.  
Raman spectroscopy was performed using Renishaw inVia Raman Microscope using an 




Samples were placed on clean aluminium or glass substrates. Powder XRD spectra were 
acquired using BRUKER D8-Advance (Cu radiation). 
 
TEM images were acquired on a Jeol 1200EXII TEM (with EDS). Samples were prepared by 
aliquoting small quantities of graphene derivative after sonication in their respective solvents 
onto copper or lacey carbon grids and placed in a desiccator for vacuum drying for a 
minimum of 24 hours. 
 
Electrochemical Impedance Spectroscopy (EIS) Gold macroelectrode were used for the 
measurements. For the SAM formation, an amine-terminated linker molecule, namely 11-
amino-1-undecanethiol hydrochloride (AUT), was used instead of the usual carboxyl-
terminated alkanethiols. This strategy allowed the immobilisation of the peptide in the 
orientation that guarantees the cellular recognition i.e. the carboxyl termination of the peptide 
binds the SAM while the amine-side termination is left free and exposed for the recognition 
of the cellular membrane. 
Electrodes were incubated overnight in a solution of AUT/MCH in a ratio 1:200 followed by 
a further 1 hour backfilling step using a solution of 1 mM MCH. In order to confer better 
antifouling properties to the SAM, poly(ethylene glycol) 2-aminoethyl ether acetic acid 
(amine-PEG-carboxylic acid) was also used as an intermediate compound between the 
formed structure and the BBN. An incubation step using a mixture of amine-PEG-carboxylic 
acid and sulfo-EDC elongated the SAM by n-chains of PEG molecules keeping the amine 
termination exposed for further immobilisation steps. By using this strategy the carboxylic 
acid of amine-PEG-carboxylic acid is involved in binding the amine termination of AUT 
whilst the final structure still presents a free amine termination for successive immobilisation 
steps. 
In order to prevent an excessive PEG-ylation a short incubation time (10 minutes) was used, 
followed by stabilisation in measurement solution. An ideal condition consists in having a 
certain n-number of PEGs that ensure BBN to be internalised by the GRP receptors of the 





The BBN immobilisation was successively performed incubating the electrodes with a 
mixture of 35 μM BBN and 80 mM sulfo-EDC in aqueous solution for 20 minutes. The 
electrodes were then rinsed and left in measurement solution for 1 hour before the first set of 
EIS measurements. The cells used for the binding assay were suspended in PBS 0.1 mM with 
addition of 0.05 % of Tween20 that helped to reduce the non-specific interaction with the 
















Section A. Xray analysis of p-fluoro-phenylalanine-naphthalenediimide 
 
Table S1. Crystal and structure refinement data for 3.CHCl3 and 3.C6F6 
 3.CHCl3 3.C6F6 
Empirical formula C33 H21 Cl3 F2 N2 O8 C38 H20 F8 N2 O8 
Formula weight 717.87 784.56 
Crystal system Orthorhombic Triclinic 
Space group P212121 P1 
a/Å 7.17710(10) 7.6897(6) 
b/Å 11.6947(2) 10.3258(8) 
c/Å 37.2778(7) 11.4856(14) 





β/º 90 95.8680(10) 
γ/º 90 106.0120(10) 
Volume/ Å
3
 3128.88(9) 799.34(13) 
Z 4 1 
Density (calculated)/ Mg/m
3
 1.524 1.630 
Absorption coefficient mm
-1
 3.257 0.145 
F(000) 1464 398 
GOF 1.053 1.046 
Reflections collected 21909 8900 
Independent reflections 6078  
[R(int) = 0.0444] 
8059 
[R(int) = 0.0148] 
Final R indices [I>2sigma(I)] R1 = 0.0442 
wR2 = 0.1131 
R1 = 0.0449 
wR2 = 0.1192 
Largest diff. peak and hole/ e.Å
-3







Table S2. Selected bond distances (Å) and angles (º) for 3.CHCl3 and 3.C6F6 
 3.CHCl3 3.C6F6  3.CHCl3 3.C6F6 
F(1)-C(1) 1.357(5) 1.354(3) F(2)-C(30) 1.359(5) 1.355(3) 
N(1)-C(21) 1.395(5) 1.403(3) N(2)-C(16) 1.406(5) 1.405(3) 
N(1)-C(10) 1.404(4) 1.401(3) N(2)-C(15) 1.400(5) 1.396(3) 
N(1)-C(8) 1.467(4) 1.465(3) N(2)-C(24) 1.469(4) 1.480(3) 
O(1)-C(9) 1.286(4) 1.261(3) O(8)-C(25) 1.283(4) 1.257(3) 
O(2)-C(9) 1.237(5) 1.267(3) O(7)-C(25) 1.247(5) 1.273(3) 
C(8)-C(9) 1.512(5) 1.515(3) C(24)-C(25) 1.504(5) 1.512(3) 




O(4)-C(21) 1.221(5) 1.219(3) O(6)-C(16) 1.204(5) 1.211(3) 
C(10)-C(11) 1.483(5) 1.494(3) C(14)-C(15) 1.481(5) 1.493(3) 
C(11)-C(22) 1.405(5) 1.414(3) C(14)-C(23) 1.412(5) 1.408(3) 
C(20)-C(22) 1.407(5) 1.406(3) C(17)-C(23) 1.402(5) 1.408(3) 
C(20)-C(21) 1.479(5) 1.476(3) C(16)-C(17) 1.486(5) 1.479(3) 
C(11)-C(12) 1.387(5) 1.373(4) C(12)-C(13) 1.399(5) 1.416(4) 
C(13)-C(14) 1.373(5) 1.381(3) C(17)-C(18) 1.383(5) 1.377(3) 
C(18)-C(19) 1.402(5) 1.402(4) C(19)-C(20) 1.375(5) 1.380(3) 
C(22)-C(23) 1.414(5) 1.415(3)    
N(1)-C(8)-C(9) 110.1(3) 112.9(2) N(2)-C(24)-C(25) 109.3(3) 111.4(2) 
N(1)-C(8)-C(7) 116.0(3) 117.0(2) N(2)-C(24)-C(26) 113.2(3) 113.2(2) 
C(9)-C(8)-C(7) 113.9(3) 111.0(2) C(25)-C(24)-C(26) 114.3(3) 113.4(2) 
C(21)-N(1)-C(10) 123.9(3) 123.6(2) C(15)-N(2)-C(16) 125.7(3) 124.9(2) 
C(21)-N(1)-C(8) 114.7(3) 113.3(2) C(15)-N(2)-C(24) 117.1(3) 118.0(2) 
C(10)-N(1)-C(8) 120.2(3) 122.7(2) C(16)-N(2)-C(24) 117.1(3) 117.0(2) 
O(3)-C(10)-N(1) 121.4(3) 121.5(2) O(5)-C(15)-N(2) 120.2(3) 120.2(2) 
O(3)-C(10)-C(11) 122.8(3) 122.5(2) O(5)-C(15)-C(14) 122.8(3) 123.0(2) 
N(1)-C(10)-C(11) 115.7(3) 116.0(2) N(2)-C(15)-C(14) 116.9(3) 116.7(2) 
O(4)-C(21)-N(1) 120.7(3) 119.9(2) O(6)-C(16)-N(2) 120.9(3) 121.1(2) 
O(4)-C(21)-C(20) 121.4(3) 122.6(2) O(6)-C(16)-C(17) 123.3(3) 122.4(2) 
N(1)-C(21)-C(20) 118.0(3) 117.4(2) N(2)-C(16)-C(17) 115.8(3) 116.5(2) 
 
 
Table S3. Hydrogen bonds (Å,°) for 3.CHCl3 and 3.C6F6 






 O(1)-H(1)...O(7)#1 0.90(3) 1.74(5) 2.586(4) 155(10) 







O(2)-H(2A)...O(8)#1 0.90(3) 1.74(3) 2.609(3) 164(8) 
O(7)-H(7C)...O(1)#2 0.91(3) 1.72(4) 2.584(3) 158(7) 
Symmetry transformations used to generate equivalent atoms:  
3.CHCl3  #1 x+1,y+1,z    #2 x-1,y-1,z        




Section B. Cyclic Voltammetry 
Figure S1 Cyclic voltammogram of F NDI (3) in THF (with ferrocene as an internal 
standard) at 35 mv/s scan rate. Inset shows peak cathodic and anodic currents dependence 
with square root of scan rate. 
 
Figure S2. Figure: Cyclic voltammogram of Cl NDI (4) in THF (with ferrocene as an internal 
standard) at 35 mv/s scan rate. Inset shows peak cathodic and anodic currents dependence 
with square root of scan rate 


















































































Figure S3: Cyclic voltammogram of Br NDI (5) in THF (with ferrocene as an internal standard) at 35 













Figure S4: Cyclic voltammogram of INDI (6) in THF (with ferrocene as an internal standard) at 35 
mv/s scan rate. Inset shows peak cathodic and anodic currents dependence with square root of scan 
rate. 
















































































Section C. NMR Characterisation 






H NMR (500MHz, 298 K, dmso-d6) δ = 13.00 (bs, 2H, Ha); 10.62 (s, 2H, Hb), 8.60 (s, 
4H,Hc); 7.48 (d, 2H, Hd, 3JHdHi = 7.83 Hz); 7.20 (d, 2H, He, 3JHehk = 7.94 Hz); 7.06 (s, 
1H, Hf);7.05 (s, 1H, Hg); 6.94 (pt, 2H, Hh ,3JHhHi = 6.93 Hz); 6.80 (pt, 2H, Hi); 5.87 (dd, 
2H, Hj , 3JHjHk= 5.5Hz, 3JHjHl = 8.9 Hz); 3.70 (dd, 2H, Hk, 3JHkHl = 14.9 Hz); 3.50 ppm 
(dd, 2H, Hl).
13
C NMR(125MHz, 298 K, dmso-d6) δ = 171.0 (COOH); 136.4 (NCO), 
131.5(CHc); 127.7 (124.1 (CHf,CHg); 127.4 (CHdCNHb); 126.4 (CHeCCCHkHl); 121.2 


























H NMR (500MHz, 298 K, dmso-d6) δ = 13.10 (bs, HA, 2H), 8.66 (s, HB, 4H), 7.33-7.04 (m, 
HC, 8H), 5.84 (dd, HD, 2H, 
3
JDF = 9.33HZ, 
3
JDE = 5.5Hz), 3.59 (dd, HE, 2H, 
2
JEF = 14Hz), 
3.30 (dd, HF, 2H) ppm. 
13
C NMR (500MHz, 298 K, dmso-d6) δ = 170.5 (NCO), 162.8 
(COOH), 131.8, 131.4, 128.6, 126.6 (aromatic C within phenyl rings and naphthalene core), 




















H NMR (300MHz, 298 K, dmso-d6) δ = 13.10 (bs, H
a
, 2H), 8.63 (s, H
b
, 4H), 7.21-6.88 (m, 
H
c




Jdf = 9.9HZ, 
3




Jef = 14.4Hz), 3.30 
(dd, H
f
, 2H) ppm. 
13
C NMR (125MHz, 298 K, dmso-d6) δ = 170.5 (NCO), 162.4 (COOH), 
131.7, 131.3, 131.2, 126.4, 126.0 (aromatic C within phenyl rings and naphthalene core), 54.9 
(NCH
d
COOH), 33.8 (NCCPh) ppm. 
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H NMR (300 MHz, 298 K, dmso-d6) δ = 13.12 (bs, H
a
, 2H), 8.64 (s, H
b
, 4H), 7.59-6.82 (m, 
H
c
, 8H), 5.81 (dd, H
d
, 2H, 3Jdf = 8.8HZ, 
3




Jef = 14.1 Hz), 3.23 
(dd, H
f
, 2H) ppm. 
13
C NMR (75.5 MHz, 298 K, dmso-d6) δ = 170.5 (NCO), 162.4 (COOH), 
138.1, 137.3, 131.8, 131.7, 126.5, 126.0, 92.65 (aromatic C within phenyl rings and 













1H NMR (500MHz, 298 K, dmso-d6) δ = 13.16 (bs, H
a
, 2H), 8.65 (s, H
b
, 4H), 7.51-6.95 (m, 
H
c
, 8H), 5.78 (dd, H
d
, 2H, 3JDF = 8.9HZ, 3Jde = 5.2Hz), 3.55 (dd, H
e
, 2H, 2Jef = 14.3Hz), 3.26 
(dd, H
f







), 131.5 (CBr), 138.5, 131.8, 126.6, 126.2 (aromatic C 
within phenyl rings and naphthalene core), 55.2 (NCH
d













H NMR (300MHz, 298 K, dmso-d6) δ = 13.10 (bs, H
a
, 2H), 8.66 (s, H
b









Jdf = 9.3HZ, 
3




Jef = 14Hz), 
3.30 (dd, H
f
, 2H) ppm. 
13







), 137.5, 126.6, 126.1 (aromatic C within 
phenyl rings and naphthalene core), 54.9 (NCH
d





























































































C NMR of p-fluoro-phenylalanine naphthalenediimide, [FNDI], (3). § refer to 
















Figure S9.  
1


















































C NMR of p-iodo-phenylalanine naphthalenediimide, [INDI], (6). § referes to 








H COSY NMR of p-iodo-phenylalanine naphthalenediimide, [INDI], (6). Cross 

















C HMQC NMR of p-iodo-phenylalanine naphthalenediimide, [INDI], (6). 
Cross peaks show the structural correlation between phenylalanine, α and β protons with their 
























H COSY NMR of p-chloro-phenylalanine naphthalenediimide. Cross peaks 
show the structural correlation between phenylalanine resonances and α and β protons 










H NOESY NMR in DMSO of compound 2 showing no spatial cross-









4.1 Fitting of 1:1 NDI : coronene binding module  
 
 
Figure S18. Solid markers show the up-field and low-field shifting of the naphthalene protons 
(positive progression) and β protons (negative progression) chemical shift. Blue and red lines show 





4.2 Fitting of 2:1 NDI : coronene binding module  
 
 
Figure S19. Solid markers show the up-field and low-field shifting of the naphthalene protons 
(positive progression) and β protons (negative progression) chemical shift. Blue and red lines show 





Section D. UV-Vis spectroscopy 
 
Figure S20. Concentration dependant UV/Vis spectra of (3) in THF. Inset shows variation in ε λmax 
with respect to concentration. 
Figure S21. Concentration dependant UV/Vis spectra of (4) in THF. Inset shows variation in ε λmax 
with respect to concentration. 
































































Figure S22. Concentration dependant UV/Vis spectra of (5) in THF. Inset shows variation in ε λmax 
with respect to concentration. 
 
 
Figure S23. Concentration dependant UV/Vis spectra of (6) in THF. Inset shows variation in ε λmax 
with respect to concentration. 





































































Section  E. Fluorescence Titrations 
 
 
Figure S24. Fluorescence titration of Coronene (3000 μM) in (3) (10 mM) in 1:1 mixture of Toluene 
and THF at 380 nm excitation. 
 
Figure S25. Fluorescence titration of Coronene (3000 μM) in (4) (10 mM) in 1:1 mixture of Toluene 






Figure S26. Fluorescence titration of Coronene (3000 μM) in (5) (10 mM) in 1:1 mixture of Toluene 
and THF at 380 nm excitation. 
 
Figure S27. Fluorescence titration of Coronene (3000 μM) in (6) (10 mM) in 1:1 mixture of Toluene 





Figure S28. Fluorescence titration of TRGO in (3) (10 mM) in 1:1 mixture of Toluene and THF at 
380 nm excitation. 
 
Figure S29. Fluorescence titration of TRGO in (4) (10 mM) in 1:1 mixture of Toluene and THF at 





Figure S30. Fluorescence titration of TRGO in (5) (10 mM) in 1:1 mixture of Toluene and THF at 
380 nm excitation 
 
Figure S31. Fluorescence titration of TRGO in (6) (10 mM) in 1:1 mixture of Toluene and THF at 




Section F. Time Correlated Single Photon Counting (TCSPC) 
 
 
Figure S32. Fluorescence lifetime decay traces of (3) (red), (3) + Coronene complex (blue) and (3) + 
TRGO complex (green) in THF. 
 
Figure S33. Fluorescence lifetime decay traces of (4) (red), (4) + Coronene complex (blue) and (4) 





Figure S34. Fluorescence lifetime decay traces of (5) (red), (5) + Coronene complex (blue) and (5) + 
TRGO complex (green) in THF. 
 
Figure S35. Fluorescence lifetime decay traces of (6) (red), (6) + Coronene complex (blue) and (6) + 






Section G. HPLCs 
 
 
Figure S36. HPLC traces for NDI compounds 1, 2 and 3 showing retention times of 





























Figure S37. HPLC traces for NDI compounds 4, 5 and 6 showing retention times of 






























Figure S38. HPLC traces for NDI compounds 7, 8 and 9 showing retention times of 








Figure S39. HPLC traces for NDI compounds 10, 13 and 14 showing retention times of 





Section H. Circular Dichroism 
 
Figure S40. CD spectrum of compound 4 in CHCl3 before and after the addition of 20μL of 












Figure S41. CD spectrum of compound 5 in CHCl3 before and after the addition of 20μL of 
THF.. 
 



























































Figure S42. Two-photon fluorescence lifetime map in PC-3 cells of control (DMSO-top) 
compound 6 (middle) and associated distribution curve (bottom left) and lifetime decay 
profile (bottom right) at 100 μM after 810 nm laser irradiation. 
 










































Section J. Confocal Microscopy 
 
 
Figure S43. 3-dimentional render of confocal fluorescence Z-stack series of images for 3 (a), 
3-coronene (b) and 3-TRGO (c) after 15 minutes of incubation in PC-3 cells at 37 °C (50 μM, 
in 5 : 95 DMSO : serum free medium) obtained by overlapping blue green and red channels. 
blue channel (417-477 nm), green channel (500-550 nm), red channel (570-1000 nm). λex = 






Figure S44. Epi-fluorescence acquisition of PC-3 cells incubated for 15 minutes with 
compound 4 (a-d), 4-coronene (e-i), 4-TRGO (j-n). Final concentrations 50μM in 5 : 95 
DMSO : serum free medium at 37°C: DIC channel  (a, e and j); overlay of DIC-blue-green-
red channels (b, f, and k); blue channel, λem = 460 nm (c, g and l);  green channel, λem = 525 
nm (h and m); red channel λem = 629.5 nm (d, i and n). Scalebar: 50μm  
 
Figure S45. Single-photon laser-scanning confocal microscopy of PC-3 cells incubated at 
37°C for 15 minutes with 4 (50μM, in 5 : 95 DMSO : serum free medium). a) blue channel 
(417-477 nm). b) green channel (500-550 nm). c) red channel (570-1000 nm). d) overlay of 
the blue-green-red channels. λex = 405.0, 588.0 561.0 nm. e) 3-dimentional render of confocal 





Figure S46. Single-photon laser-scanning confocal microscopy of PC-3 cells incubated at 
37°C for 15 minutes with 4-coronene (50μM, in 5 : 95 DMSO : serum free medium). a) blue 
channel (417-477 nm). b) green channel (500-550 nm). c) red channel (570-1000 nm). d) 
overlay of the blue-green-red channels. λex = 405.0, 588.0 561.0 nm. e) 3-dimentional render 
of confocal fluorescence Z-stack series of images for 4-coronene. Scalebar: 50μm 
 
Figure S47. Single-photon laser-scanning confocal microscopy of PC-3 cells incubated at 
37°C for 15 minutes with 4-TRGO (50μM, in 5 : 95 DMSO : serum free medium). a) blue 
channel (417-477 nm). b) green channel (500-550 nm). c) red channel (570-1000 nm). d) 
overlay of the blue-green-red channels. λex = 405.0, 588.0 561.0 nm. e) 3-dimentional render 





Figure S48. Epi-fluorescence acquisition of PC-3 cells incubated for 15 minutes with 
compound 5 (a-e), 4-coronene (f-j), 4-TRGO (k-o). Final concentrations 50μM in 5 : 95 
DMSO : serum free medium at 37°C: DIC channel  (a, f and k); overlay of DIC-blue-green-
red channels (b, g, and l); blue channel, λem = 460 nm (c, h and m);  green channel, λem = 525 
nm (d, i and n); red channel λem = 629.5 nm (e, j and o). Scalebar: 50μm  
 
Figure S49. Single-photon laser-scanning confocal microscopy of PC-3 cells incubated at 
37°C for 15 minutes with 5 (50μM, in 5 : 95 DMSO : serum free medium). a) blue channel 
(417-477 nm). b) green channel (500-550 nm). c) red channel (570-1000 nm). d) overlay of 
the blue-green-red channels. λex = 405.0, 588.0 561.0 nm. e) 3-dimentional render of confocal 





Figure S50. Single-photon laser-scanning confocal microscopy of PC-3 cells incubated at 
37°C for 15 minutes with 5-coronene (50μM, in 5 : 95 DMSO : serum free medium). a) blue 
channel (417-477 nm). b) green channel (500-550 nm). c) red channel (570-1000 nm). d) 
overlay of the blue-green-red channels. λex = 405.0, 588.0 561.0 nm. e) 3-dimentional render 

















Section K.  TEM &SEM of TRGO and NDIs composites 
 
 


















In proportion to the size of the graphene sheets and the associated quantity of carbon and 
residual oxygen atoms after thermal reduction, we would expect it to be difficult to observe 
the presence of halogen atoms via elemental analysis as they would make up a very low 
percentage of the elemental bulk. Never the less Energy Dispersive X-ray Analysis (EDX) 
analysis was carried and halogen atoms could be identified. 
Energy Dispersive X-ray analysis 
 
Figure S55. EDX spectrum of 3 and thermally reduced graphene oxide composites. 
 



















Microscopy characterization of coronene and NDIs composites. 
 
 
Figure 59 TEM micrograph of red cristalline powder of 3 complexed with coronene. 3 (pale 
yellow powder) and coronene (yellow microcristalline needles) were dissolved in N-
methylpyrrolidone (NMP). By using a NMP-water liquid-liquid diffusion method a red 
powder was obtained. The solid was then resolubilised in  NMP and recrystallised by slow 






Figure S60 TEM micrograph of red cristalline powder of 3 complexed with coronene (scale 
bar 50 m). 
 
 





Microscopy characterization of p-fluoro-D-phenylalanine naphthalenediimide, 3.  
 
 
Figure S62. SEM micrograph of crystalline 3. In aggrement with the Xray structure of p-
fluoro-D- phenylalanine naphthalenediimide, the pictures shows a laminar morphology. 
 
 




























Figure S64. Fluorescence contour plots of free NDI-top (compound 6), coronene complex 







Section L. Additional Mass Spectrometry 
 












Figure S66. Mass spectrometry calculated mass of compound 13 was calculated to be 
2213.87929 and MALDI-TOF performed at the University of Oxford revealed a peak at m/z 
ratio of 2277.55224 corresponding to the[ M+ACN+Na]
+






Figure S67 IC50 of L- and D-NDI compounds in PC-3 cells over 48 h incubation at 37 °C. L-
phenylalanines: (L-H) NDI IC50 = 3.38 × 10
−4
 M ± 1.58 × 10
−5
 M; (L-F) IC50 = 1.10 × 10
−4
 M 
± 5.07 × 10−5 M; (L-Cl) IC50 = 2.22 × 10
−4
 ± 3.73 × 10
−5
 M; (L-Br) IC50 = 2.98 × 10
-4
 M ± 
7.92 × 10
−6
 M; (L-I) IC50 = 2.99 × 10
−4
 M ± 4.93 × 10
−5
 M; D-phenylalanines (D-H) NDI 
IC50 = 3.47 × 10
−4
 M ± 5.66 × 10
−5
 M; (D-F) IC50 = 4.65 × 10
−4
 M ± 7.46 × 10
−5
 M; (D-Cl) 
IC50 = 0.40 ± 3.86 × 10
−4
 M; (D-Br) IC50 = 6.24 × 10
−3
 M ± 5.40 × 10
−5
 M, (D-I) IC50 = 7.78 
× 10
−5
 M ± 7.05 × 10
−6
 M. 
